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SUMMARY
The pattern of transcription initiation for the human 
c-Ha-rasl gene has been investigated using several 
experimental methods. These analyses demonstrated multiple 
clusters of transcription initiation sites distributed over 
an approximately 2 00 bp non-coding, upstream exon (termed 
exon -1), which is separated from the ATG codon by an 1040 
bp intron. Mutational analysis of the promoter region 
identified a short positive regulatory element, located 
between positions -243 to -196, relative to the donor 
splice site of exon -1. This element contains known 
regulatory sequence motifs. Furthermore, a putative 
negative regulatory element, with an unusual DNA sequence, 
was identified between positions -103 to -34, relative to 
the same donor splice site. It has also been demonstrated 
that the human c-Ha-rasl promoter region can function
bidirectionally. The sequence directing the
"reverse-orientation" promoter activity was located to 
between positions, -392 to -196, relative to the exon -1 
donor splice site of the c-Ha-rasl gene. Transcription of 
the c-Ha-rasl gene was shown to be increased approximately 
2 0 fold when covalently linked to the SV4 0 enhancer
element. This result is the first direct demonstration that 
the SV40 enhancer can increase transcription of 
"housekeeping-type" genes and this result also has 
important implications for the possible methods of 
oncogenic activation of this gene. The 1040 bp intron 
located between exon -1 and the first coding exon (exon 1) 
was found to contain sequences within its 5 1 end, which
were moderately repetitive within the human and mouse 
genomes, and homologous to abundantly transcribed, 
non-polyadenylated RNAs from various human cell lines. 
However, the functional significance, if any, of this
result is unclear.
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INTRODUCTION
The human cellular Harvey ras oncogene (c-Ha-rasl) is 
a gene believed to be important in the process of 
oncogenesis (reviewed in Cooper, 1982; Weinberg, 1985; 
Bishop, 1985 and Levinson, 1986). An important question is 
whether the function of the c-Ha-rasl encoded protein is so 
vital to the cell, that quantitative differences in its 
level of expression could lead to carcinogenesis? 
Therefore, this thesis will be introduced in two main 
sections, (I) the involvement of the ras genes in 
oncogenesis and (II) some aspects of gene regulation 
relevant to the expression of ras genes. In the first of 
these sections the ras gene family will be described, with 
particular emphasis on the so called "classical" ras genes, 
Harvey (Ha)-, Kirsten (Ki)- and N- ras. Some details of the 
expression pattern of the ras genes during malignancy, 
development and the cell cycle will then be discussed and 
finally, some recent speculations on the possible functions 
of the ras genes will also be discussed. In section II, 
some aspects of transcriptional regulation will be 
considered. To conclude this section distinct features of 
promoter regions for "housekeeping" genes, which parallel 
those of the ras genes, will be briefly discussed.
I. THE RAS GENES AND ONCOGENESIS
The first real progress towards identifying some of 
the genes which, under certain circumstances, may be 
implicated in the development of malignancy, came from the 
study of tumour inducing viruses, particularly the 
retroviruses. As early as 1910, Peyton Rous showed that a 
cell-free filtrate from chicken sarcomas could induce new 
sarcomas in chickens, but it was not until decades later 
that a retrovirus, now called Rous sarcoma virus (RSV), was 
identified as the sarcoma inducing agent. Later, a 
RSV—encoded gene was identified as the tumour inducing
agent within the virus and was called the src (for sarcoma) 
oncogene. This oncogene was the first of many to be 
discovered and to date at least 4 0 distinct oncogenes have 
been identified (reviewed by Bishop, 1985; Weinberg, 1985). 
However, it is now clear that although most of these
oncogenes were first identified in tumour viruses, most are 
not endogenous to these viruses but are also present in 
normal cells, where they apparently function in normal 
cellular processes. To distinguish between the oncogenic
versions of these genes and their normal cellular
counterparts, the latter are termed proto-oncogenes. It is 
now known that the proto-oncogenes can be converted into 
oncogenes by various mechanisms which can be broadly
grouped into two categories, quantitative and qualitative. 
Quantitative conversion results from abnormal levels of 
expression of the "normal" gene product, whereas 
qualitative conversion results from mutation of the
proto-oncogene to produce an aberrantly acting,
qualitatively different gene product. Since elevated
transcription of the ras proto-oncogenes has recently been 
shown to be a mechanism whereby they are converted into 
oncogenes (see section I.c), a detailed understanding of
the transcriptional regulation of these genes is now 
especially important.
(a) The ras genes: a family of highly conserved genes
In the genomes of all eukaryotes examined, at least 
one member of the ras multigene family has been detected. 
Organisms as diverse as the yeasts, Saccharomcyes
cerevisiae and Schizosaccharomyces pombe (DeFeo-Jones et 
al., 1983; Powers et al., 1984; Fukui and Kaziro, 1985, 
Nadine-Davis et al., 1986), the slime mould, Dictyostelium 
discoideum (Reymond et al., 1984), the sea slug, Aplysia 
(Madaule and Axel, 1985) and the fruit fly, Drosophila 
melanogaster, (Neuman-Silberburg et al., 1984; Moser et 
al., 1985; Schejter and Shilo, 1985), all have genes
'•Vrelated to the more intensely studied ras genes of 
mammalian genomes. A detailed description of these 
intensively studied mammalian ras genes, sometimes referred 
to as the "classical" ras genes and which include the
Harvey (Ha), Kirsten (Ki) and N-ras genes, will be 
presented in the next section.
Recently, other more distantly related members of the 
ras multigene family have been identified in mammalian 
genomes. Lowe et al. (1987) have reported a novel ras gene 
in human and murine cells which they have termed R-ras. The 
amino-acid sequence of the human R-ras gene product was
found to be 55% homologous with that of the classical 
Ha-ras encoded protein. However, the R-ras sequence 
contains an amino-terminal extension of 2 6 residues, has an 
entirely different exon-intron structure and resides on a 
different chromosome to the "classical" ras genes. The 
Aplysia ras gene, which Madaule and Axel (1985) have called 
rho, shares approximately 3 5% homology in its protein 
product with the "classical" ras gene products. However, 
two putative human rho genes have also been identified, 
which are at least 85% homologous with the Aplysia rho 
gene. Thus the human genome contains at least three 
classical ras genes, one R-ras gene and possibly two 
ras-related rho genes. Furthermore, another ras-related 
gene, termed YPT1, has been isolated from S. cerevisiae 
(Gallwitz et al., 1983), whose protein product shows 38% 
homology with the "classical" ras proteins. Since both the 
rho and the YPT1 genes were identified purely by chance, in 
the course of the analyzing cloned DNA, it is likely that
several other members of the ras multigene family may exist
within the genomes of eukaryotes. Whether most, or only a 
few members of this emerging multigene family can act as 
oncogenes under certain conditions is not yet known. 
Interestingly, Padua et al. (1984) have identified a novel 
transforming gene from a human melanoma cell line, by 
DNA-mediated transfection into NIH 3T3 mouse fibroblasts, 
which shows only weak homology to the classical ras genes.
As yet the identity of this tentative member of the ras 
multigene family awaits further characterization.
The extraordinary evolutionary conservation of this 
multigene family, from unicellular eukaryotes to mammals, 
together with the oncogenic potential of specific mutants 
of at least some members, suggests that the ras multigene 
family must play a fundamental role in aspects of growth or 
development of eukaryotic cells.
(b) Detailed structure of the "classical" ras genes
The so called "classical" ras genes, Harvey (Ha), 
Kirsten (Ki) and N-ras, all encode immunologically related 
proteins (referred to as p2lras) which have a molecular 
weight of 21,000 daltons (Levinson, 1986). The Harvey and 
Kirsten ras genes were originally discovered as the 
oncogenes of the Harvey and Kirsten strains of murine 
sarcoma viruses, Ha-MuSV and Ki-MuSV (Ellis et al., 1981), 
while the N-ras gene was identified by low stringency 
hybridization to a viral Harvey ras probe (Shimizu et al., 
1983b). From sequence comparisons of a viral Ki-ras gene, 
a Kirsten pseudogene and Kirsten cDNA clones, with genomic 
clones (Shimizu et al., 1983a; McGrath et al., 1983; Capon 
et al., 1983b), it is known that the human c-Ki-ras2 locus 
(c-Ki-rasl is a processed pseudogene) spans more than 38 Kb 
and is divided up into five coding exons separated by as 
much as 17 Kb (Figure 1). This large gene locus has a 
rather unusual organization of introns and exons. It has an 
additional non-coding upstream exon, called exon 0, and 
only four of the five available coding exons are ever 
represented in the mature transcripts of 5.5 Kb and 3.8 Kb. 
The vast majority of mature transcripts (approximately 99%) 
were spliced in such a manner that the 16 Kb of RNA 
sequence corresponding to the fourth exon and its flanking 
introns, were eliminated by the fusion of the third exon to 
the downstream fifth exon (Capon et al., 1983b). Hence, the
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c-Ki-ras2 38Kb
0 1 2 3 4a 4b
3 7 0 0  1 70 0 0 1 8 0 0 9 90 0 9 8 0 0
N-ras 18Kb
1 1 2 3 4 5 6
110 179 180
Figure 1 The "classical" human ras genes.
The human c-Ki-ras2 , N-ras and c-Ha-rasl genes are shown in schematic
form. Open boxes indicate known coding exons and shaded boxes indicate 
non-coding exons. The overall size of each locus is given in kilo base
pairs (Kb) and where known, the sizes of exons and introns are given in
base pairs (bp). The diagram is not to scale.
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fourth and fifth exons are termed exon 4A and 4B, 
respectively. This differential splicing of the precursor 
RNA to give an abundant species containing exon 4B and a 
rarer species containing exon 4A, does not explain the two 
discretely sized mature transcripts observed by northern 
blot analysis. Probes for exon 4A or for exon 4B detect 
similar proportions of each of these transcripts, which 
shows that each species contains sequences from both coding 
exons. Therefore, the two transcripts must differ at their 
5 f or 3 1 ends. This implies either the existence of two
promoters, the upstream promoter being more efficient or, 
two polyadenylation sites, the more downstream one being 
used preferentially. An analogous situation has been 
observed in mouse adrenal tumour cells (George et al., 
1985), where two c-Ki-ras transcripts of 5.2 Kb and 2.0 Kb 
are detected. Finally, it is interesting that exon 4A and 
exon 4B-encoded amino acid sequences are related for the 
first 14 residues and the last 5 residues at the carboxy 
terminus, but that the intervening amino acids are highly 
divergent (Shimizu et al., 1983a). Exon 4B-encoded amino 
acids include a polylysine stretch within the divergent 
region, thereby making the carboxy-terminal end 
significantly more basic. Thus, it is possible that the two 
alternative forms of c-Ki-ras may have different 
properties.
Hall and Brown (1985) used sequence comparisons of 
cDNA and genomic clones to define the structure of the
human N-ras gene. A rather complex but familiar pattern 
emerged. Like c-Ki-ras, the human N-ras gene has a 5' 
untranslated exon (which is termed exon —1, rather than 
exon 0), four coding exons, but no alternative fourth
coding exon. Instead, it has a small (39 bp) 3' 
untranslated exon 5, located between the fourth coding exon 
and exon 6, which contains the remainder of the 3 
untranslated sequences (Figure 1). All seven exons are 
contained within three EcoRl fragments spanning 18 Kb; that
is, less than half the size of the c-Ki-ras locus. In
addition to determining the arrangement of introns and 
exons, Hall and Brown (1985) were able to show that the two 
N-ras specific transcripts of 4.3 Kb and 2.0 Kb were due to 
differential ultilization of polyadenylation sites. The 2.0 
Kb transcript is less abundant since it uses a less
efficient polyadenylation processing signal, AAUAUA, rather 
than the normal AAUAAA found just upstream of the
polyadenylation site of the longer transcript. The 5 1 
boundary of the N-ras transcription unit was also 
determined and shown to consist of two initiation or cap 
sites, separated by 10 bp at positions 225 +2 bp and 235 +2 
bp upstream from the donor splice site of exon -1 (both 
appear to be used with equal frequency). The 5 1 
untranslated region contains two AUG translation initiation 
codons, followed by termination codons 23 and 32 triplets 
further downstream, the last termination codon overlapping 
the AUG codon used for protein synthesis. Upstream of the 
two cap sites there are no TATA or CAAT boxes close to 
positions -30 and -80 respectively. Instead, the 100 bp
preceding the cap sites contains approximately 65% A + T
residues, in contrast to the overall approximately 75% G + 
C richness of the 5 1 end of the human N-ras gene. The only 
recognizable sequence motif in the promoter region of this 
gene is four GGCGGG hexanucleotide repeats, which 
potentially bind the transcription factor Spl (see section
II.b). Unusually, only one of these repeats is present 
upstream of the cap sites, the other three being in the 
upstream non-coding exon -1. Thus, the human N-ras gene 
can be seen to have a very unusual genomic organization 
with one upstream non-coding exon and two downstream 
non-coding exons, one of which, exon 5, is only 39 bp long 
and may be a redundant vesticjjal exon, analogous to exon 4B 
of the Kirsten ras gene (see Figure 1).
The cloning of the human cellular Harvey ras oncogene, 
c-Ha-rasl (c-Ha-ras2 is a processed pseudogene, O'Brien et 
al., 1983) was made possible by an initial series of 
experiments designed to identify and study DNA segments in
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tumour cells which were responsible for the oncogenic 
conversion of those cells. High molecular weight DNA from 
tumour cells was transfected into normal NIH 3T3 mouse 
fibroblasts and foci of transformed cells were counted in 
the recipient NIH 3T3 monolayer culture. The observation 
that transformed foci were obtained with high molecular
weight DNA from some tumour cell lines, demonstrated not 
only the existence of oncogenic DNA sequences in tumour 
cell DNA, but also facilitated the isolation of the DNA 
sequences involved. Thus, the transforming gene of the 
human bladder carcinoma cell lines T24 and EJ, now known to 
be identical cell lines (O'Toole et al., 1983), was cloned 
independently by three groups (Goldfarb et al., 1982 ; 
Pulciani et al., 1982; Shih and Weinburg, 1982) and more
recently another allele of the same gene was cloned from a 
human squamous cell lung carcinoma (Kagimoto et al., 1985). 
A subsequent study of the bladder carcinoma oncogene and 
its related proto-oncogene present in normal cells, was 
facilitated by the later discovery that this oncogene was 
homologous to the transforming gene of the rat-derived 
Harvey murine sarcoma virus (Parada et al., 1982; Santos et 
al., 1982). This rat sarcoma virus gene, termed v-Ha-ras, 
had been acquired from the rat genome by retroviral 
transduction, and during the course of the study of this 
gene, both the rat and the human cellular homologues of 
v-Ha-ras were isolated (DeFeo et al., 1981; Chang et al., 
1982). The human cellular homologue of the v-Ha-ras was 
found to correspond precisely to the normal version of the 
EJ/T24 bladder oncogene (Parada et al., 1982) and 
therefore, comparisons between oncogenic and
proto—oncogenic versions of the human Harvey ras gene could 
be made. From this and later comparisons it was shown that 
oncogenic ras proteins differ from their normal homologues 
by a single amino acid substitution, usually at position 12 
or 61 (Tabin et al; 1982; Taparowsky et al., 1983; Shimizu 
et al., 1983a; Yuasa et al, 1983; Capon et al, 1983b; see 
also the next section). The data from these studies are
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strongly in favour of the qualitative hypothesis for 
oncogenic activation (see earlier), as it was only a 
qualitative change in the protein product, not a change in 
its level of expression, which appeared to be responsible 
for oncogenic activation. However, it is also clear that 
elevated expression of the normal human c-Ha-rasl 
proto-oncogene may induce tumourogenic transformation. 
Chang et al. (1982) have shown that when this gene is 
ligated to strong transcriptional control elements (the 
long terminal repeats from a murine or feline retrovirus)
2Tcl 2the corresponding high p21 levels produced, could induce 
tumouragenic transformation of NIH 3T3 mouse fibroblasts. 
Thus it appears that transformation by this gene can be 
accomplished by either quantitative or qualitative events 
(other examples of "quantitative transformation" are also 
discussed in section I.c). It is possible that
quantitative activation could occur due to defects in the 
transcriptional regulation of c-Ha-rasl .
Sequence analyses of the c-Ha-rasl gene and comparison 
with viral Harvey ras sequences have shown that there are 
four coding exons spread over less than 3 Kb (Reddy 1983; 
Capon et al., 1983a). However, the presence of an 
additional downstream coding exon, analogous to the 
situation in c-Ki-ras2 (see Figure 1), cannot be excluded. 
Interesting features of the c-Ha-rasl sequence include the 
presence of potential donor and acceptor splice sites in 
the region upstream from the four coding exons. This 
implied the presence of an upstream non-coding exon 
analogous to exon 0 of c-Ki-ras, or exon -1 of N-ras
(Figure 1). The presence of a putative upstream exon is 
also supported by comparison with the sequence reported for 
viral Harvey ras (Dhar et al., 1982). The viral sequence 
is homologous up to the upstream acceptor splice site in 
the genomic sequence and is again homologous to genomic
sequences just after the upstream donor site (Figure 2). 
Alternatively, it has been suggested (Capon et al., 1983a)
that the 1 Kb of DNA corresponding to the putative intron
9
Figure 2 The human c-Ha-rasl locus.
The approximately 6.4Kb BamHI fragment containing the human c-Ha-rasl gene 
is shown in schematic form and numbered according to Reddy (1983). The 
four known coding exons are shown as shaded boxes, the large closed dot 
indicates the position of the polyadenylation site (poly A ) . The 
positions of two concensus splicing signals in the 5' region are indicated 
by vertical arrows, where D and A refer to the donor and acceptor splice 
sites respectively. Also shown is the position of a tandemly repeated 28 
bp sequence present in the 3' flanking sequence (hatched open rectangle). 
An expanded view of the 1905 bp BamHI/Xbal fragment is shown below the 
line drawing of the c-Ha-rasl locus. In addition, the sequence of the 
concensus splice sites are shown and the open rectangle indicates the 
position of the proposed TAAT/CAAT promoter region (Capon et al., 1983a 
and Reddy, 1983). The letters a to e indicate the positions of weak 
homologies to the concensus TATA or CAAT motifs. 1 * CCTTT; 2 — CTAAT; 3 - 
TAATTT; 4 - CCTTT and 5 - ATTAAG.
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could have been deleted during the viral transduction of 
the cellular Harvey ras gene. This possibility is supported 
by the presence of 15 bp direct repeats flanking the 1 Kb 
of DNA in the genomic sequence (Capon et al ., 1983a). It 
is interesting that the TATA and CAAT boxes proposed for 
this gene (Capon et al., 1983a; Reddy 1983 and Figure 2) 
occur within the 1 Kb putative intron and hence would not 
be used if there was an upstream exon. However, it should 
be pointed out that these proposed transcription signals 
are very poor fits to their concensus sequence motifs.
Finally, a particularly unusual feature of the human 
c-Ha-rasl DNA sequence is the presence of a stretch of 
tandemly repeated DNA, nearly 1 Kb in length, located 
approximately 1 Kb downstream from the polyadenylation site 
(see Figure 2). It is composed entirely of tandem repeats 
of a 28 bp concensus sequence (Capon et al ., 1983a) and the 
number of these repeats accounts for the size polymorphisms 
reported for the human c-Ha-rasl locus (Krontiris et al.,
1985) . Interestingly, it has been suggested that some rare 
allelic variants of this polymorphism may be linked to 
genetic susceptibility to cancer in individuals carrying 
them (Krontiris et al., 1985). However, a recent report 
using a larger sample size of sporadic and familial 
melanoma cases has provided strong evidence against this 
hypothesis (Gerhard et al., 1987). Jeffreys et al. (1985) 
have reported similar tandem-repetitive sequences in human 
DNA which they have termed hypervariable "minisatellite" 
regions. As yet the tandemly repeated sequence closely 
linked to the human c-Ha-rasl gene has no know function. 
However, Seeburg et al. (1984) speculate that it may have a 
role in transcriptional regulation as its presence 
restores a more strongly transforming phenotype to cells 
transfected with codon 12 mutants.
(c) Expression of ras genes during malignancy
The development of cancer is believed to be a
11
multistage process (Foulds, 1969; Cairns, 1975) and
epidemiological studies have shown that tumours are the end
product of a series of independent events, the exact number
of which may vary depending on the particular target cell
(Peto, 1977) . Tumour development, at least in part, is
believed to be a consequence of the activation of cellular
proto-oncogenes by qualitative or quantitative mechanisms.
The classical ras genes have dominant transforming activity
when transfected into NIH 3T3 mouse fibroblasts (Cooper,
1982). This is believed to be due to various mutations
clustered around amino acid codons 12 and 61 and at present
there are at least 50 different mutations in five different
ras codons known to confer varying degrees of
transformation to NIH 3T3 cells (reviewed by Levinson,
1986). From an analysis of a large number of activated ras
genes derived from tumours, it was found that changes at
amino acid codons 12, 13 or 61 can activate the
transforming potential of p2lras. In addition, analysis of
randomly mutated ras genes demonstrated that amino acid
substitutions at residues 59 and 63 can also activate 
sp21 (Fasano et al., 1984). However, the best studied 
activating, or transforming, mutations are those affecting 
the codon which encodes the amino acid at position 12 of 
p2lras. Seeburg et al (1984) have constructed twenty Ha-ras 
genes in vitro each encoding a different amino acid at 
position 12 and it was found that other than the
normally occuring glycine, only proline had no transforming 
activity. Glycine and proline are the two amino acids 
predicted to disrupt protein or-helices and therefore, the 
transforming mutations are likely to exert their effect by 
allowing a longer Qf—helical region within this crucially 
important domain. Recently, a similar study has introduced 
mutant Ha-ras genes encoding 17 different amino acids at 
codon 61, into NIH 3T3 mouse fibroblast (Der et al., 1986). 
In this case, glutamine is the normally occuring amino acid 
at position 61 and of the 17 different mutants created, all 
but proline and glutamic acid, produced transforming
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alleles. However, the transforming activity of the codon 61 
Ha-ras mutants varied over a 1000-fold range in biological 
activity and increased levels of expression of the weakly 
transforming mutants, were reguired for morphological 
transformation of the NIH 3T3 cells.
It is possible that the NIH 3T3 transfection assay, 
routinely used to detect activated ras genes, may be biased 
in some way, such that, any involvement of ras genes in 
tumour development due to its overexpression, i.e. 
quantitative activation, may not be detectable. Thus, for 
the remainder of this section evidence in support of the 
quantitative hypothesis will be discussed. As mentioned 
earlier, the first direct experimental evidence for this 
hypothesis was the observation by Chang et al. (1982) that 
elevated expression of the normal c-Ha-rasl gene, by 
placing it under the control of retroviral long terminal 
repeat control elements, could also induce tumourigenic 
transformation. Transfection of normal and mutant human 
c-Ha-rasl genes linked to transcriptional enhancers, into 
primary cells rather than immortalized NIH 3T3 cells has 
also been reported (Spandidos and Wilkie, 1984; Yoakum et 
al., 1985). Transfection of the enhanced and mutated 
oncogene led to morphological transformation of primary 
cells, previously only possible with two cooperating 
oncogenes (Land et al., 1983; Ruley, 1983; Newbold and 
Overall, 1983). The enhanced "normal" c-Ha-rasl caused 
immortalization of the primary cells, a property not 
normally associated with ras genes, but did not induce 
morphological transformation. Thus, this ras gene can have 
a range of biological effects depending on the progressive 
addition of quantitative and qualitative alterations and it 
may be that elevated ras expression is a more common event 
in tumour progression than previously anticipated. This 
suggestion is supported by the observation that only 10 to 
15% of human tumours examined have been found to have a 
transforming mutation detectable in the NIH 3T3 
transfection assay (reviewed by Varmus, 1984). It is
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possible that elevated ras expression may have had an 
important role in the etiology of some of the remaining 
tumours examined.
Elevated ras expression has indeed been implicated 
with malignancy in a number of different studies. Slamon et 
a l . (1984) have examined twenty different fresh human
tumour types, from fifty-four patients, for the expression 
of fifteen oncogenes. They observed three different 
patterns of expression: no detectable transcription,
transcription in some types of tumours only, and 
transcription in all tumours examined. It is to this third 
category that the two ras genes examined (Kirsten and 
Harvey) belong, along with the myc and fos genes. 
Furthermore, in sixteen of the fifty-four patients a 
comparison between apparently normal, adjacent tissue and 
the corresponding malignant tissue, could be made. This 
consistently showed elevation of ras specific transcripts 
in the malignant tissue. However, in three cases, the 
levels of all the expressed oncogenes examined were similar 
in the tumour and the histologically normal adjacent 
tissue. In these cases qualitative, rather than
quantitative activation of the oncogenes responsible may 
have been more important. Alternatively, an oncogene not 
examined, or one yet to be identified, may have been 
responsible. Caution should be used in interpreting 
observations such as these ^  as in some cases, the 
differential expression between apparently normal and 
malignant tissue may be simply explained by cell-type 
differences between the two tissues. While this
consideration is obviously important, the similar levels of 
expression of Harvey and Kirsten ras genes reported in all 
tissues thus far examined (see next section), may exclude 
these genes from this criticism.
Other studies have also correlated elevated ras 
expression with malignancy. Spandidos and Kerr (1984) have 
observed that malignant tumours of the colorectum have 4 to 
14 times higher Harvey and 3 to 19 times higher Kirsten
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specific transcripts than the corresponding normal 
colorectal mucosa. Interestingly, even higher levels of 
expression of these genes were detected in most of the 
premalignant lesions examined, i.e. 8 to 13 times higher 
Harvey and 9 to 20 times higher Kirsten specific 
transcripts. In an independent study (Gallick et al., 
1985) the levels of ras protein (p21 ) were shown to
mirror almost exactly the levels of ras specific RNA 
observed by Spandidos and Kerr (1984). Similarly, enhanced 
ras protein levels have been detected in the majority of 
human colon and mammary carcinomas examined by Horan-Hand 
et al. (1984). Another pathway towards elevated ras 
expression which has been well documented, is amplification 
of ras genes. For example, transformation of NIH 3T3 murine 
fibroblast cells with the normal human c-Ha-rasl gene, has 
been shown to result from elevated transcription from 
multiple copies of this proto-oncogene, rather than from 
spontaneous mutation of any of the transfected c-Ha-rasl 
genes (Pulciani et al ., 1985). Furthermore, Pulciani et 
al. (1985) were also able to detect 50 to 60 fold 
amplification of the human c-Ki-ras2 locus in one lung 
carcinoma out of 75 tumour biopsies. Schwab et al. (1983) 
have also detected an amplified (30 to 60 fold) c-Ki-ras 
gene in Y1 mouse adrenocortical tumour cells. In this 
latter study, c-Ki-ras specific mRNA and protein were shown 
to be correspondingly elevated. More recently, a human 
gastric carcinoma has been described (Bos et al., 1986), 
containing not only an amplified normal allele of the 
c-Ki-ras2 gene, but also a single mutated c-Ki-ras2 
oncogene. Using a transformation assay, the mutated allele 
was shown to have replaced the usual glycine of codon 12 
with a serine residue, a moderately transforming allele as 
defined by Seeburg et al. (1984). In this case it is 
possible that neither the serine mutation, nor the 
amplification itself, were sufficient for tumour 
development and that the second potential activating step 
occurred during tumour progression. However, the possible
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involvement of other oncogenes was not examined by Bos et 
al. (1986). While the data described above can be 
interpreted as evidence for an involvement of expression of 
ras proto-oncogenesis in the development, it is also 
possible, given the likely involvement of elevated ras 
expression in cellular proliferation (see next section), 
that such increases may be a consequence of cell 
proliferation in tumour cells. Therefore, until it is more 
precisely known what levels of ras expression are required 
to trigger malignant growth in different cells, increased 
ras expression should be viewed cautiously as a model for 
such growth.
Finally, the animal model systems for carcinogenesis 
have been developed and have the great advantage that 
tumour progression can be studied from initial treatment 
with carcinogens, through benign to malignant lesions. One 
such experimental system has been well characterized (Burns 
et al., 1978) and is based on the chemical induction of 
tumours in mouse skin. Tumours are induced on the skin of 
sensitive mice byj a single treatment with a mutagen, termed 
the tumour initiator, followed by multiple treatments with 
a tumour promoter. The tumour promoter is believed to be 
necessary for the rapid proliferation of appropriately 
mutated cells into benign papillomas. Most of these benign 
papillomas are tumour promoter-dependent since they regress 
once tumour promoter treatment is stopped. This suggests 
that the initial mutational event(s) cannot be sufficient 
for full malignant transformation. However, some of the 
benign papillomas progress to form autonomous benign 
lesions and malignant carcinomas, presumably determined by 
other mutational events. The early dominant mutational 
event has been shown to involve mutational activation of 
the mouse c-Ha-rasl oncogene, which is also coupled to 
elevated expression of this gene in the papillomas relative 
to the normal epidermis (Balmain and Pragnell, 1983; 
Balmain et al., 1984). Thus, in this case, both activation 
and elevated expression of the mouse c-Ha-rasl oncogene
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occurred early in tumour progression. Since papillomas 
proliferate rapidly and reach a substantial size, ras gene 
activation and elevated expression also directly
correlated with proliferating cells. Recently,
introduction of the Harvey murine sarcoma virus (HaMSV) 
directly into mouse epidermal cells has been shown to 
substitute for treatment with the initial carcinogen (Brown 
et al., 1986). In this case, the latency period before the 
appearance of the papillomas, and also for conversion of 
papillomas to carcinomas, was shorter after initiation with 
HaMSV than it was with initiating carcinogen. This is 
probably due to the viral promoter elements which induce 
higher levels of expression than are observed in chemically 
induced tumours.
In summary, it has been shown that oncogenic
activation of the classical ras genes may not solely be a 
function of activating mutations clustered around codons 12 
and 61. There is now evidence that oncogenic activation
of these genes may also be caused by elevated expression
and it is entirely possible that both these mechanisms may 
act together in the genesis of at least some tumours. Thus 
it is clear that the regulation of these important genes 
must be tightly controlled to prevent cells acguiring some 
neoplastic characteristics. No known regulatory defects in 
any ras genes have been identified and characterized in
cells from naturally occuring tumours. The question of how 
ras expression is genetically controlled is unanswered.
(d) Expression of ras genes during development, cell 
proliferation and the cell cycle
A systematic investigation of proto-oncogene 
transcription during pre- and post-natal development of 
mice has been undertaken by Muller and colleagues (Muller 
et al., 1982, 1983). Most of the proto-oncogenes they 
examined were expressed transcriptionally in a tissue- and 
developmental stage-specific manner. In contrast, the
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cellular Harvey and Kirsten ras genes were found to be 
expressed ubiquitously in mouse embryos, fetuses, placentas 
and extraembryonal membranes, as well as in various 
post-natal tissues. Furthermore, the level of expression 
of both of these ras genes represented a constant level of 
between 0.01% and 0.05% of the total cellular 
polyadenylated RNA. Hence, expression of these ras genes 
is unlikely to be involved with the differentiation of 
particular cell types. In Drosophila melanogaster, which 
has three genes homologous to Harvey ras probes (Shilo and 
Weinberg, 1981), ras expression from each of these genes 
was also found in all developmental stages examined. 
Interestingly, each gene encoded at least two distinct 
transcripts, the shorter transcript from each being more 
abundant in embryos, whereas the longer transcript was 
expressed ubiquitously at a constant level (Lov. et al., 
1985).
Evidence that ras gene expression may be involved in 
cellular proliferation comes from studies on regenerating 
liver cells. Liver regeneration is one of the most striking 
examples of compensatory growth in mammals, and rat 
hepatocytes are known to respond to liver damage induced by 
partial hepatectomy or chemical injury, by undergoing a 
burst of DNA synthesis and replication. This burst of cell 
division proceeds synchronously for at least two cell 
cycles and it was observed that the levels of both Kirsten 
and Harvey ras transcripts increases 2 to 4-fold 
concommitant with the onset of DNA synthesis (Goyette et 
al., 1983; Goyette et al., 1984). To control for the 
general increase in transcriptional activity observed in 
this system, the levels of albumin transcripts were shown 
not to increase during liver compensatory growth. 
Furthermore, the peak in the amount of ras transcripts was 
shown to be both greater and to occur earlier, than that of 
ot—fetoprotein transcripts, which are known to increase in 
regenerating liver. Goyette and colleagues interpreted 
their observations as indicating that there is regulated
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transcription of the Harvey and Kirsten ras genes during 
the physiological growth process of liver regeneration. 
However, they did not eliminate the possibility that these 
ras transcripts are differentially stabilized during the 
regeneration process. Furthermore, the correlation of ras 
expression with DNA synthesis does not imply a causal 
involvement with cell growth. Interestingly, the levels of 
most other proto-oncogenes examined in this system remained 
unchanged, the exception being the elevation of the c-myc 
gene, which preceded that of the Harvey and Kirsten genes 
(Goyette et al., 1983, 1984).
The liver regeneration system suggests ras gene
expression may be regulated within the cell cycle. In
animal cells, the cell cycle has been divided into four
distinct phases (reviewed by Pardee et al., 1978). They
are; 1) the gap period between mitosis and the initiation 
of DNA synthesis, called G1 phase; 2) the synthesis of DNA, 
called S phase; 3) the gap period between DNA synthesis and 
mitosis, called G2 phase and 4) mitosis, called M phase. 
In addition, it is known that the crucial events for the 
regulation of growth occur mainly in the G1 phase and a 
"commitment" point in mid to late G1 has been defined 
(Pardue et al., 1978). At the commitment point, the cell 
may either enter the S phase, or cease proliferation and 
enter a prolonged G1 phase (sometimes called GO) referred 
to as quiescense. Campisi et al. (1984) have shown, using 
Balb/c 3T3 (A31) murine fibroblasts, that the relative
abundance of c-Ha-rasl specific transcripts was increased 
five to seven fold in S phase cultures. This cell cycle 
dependent elevation of ras transcripts was not affected in 
chemically transformed sub-lines of these cells. 
Furthermore, the elevation of the c-Ki-ras2 specific 
transcript was first detected in mid to late Gl. This 
contrasts with the c-myc proto-oncogene whose expression is 
now known to be continuous throughout the cell cycle 
(Thompson et al., 1985). This analysis prompted Campisi et 
a l . (1984) to speculate that ras gene expression is
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involved in G1 regulatory events which prepare the cell for 
DNA synthesis and subsequent cell division. This
speculation is supported by the observation that NIH 3T3 
murine fibroblasts, induced to divide^the addition of serum 
to the culture medium, are unable to enter S phase
following microinjection of anti-ras antibodies (Mulcahy et 
a l ., 1985). This observation provides strong evidence that 
the protein product of the ras proto-oncogene is required
for the initiation of S phase in, these cells. In the
inverse experimental approach, Ferramisco et al., (1984) 
microinjected the T24/EJ bladder carcinoma cell line 
c-Ha-rasl protein product into quiescent cells. After 
microinjection, DNA synthesis was induced, but cell 
division in at least one cell line examined required 
re-feeding with serum. These data also suggest that the 
c-Ha-rasl function at least, is required for the initiation 
of S phase, but that cell division requires other
regulatory events.
The remarkable evolutionary conservation of the ras 
multigene family (see section I.a) suggests that these 
genes encode functions that are essential to all eukaryotic 
cells. Therefore, the study of the function of ras genes 
during the development of lower eukaryotic organisms, which 
have simple life cycles and are more amenable to genetic 
analysis, should provide insight into the function of ras 
genes in the higher eukaryotes. One such suitable organism 
is the slime-mould, Pietyostelium discoideum, which is 
unusual in that the processes of cell division and 
differentiation are largely separate. That is, there is a 
proliferative amoeboid stage which when starved, ceases 
cell division and aggregates to differentiate into spore 
and stalk cells (Loomis, 1975). Expression of the single 
ras-related gene in D. discoideum appears to be linked to 
the mitotically active proliferative cells only (Reymond et 
al., 1984). Furthermore, the single ras-related protein, 
which is specifically precipitated by monoclonal antibodies 
raised against mammalian p2lraS, is detected only in
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mitotically active cells (Pawson et al., 1985). The most 
intensively studied lower eukaryote is the yeast, 
Saccharomcyes cerevisiae. In this organism ras gene 
expression is also required early in the cell division 
cycle (CDC) as double mutants of the RAS1 and RAS2 alleles 
fail to germinate or to form buds (Tatchell et al., 1984; 
Kataoka et al ., 1984), suggesting a block quite early in
the yeast cell division cycle. However, comparisons 
between yeast and mammalian ras genes should be interpreted 
cautiously because of recently determined differences in 
their biochemical properties (Beckner et al., 1985), as 
discussed in the next section. Despite these differences, 
it is of interest that the human c-Ha-rasl gene can be used 
to complement the inviability of yeast rasl~ ras2~ double 
mutants and conversely that a modified RAS 1 yeast gene 
can transform NIH 3T3 cells (Kataoka et al., 1985; 
DeFeo-Jones et al., 1985). Therefore, although aspects of 
the biochemistry of mammalian and yeast ras genes are known 
to have diverged, it is clear that functional homology must 
exist, as well as the obvious sequence homologies, between 
mammalian and yeast ras genes.
In this section, it has been observed that the 
expression of the Harvey and Kirsten ras genes appears to 
be ubiquitous in all cell types and developmental stages, 
accounting for constant levels of between 0.01% and 0.05% 
of the total polyadenylated RNA in non-malignant mammalian 
cells. Furthermore, evidence has been given which suggests 
that ras expression is cell cycle regulated, such that a 
peak of ras specific transcription is observed in mid to 
late Gl, which is a period of the cell cycle known to be 
important for regulation of cell division. Furthermore, 
there is now direct evidence implicating ras gene function 
in the initiation of the S phase of the cell cycle.
(e) Function of the ras gene products
Recent biochemical and structural studies support 
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the hypothesis that ras proteins are involved in the 
transduction of extracellular signals in a manner analogous 
to the G proteins. The G proteins are known to transduce 
extracellular signals from their various receptor molecules 
to their appropriate effector enzymes (Stryer, 1983; 
Lefkowitz, 1983). These signals can be as diverse as a 
photon of light impinging on the retina, to a hormone 
molecule binding to a receptor molecule on the surface of a 
cell. Like G proteins, the mammalian ras gene products are 
associated with the inner leaflet of the cell membrane 
(Willingham et al., 1980), bind GTP (Scholnick et al., 
1979) and they exhibit a slow GTPase activity (Sweet et 
al., 1984). Furthermore, the nucleotide sequence of the T^ 
subunit of bovine transducin (the G protein involved in 
light transduction), has been determined and found to have 
several domains closely homologous to the mammalian ras 
proteins and to various other GTP binding proteins (Lochrie 
et al., 1985; Tanabe et al., 1985; Medynski et al., 1985; 
Yatsunami and Khorana, 1985). Hurley et al. (1984) have 
also observed significant homology between the N-terminal
ITclSsequence of the human p21 proteins and the two mammalian 
G proteins, Gg and G^, which are known to interact with 
adenylate cyclase. In the yeast, Saccharomcyes cerevisiae, 
genetic and biochemical analyses have suggested that the 
main physiological function of the RAS gene products, is 
the control of adenylate cyclase activity (Toda et al.,
1985) . This suggests that the yeast ras proteins are 
functional equivalents of the mammalian G proteins 
controlling adenylate cyclase. In this yeast the level of 
cAMP is known to be involved in cell cycle control 
(Matsumoto et al., 1982). Conversely, it is now known that 
the mammalian Harvey, Kirsten and N-ras gene products are 
not controlling elements of mammalian adenylate cyclase 
(Beckner et al., 1985). This functional divergence between 
yeast and mammalian ras proteins suggests that the putative 
G protein function of the mammalian ras proteins must be 
coupled to effector enzymes other than adenylate cyclase.
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A good candidate for the ras effector enzyme is
phospholipase C (Berridge and Irvine, 1984; Berridge,
1984), which is responsible for the generation of two
specific second messengers from inositol lipids, the
so-called phosphatidylinositol (PI) turnover cycle (see
review by Berriddge and Irvine, 1984) . Of the two second
messengers generated, diacylglycerol (DG) acts in the plane
of the cell membrane to activate protein kinase C,
generating a cascade of events ultimately leading to an
increase in cellular pH. The other second messenger
generated, inositol trisphosphate (InsP^), is released into
the cytoplasm where it leads to a mobilization of
intracellular calcium stores. Increased cellular pH and
calcium concentration are characteristic features of the
action of growth factors and are the two major ionic events
implicated in cell proliferation. Evidence for the
hypothesis that the mammalian ras proteins are candidates
for the unknown G protein(s) that modulate the PI turnover
cycle comes from studies on ras-transformed cells.
Fibroblast cell lines have been transformed with Harvey,
Kirsten and N-ras genes and the levels of PI turnover cycle
catabolites, including DG and InsP3, were shown to be
elevated with respect to the untransfromed cells
(Fleischman et al., 1986; Wolfman and Macara, 1987). Also,
Wakelam et al. (1986) have constructed an NIH 3T3 murine
fibroblast cell line containing the unmutated "normal"
N-ras gene under the control of a glucocorticoid inducible
promoter. In uninduced cells the level of p21 protein
is negligible^ however, induced cells contain large amounts
of this protein. This is correlated with a dramatic
increase in the levels of inositol phosphates and an
increase in DNA synthesis when the cells are treated with
certain growth factors. The fact that several growth
factors elicited this response to varying degrees, suggests
that p21^ interacts with a spectrum of growth factor
oi N-ras
receptors. Furthermore, since the expression or p2i
caused such a dramatic response, this suggests that in
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these cells the concentration of the usual complimentary G 
protein is limiting. These observations led Wakelam et al. 
(1986) to propose that normal p21^ j_s ^ complimentary
protein, akin, if not identical to, the putative G protein
which allows growth factor receptors to stimulate inositol 
lipid metabolism by activating phospholipase C.
Given the large number of ras genes now known to exist 
(see section I.a), it is possible that most may serve only 
a few common effector enzymes, like phospholipase C, but 
couple to many distinct signal receptor molecules in a 
manner analogous to p21 * . Thus, the proteins of the
ras multigene family could respond to many different
signals in an integrated way. Previously discussed 
observations on the pattern of ras expression during
development and the cell cycle (section I.d), suggested 
that ras gene expression is involved in the control of cell 
growth, possibly by having a role in the initiation of DNA 
synthesis. However, it is also possible that other members 
of the ras multigene family, which are more divergent in 
sequence from the classical ras genes, may have a function 
in different cellular processes. For example, the S. 
cerevisiae ras-related YPT1 gene product, which is nearly
ITclS40% homologous to the mammalian p21 gene products 
(Gallwitz et al., 1983), seems to be involved in 
microtubule organization and function (Schmitt et al.,
1986). Furthermore, the Schizosaccharomyces pombe RAS1 
protein, which is highly homologous to the S. cerevisiae
RAS 1 and RAS2 proteins, is not involved in vegetative
growth nor regulation of cAMP levels, but is required for 
mating (Fukui and Kaziro, 1985; Fukui et al., 1986).
As yet no known functions for other ras-related genes, 
such as the rho and R-ras genes found in the genomes of 
higher eukaryotes (see section I.a), have been reported. 
However, some studies have even suggested that the
mammalian ras genes may also function in the
differentiation of certain cell types. Treatment of rat 
pheochromocytoma cells (PC12) with nerve growth factor
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(NGF) results in the induction of a number of phenotypic 
characteristics of sympathetic neurones, including 
cessation of cell division and outgrowth of neuronal 
processes (neurites). Microinjection of the oncogenic 
(T24/EJ) form of the human Ha-ras protein, but not the 
proto-oncogenic form, mimics the effect of NGF treatment on 
these cells (Bar—Sagi and Feramisco, 1985). Furthermore, 
the NGF-induced differentiation was inhibited when 
monoclonal antibodies raised against viral Harvey ras 
protein, which recognize all ^rat p21ras species, were 
microinjected into PC12 cells (Magag et al., 1986). Thus, 
in this system, p21Ha ras appears to be involved in the 
induction of neurite formation in PC12 cells, but only an 
oncogenic form of this protein provides a sufficiently 
powerful signal for this differentiation process. It is not 
known whether the classical ras proteins are typically 
involved in other differentiation processes. However, it
3T3.S t (
may be that p21 involvement in neuronal development is a 
pecularity of PC12 cells.
Finally, Birchmeier et al. (1985) have shown p21ras 
involvement in another highly specialized cellular 
function. They have shown by microinjection, that both 
normal and oncogenic Harvey ras proteins can induce 
maturation (meiosis) of Xenopus oocytes. This maturation is 
independent of progesterone treatment, which is the normal
H cl "* 2^ cl Sphysiological inducer of oocyte maturation. The p21 
induced oocyte maturation is nearly 100-fold more potent 
for the oncogenic version of the protein than it is for the 
normal wild type version. As oocyte maturation involves 
the stimulation of oocytes arrested at prophase of meiosis 
to complete meiosis, this phenomenon may be related to the 
ability of ras proteins to advance somatic cells through 
the mitotic cell division cycle.
In summary, there is strong evidence that ras proteins 
are of vital importance to all cells. This provides a 
basis for the hypothesis, that elevated expression of ras 
genes can directly lead to oncogenesis. Moreover, as
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already discussed, elevated ras expression has been 
correlated with oncogenesis. Many observations suggest that 
the ras gene products act at a key regulated step in the 
transduction of extracellular information into the cell, in 
a manner analogous to the various known G proteins.
Similarities have been found between these G proteins and 
the ras proteins and it has been hypothesised that the 
mammalian classical ras proteins regulate the production of 
the second messengers, diacylglycerol and inositol 
trisphosphate. The possibility has been raised that members 
of the ras multigene family of closely related proteins may
differ in functional properties, such as the reception of
different extracellular signals or coupling to different 
effector enzymes. The intriguing possibility that the 
mammalian ras gene products may function in the
differentiation or maturation of certain cell types, has 
also been suggested.
II. ASPECTS OF GENE REGULATION
Multiple levels of control are exerted on the genetic 
information contained within the cell nucleus. Nuclear 
architecture, chromatin structure, transcription, RNA 
transport, RNA stability, translation, and processing of 
RNA and protein products, are all levels at which genetic 
information may be regulated. However, as this thesis is 
concerned with the transcriptional regulation of the human 
c-Ha-rasl gene, this discussion will be limited to aspects 
of gene regulation which are likely to have relevance to 
the transcription of this gene. Later discussion will focus 
on the hypothesis that transcription of the ras genes is 
more like that of the "housekeeping" genes, than that of 
the more often studied "luxury-protein" genes. 
"Housekeeping genes" are those whose products are involved 
in various metabolic processes common to all cells. 
Examples of such processes are energy production, energy
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utilization and DNA synthesis. The so called 
"luxury-protein" genes are those which encode and produce 
proteins, usually in bulk, in specific types of terminally 
differentiated cells. Such genes are exemplified by the 
globin genes (reviewed by Karlsson and Nienhuis, 1985).
(a) Transcriptional control signals
Genes are transcribed by one of three different RNA 
polymerases in higher eukaryotes. The class of RNA 
polymerase used for transcription depends on recognisable 
structures (DNA or DNA-protein binding complexes) 
surrounding the gene (Baker and Platt, 1986; Nevins, 1983; 
Enver, 1985) . These structures constitute the "promoter1 
and for protein coding genes they allow the promoter to be 
recognized by RNA polymerase II (pol II) and its associated 
transcription factors (recently reviewed by Gidoni et al., 
1984; Dynan and Tjian, 1985; Serfling et al., 1985; 
Ptashne, 1986; McKnight and Tjian, 1986). Unlike
prokaryotic RNA polymerases, purified pol II requires 
protein factors for promoter recognition and correct 
initiation of transcription in vitro (Manley et al., 1980). 
Some of these factors seem to be required for initiation at 
all promoters, whereas others are required for initiation 
at specific promoters only (Dynan and Tjian, 1983a). The 
sequence-specific DNA binding proteins can activate 
transcription and probably allow the transcription 
machinery to discriminate between different promoters.
(i) The TATA box
Early experiments on "luxury-protein" genes involved 
functional testing of in vitro manipulated cloned DNA and 
demonstrated the importance of several concensus sequences, 
located upstream from these genes. One such concensus 
sequence, TATAAA, called the TATA box, is located 25-30 bp 
upstream from the transcription start site (Breathnach and
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Chambon, 1981) . Mutation of the TATA box in a sea urchin 
histone gene (Grosschedl and Birnsteil, 1981) and in the 
SV40 early gene region (Ghosh et al., 1981; Benoist and 
Chambon, 1981), generates 5 1 (upstream) heterogeneity in 
the transcripts produced, although the overall level of RNA 
synthesis was not significantly reduced. In the case of 
Drosophila heat shock genes, a protein, or proteins, have 
been shown to bind to the TATA box, independently of heat 
shock, both in in situ chromatin (Wu, 1984) and on free 
linear DNA (Wu, 1985). Davidson et al. (1983) have 
reported a HeLa cell factor which is necessary for in vitro 
transcription from conalbumin and adenovirus late gene 
promoters and which also binds to the TATA box region. 
Weintraub (1985) has used novel high resolution mapping 
techniques t.o show that the TATA box region of the major 
late promoter in adenovirus chromatin, is a dominant site 
of SI and DNAse I hypersensitivity. This suggests that the 
DNA structure at the TATA box is in an altered 
conformation, perhaps caused by protein binding. Recently, 
the technique of photofootprinting in vitro, has been used 
to detect transcription-dependent changes in the 
photomodification of yeast TATA boxes (Selleck and Majors,
1987) . It is believed that the altered sensitivity to 
photomodification results from a DNA structural change, 
mediated by the binding of the TATA-specific protein(s) in 
yeast. This structural change, induced by binding, could 
be a similar or related feature to that detected by SI and 
DNAse I nucleases as a hypersensitive site.
(ii) The CAAT box
Further upstream from the TATA box, usually at 
position —70 to -80 relative to the transcriptional start 
site, an additional conserved sequence of concensus 
GG(C/T ) CAATCT, the so called CAAT box, has been found in 
several cellular and viral protein-coding genes (Benoist et 
al., 1980; Efstratiadis et al., 1980; Breathnach and
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Chambon, 1981; Shenk, 1981). However, with the
accumulation of DNA sequence information on the promoter 
regions of many more genes, it is now known, that the CAAT 
consensus sequence is not so widespread in promoters, as 
that of the TATA box. The CAAT box is believed to function 
as a transcriptional activator, as mutation of the CAAT 
boxes of the herpes simplex virus (HSV), thymidine kinase, 
the human and mouse 0 -globin and the Xenopus hsp 70 genes, 
reduced RNA synthesis by as much as 10-fold in vivo 
(McKnight et al., 1984; Graves et al., 1986; Charnay et 
al., 1985; Myers et al., 1986; Bienz and Pelham, 1986). 
Furthermore, deletion of the human cr-globin CAAT sequence, 
reduces transcription in vivo, at least 25-fold (Mellon et 
al., 1981).
At least two different protein complexes are now known 
to bind CAAT sequence motifs, one isolated from HeLa cells, 
called CAAT-binding transcription factor, CTF (Jones et 
al., 1985) and the other from rat liver, called CAAT 
binding protein, CBP (Graves et al., 1986; Jones et al.,
1985) . Cohen et al. (1986) have also reported an activity 
which binds to mouse a- and 0 -globin promoter CAAT 
sequences, but it is not yet known if this factor(s) 
correspond to CTF or CBP, or even to a third distinct CAAT 
box binding factor. The factors, CTF and CBP, have been 
shown to have distinct biochemical properties and sequence 
requirements (Graves et al., 1986; Jones et al., 1987). For 
example, their chromatographic and heat stability 
properties are different, and they do not generate 
identical footprint patterns on the HSV1 tk promoter. 
Furthermore, mutation of the CCAAT sequence to GCAAT, which 
inhibits transcription in HeLa cells, eliminates binding of 
CTF but enhances binding of CBP. Jones et al. (1987) have 
also shown that CTF is identical to the previously 
identified adenovirus DNA replication stimulating factor, 
NF-1. This surprising result, indicates that CTF/NF-1 can 
have multiple functions, as it activates both viral DNA 
replication and transcription. Multiple functions for
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CTF/NF-1 are also suggested by its complex multimeric 
nature. The purified CTF/NF-1 activity consists of a 
heterogeneous population of polypeptides of 52 to 66 
kilodaltons (Jones et al., 1987). Transcriptional 
activation by CTF/NF-1 is likely to be determined by the 
context of the binding site, in relation to the location of 
other transcription factors. This suggestion comes from 
the observation that the high affinity CTF-binding site, 
located upstream of the human -globin promoter, at about 
position -2 00, does not contribute to -globin gene 
expression, whereas the low affinity binding site at 
position -80, is fully functional (Jones et al., 1987). A 
possible explanation for such differential behaviour, is 
that transcriptional activation requires interaction of CTF 
with other linked transcription factors. Such an
interaction is suggested by the demonstration that the 
inverted CAAT box at position -55 of the Xenopus hsp 7 0 
gene is required for long distance activation of the 
promoter by the upstream heat shock elements (HSEs). 
However, the CAAT box was not required if the HSEs were 
moved close to the TATA box (Bienz and Pelham, 198 6) . A 
similar effect was noticed for the SV40 enhancer region, as 
maximal long-range activation of 0-globin genes by this 
enhancer, requires a CAAT box located within 80 bp of the 
TATA box (Dierks et al., 1983). Another role for the CAAT 
box binding proteins which bind the inverted CAAT box at 
position -55 of the hsp 70 gene, is suggested by the 
apparent cell-type-specific regulation of this gene during 
oogenesis. The hsp 70 gene is constitutively expressed in 
Xenopus oocytes (Bienz, 1984) and this level of expression 
is unaffected by heat shock, whereas hsp 70 transcripts are 
undetectable in all somatic cells prior to heat shock. The 
HSEs and the CAAT box were the only sequences which could 
be defined by mutational techniques as regulators of this 
cell-type specific response (Bienz, 1986). Thus, cell-type 
specific activation of the Xenopus hsp 70 gene does not 
require a cell-type specific promoter element. To explain
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this observation, Bienz (1986) suggested that oocytes 
contain high levels of the heat shock transcription factor 
(HSTF) and/or the CAAT-binding activity, which leads to 
"permissive" expression of hsp 70, while somatic cells 
contain subcritical amounts of at least one of the two 
factors. Alternatively, enhanced interaction between HSTF 
and the CAAT-binding activity may occur in oocytes due to 
oocyte-specific forms of either one of the binding 
activities.
(iii) The GC box
Another upstream sequence motif which is found in 
many genes is the GC box. This motif has a concensus 
sequence of 5 1 (G/T )GGGCGG(G/A )(G/A )(C/T ) 3', although
analysis of the human immunodeficiency virus (HIV) long 
terminal repeat (LTR) promoter, suggests that other related 
sequences may also be functional GC boxes (Kadonaga et al.,
1986) . The GC box was first identified as the binding site 
of a factor isolated from human HeLa cells, called Spl. 
This factor was found to activate transcription of the 
early transcription unit of the simian virus 40 (SV40)
genome (Dynan and Tjian, 1983a). As the SV40 early 
promoter is central to any discussion of the Spl 
transcription factor, but also because the early promoter 
shares some characteristics with the c-Ha-rasl gene 
promoter and the promoters of most housekeeping genes, it 
is worthwhile considering this promoter in some detail.
The 3 00 bp region that lies between the early and late 
SV40 transcription units, contains at least four specific 
types of regulatory elements and functions as a 
bidirectional promoter unit for early (anticlockwise) and 
late (clockwise) viral transcription (reviewed by McKnight 
and Tjian, 1986 and see Figure 3-1). Proceeding clockwise 
from the early to the late transcriptional units, the first 
regulatory elements encountered are three T antigen binding 
sites, the middle one of which overlaps the early RNA
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initiation sites. These binding sites, when bound by T 
antigen, function to repress early gene transcription. 
Also, within this region is the origin of DNA replication, 
which is also bound by T antigen. Adjacent to and 
overlapping the replication origin, is a TATA-like sequence 
motif which specifies the locations of early gene 
transcriptional initiation sites and directly following 
this motif are three direct repeats of a G + C rich 21 bp 
sequence. Each 21 bp repeat contains two copies of the 
concensus GC box sequence and complete deletion of this 
regulatory element severely limits early promoter function. 
Finally, two more tandem repeats of 72 bp each are found to 
the right of the 21 bp repeats on the "late" side of the 
300 bp SV4 0 control region. It is from the 72 bp repeat, 
nearest to the late transcription unit that late 
transcription is initiated. However, deletion of both 72 bp 
repeats also reduced early transcription, whereas deletion 
of just one has virtually no effect on early transcription 
and virus viability. Like the 21 bp repeats, the 72 bp 
elements stimulate transcription in either orientation but 
unlike the 21 bp repeats, the 72 bp elements can have their 
effect even when placed thousands of base pairs away from 
the 300 bp SV40 control region. This is the basis of the 
so called enhancer activity, which will be discussed more 
fully in the next section.
Dynan and Tjian (1983b) have shown that Spl 
selectively binds to the 21 bp repeats using the in vitro 
DNAse I footprinting technique. Further DNAse I 
footprinting analysis, along with dimethyl sulphate (DMS) 
methylation protection experiments, have shown that Spl 
binds in a sequence-specific manner to the GC boxes, that 
occur twice in each 21 bp repeat (Gidoni et al., 1984; 
Gidoni et a l . , 1985; Dynan and Tjian, 1985). However, Spl 
forms strong contacts with only three of the six GC boxes 
and weakly contacts two others. This is because steric 
constraints and differences in binding affinities between 
the six potential sites limits binding to only five sites
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at any one time. It is believed, that when the 21 bp
repeat region is fully occupied, Spl binds as five
protamers, each of more than 100 kilodaltons (Kadonaga and 
Tjian, 1986). These promoters lie predominantly on the same 
face of the DNA helix and each is capable of protecting 
approximately 20 bp of DNA from DNAse I (Gidoni et al.,
1984) . Furthermore, contacts have been detected only in 
the major groove of the DNA helix and on one strand only 
(Gidoni et al., 1984; McKnight and Tjian, 1986), an 
observation which has not been observed with the more 
intensively studied, prokaryotic DNA binding proteins.
The transcription factor Spl is also known to interact
with other viral promoters, such as the promoters of the
herpes simplex virus (HSV) immediate early genes -4/5 and 3 
(IE-4/5 and IE-3) and also the HSV tk gene. Like the SV4 0 
3 00 bp control region, which directs the synthesis of both 
early and late transcripts in divergent directions, the 
IE-4/5 and IE-3 transcripts are also divergently 
transcribed from an approximately 7 00 bp control region. 
Unlike the SV40 control region, this 700 bp control region 
has 12 GC boxes, which have been shown to bind Spl in vitro 
and are spaced at greater intervals and in either 
orientation (Jones and Tjian, 1985). Promoter activity 
correlates with the Spl binding sites proximal to each IE 
gene. Interestingly, the more distal Spl binding sites also 
closely flank the TAATGARAT elements implicated in 
transactivation of IE transcription, by virion-associated 
proteins (Jones and Tjian, 1985). It is believed that the 
Spl protein, bound to the GC boxes, potentiates this 
induction of IE transcription in vivo (Jones and Tjian,
1985). Preston et al. (1984) have also shown that deletion 
of at least one of the distal Spl binding sites, decreases 
the level of transcriptional induction of both the IE-4/5 
and IE-3 genes. Therefore, at least at this site there is 
overlap between the sequences required for viral activation
and transcription.
The role of Spl in HSV transcription is not linked
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solely to IE gene transcription, it is also implicated in 
transcription of the "delayed-early" tk gene (Jones et al.,
1985). For this gene, mutagenesis experiments have 
established that only two GC boxes are required (McKnight 
et al., 1981; McKnight and Kingsbury, 1982). One is 
located in a region termed distal region I (dsl) and is 
adjacent to a TATA box, called the proximal signal (ps). 
The other is located further upstream in distal region II 
(dsll), along with an inverted CAAT box. The distal GC box 
is orientated in the direction of transcription, while the 
dsl GC box is orientated away from the direction of 
transcription. Spl binding is appreciably greater to dsll 
than to dsl (Jones et al., 1985). Interestingly, an 
inversion mutant, which exchanges the positions of dsl and 
dsll, thereby bringing the inverted CAAT box into close 
proximity with the TATA box of ps, can now function in the 
absence of dsl (McKnight et al., 1984). As disruption of 
either dsl or dsll, in their normal positions, is known to 
severely reduce promoter function in vivo (McKnight, 1982), 
this observation suggests, that Spl bound to ps may simply 
act by linking the factors bound at dsll to those found at 
the TATA box containing ps region. The effect of a weak 
Spl binding site in dsl, would be to reduce the effect of 
the strong binding site in dsll. This would allow 
transcription of the delayed-early tk gene, only when the 
levels of the Spl factor recruited to the vicinity of the 
viral genome, were high enough to favour binding to the 
weaker Spl binding site of dsl. The possibility that these 
proteins may interact in an "interdigitated" manner, 
possibly forming a framework to which other regulatory 
proteins may bind, is also suggested by their positioning 
along the same face of the DNA helix (McKnight and Tjian,
1986).
Recently, it has become apparent that Spl may also 
interact with several cellular genes, as a number of GC 
box-containing promoters have been described. Thus far 
these genes are mainly members of the "housekeeping" class
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and the various patterns of GC boxes associated with some 
of them will be discussed later (see section II.c). As yet 
only one of these housekeeping genes, the mouse 
dihydrofolate reductase (dhfr) gene, has actually been 
tested for Spl binding in vitro (unpublished data reported 
in, Kadonaga et al., 1986; Dynan and Tjian, 1985). For 
other housekeeping genes, Spl binding has only been 
predicted from the DNA sequence. However, GC boxes have 
also been described for the human metallothionein I, and 
IIA promoters (Richards et al., 1984) and these have been 
shown to bind Spl (unpublished data reported in Kadonaga et 
al., 1986). The metallothionei n IA and IIA Spl binding 
sites are interspersed with other important regulatory 
sequences, such as the metal regulatory elements (MREs) and 
basal level enhancer sequences (BLEs). Finally, a DNA 
segment cloned from the monkey genome by homology with the 
SV40 origin of replication, which functions in vivo as a 
bidirectional promoter element (Saffer and Singer, 1984), 
contains two Spl-binding regions with closely spaced, 
tandemly arranged GC boxes (Dynan et al., 1985).
The TATA, CAAT and GC-box motifs and the trans-acting 
factors that have been identified which bind to them, have 
been described in detail. Given the large number of genes 
which contain these motifs, it is likely that they 
generally represent constitutive transcriptional elements 
for the genes containing them. The amount of factor
available to these elements within different cell types and 
also their actual arrangement within promoter regions, 
could be used to modulate gene activity. However, to 
explain tissue-specific transcription during development 
and differentiation of different cell types, 
tissue-specific promoter elements are believed to be 
involved. These include the Drosophila heat shock element, 
HSE, which is recognized by the heat shock transcription 
factor, HSTF (Parker and Topol, 1984), the glucocorticoid 
response element, GRE (Miesfeld et al., 1986), the metal 
response element, MRE (Richards et al., 1984) and the
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octameric element essential for the efficient use of 
immunoglobulin promoters in B cells (Singh et al., 1986). 
It is also possible that these site-specific DNA-binding 
proteins participate in different cellular processes. For 
example, the octamer element important in immunoglob^n gene 
transcription is also found as a regulatory motif in 
histone H2B and U2 snRNA genes (Singh et al., 1986; Sive 
and Roeder, 1986). It can also be specifically bound by 
another cellular activity required for adenovirus 
replication (Jones et al., 1987). These observations 
support the emerging notion that some DNA binding 
activities may be redundant in nature, allowing them to 
participate in many different regulatory events. The 
specificity of such events, whether transcriptional or 
replicational, being determined, at least in part, by the 
context of the particular binding site.
(iv) Enhancer elements
"’In addition to the sequence modules discussed above, 
the enhancer elements are characterized by many individual 
motifs clustered together. These elements have unusual 
properties which were first observed for the SV40 enhancer 
(Banerji et al., 1981; Moreau et al., 1981; Fromm and Berg, 
1983). They include: 1) strong transcriptional activation
(up to 1000-fold) of a linked gene, 2) transcriptional 
activation is independent of enhancer orientation and 3) 
the enhancer can function over distances of greater than 
1000 bp from an upstream or downstream position, relative 
to the transcriptional initiation sites. The SV4 0 enhancer 
is referred to as promiscuous because of its ubiquitous 
role in stimulating RNA polymerase II transcription in 
nearly all mammalian cell types and also in amphibian and 
even algal cells (reviewed by Serfling et al., 1985). The 
magnitude of the stimulation however, depends on the 
promoter examined. Nuclear run-on transcription assays 
suggest that this enhancer increases the density of RNA
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polymerase II molecules within the linked gene (Treisman 
and Maniatis, 1985; Weber and Schaffner, 1985). Both in 
vitro and in vivo competition experiments implicate trans 
acting factors in this activity (Sassone-Corsi et al., 
1985; Wang and Calame, 1986). In vitro DNA-protein binding 
techniques have identified specific factors which interact 
with the SV40 enhancer and also with various cellular 
regulatory sequences (Bohman et al., 1987; Lee et al.,
1987) .
Unlike the promiscuous SV40 enhancer many other viral 
enhancers have been described which show cell-type 
specificity, for example, the SV40-related mouse polyoma 
virus is about four times more active in mouse cells than 
in primate cells. An explanation for this observation is 
suggested by experiments showing that the polyoma enhancer 
competes only moderately for the SV4 0 enhancer factors 
(Sassone-Corsi et al., 1985). Viral enhancer elements 
exhibiting varying degrees of cell-type specificity have 
also been detected in the early region of adenoviruses, the 
immediate early regions of herpes viruses and in the long 
terminal repeats of retroviruses (Serfling et al ., 1985).
Cellular enhancers are usually found in the 5' 
flanking sequences of genes (typically between position 
-100 and -300 bp relative to the cap site(s)), where they 
may physically and functionally overlap upstream promoter 
elements, such that the distinction between these two types 
of regulatory elements becomes unclear. In the
metallothionein (MT) genes of mouse and man, the upstream 
regions contain constitutive sequence elements,
interspersed with the regulatory ones, such as a TATA box, 
GC boxes and basal level enhancer (BLE) sequences (Stuart 
et a l . , 1986; Carter et al., 1984; Karin et al., 1984;
Haslinger and Karin, 1985). Cellular enhancers are also 
found within, and 3', to their respective genes. In fact, 
the first cellular enhancer discovered, was found in the 
intron separating the rearranged V^DJ^ and C^ segments of 
the immmunoglobulin heavy-chain gene (Gillies et al., 1983;
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Banerji et al., 1983). This discovery was of particular 
importance as this immunoglobulin enhancer was the first 
regulatory element identified capable of stimulating 
transcription in a cell-type specific manner. Recently, a 
3 1 tissue-specific enhancer has been found approximately 
400 bp 3 1 to the polyadenylation signal of the chicken 
adult fi -globin gene (Choi and Engel, 1986). Thus the unique 
ability of enhancers to stimulate transcription even when 
placed downstream of genes in vitro, has now been realized 
in viv o .
Various models for enhancer function have been 
suggested and perhaps the model most often suggested is 
that enhancers provide a bidirectional entry site for RNA 
polymerase molecules, or for the other factors associated 
with the transcription complex (Wasylyck et al., 1983). 
However, at least for the Kappa immunoglobulin enhancer, 
this model has been shown to be inapplicable and thus it is 
possible that different enhancers may have different 
mechanisms of action (Atchison and Perry, 1986). Other 
models include: 1) A general domain "opening" of the Kappa 
locus, caused by the enhancer altering the torsional 
stress in the DNA (see review by Luchnik, 1985) ; 2) Direct 
interactions of the enhancer with other components of the 
chromatin fibre may direct the linked gene to
transcriptionally active regions of the nucleus. This 
speculation is supported by the presence of a nuclear 
matrix associated region, adjacent to the mouse Kappa
immunoglol^in gene enhancer (Cockerill and Garrard, 1986).
Finally, a fourth model involves interactions between
proteins bound at enhancers and proteins bound at 
promoters. An important observation for models of enhancer 
action is that immunoglobulin producing myeloma cells have 
been found, in which endogenous heavy chain genes remain 
active, even though the enhancer has been completely
deleted. This suggests that the heavy chain enhancer is 
not continually required for immunoglobulin transcription 
(Wabl and Burrows, 1984; Klein et al., 1984). In this
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case, the enhancer function is believed to be required only 
for the establishment of transcriptional activity and not 
for the maintenance of this transcriptionally active state. 
In support of this speculation, an enhancer-less heavy 
chain gene, which is transcriptionally active in its 
endogenous location, becomes enhancer-dependent when 
introduced into plasmacytoma cells by transfection (Zaller 
and Eckhardt, 1985).
In summary, the above observations suggest that 
enhancers are likely to be a hetergeneous group of 
regulatory elements and therefore the models outlined here 
may be relevant to some, but not to others. Among the 
heterogeneous enhancer elements known, those of the SV40 
virus and various retroviral LTR enhancers, are believed to 
enhance transcription from the human c-Ha-rasl gene (Chang 
et al., 1982; Spandidos and Wilkie, 1984). However, no 
enhancer-like activity for any sequences near the cellular 
ras genes has yet been adequately demonstrated.
(b) Distinct features of promoters for 1 housekeeping" 
genes
The "housekeeping" genes are generally ubiquitously 
expressed in all tissues and most, like the classical ras 
genes, may be expressed at nearly constant levels 
throughout development and differentiation. Therefore, it 
is likely that these genes have different mechanisms 
controlling their expression, than those controlling the 
highly regulated "luxury-protein" genes. As yet little 
information is available describing the details of either 
of these levels of control. It is important to remember 
that the "luxury-proteins" and "housekeeping" genes 
represent the extremes of gene control. There is likely to 
be a full spectrum of regulatory mechanisms between these 
two extremes, which in some cases may overlap. In general, 
a number of striking differences between the promoters for 
these two types of genes have been recently noticed. Of
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the "housekeeping" genes categorized so .far, all have an 
exceptionally high G + C content in their 5' flanking 
sequences. For example, the human adenosine deaminase (ADA) 
promoter has been shown to be contained within a 135 bp 
fragment, which is 82% G + C (Valero et al., 1985) and the 
5 1 flanking sequences of the adenine
phosphoribosyl transferase (APRT) gene is 66% G + C (Dush 
et al., 1985). Another particularly noteworthy feature, is 
the absence of TATA and CAAT boxes from nearly all of these 
housekeeping genes, an observation first noted for the 
mouse hypoxanthine phosphoribosyl transferase (HPRT) gene 
(Melton et al., 1984). Rare exceptions to this general
rule are known, such as the superoxide dismutase 1 (SOD-1)
gene which is known to have a TATA box (Levanon et al.,
1985) . The absence of a TATA box may help to explain
another property common to many of these genes. That is, 
the use of multiple transcription initiation sites, as the 
TATA sequence motif is believed be to involved in 
determining the specific site of transcriptional intitation 
(see section II.a.i). The hamster
3-hydroxyl-3-methylglutaryl coenzyme A (HMG CoA) reductase 
gene has five major clusters of multiple initiation sites, 
spanning approximately 90 bp (Reynolds et al., 1984). The 
mouse dihydrofolate reductase (DHFR) gene also has multiple 
initiation sites, clustered at positions 500-560 bp, 
270-310 bp and a major initiation site 115 bp, upstream 
from the ATG translational initiation codon (McGrogan et 
al., 1985; Crouse et al., 1985). Interestingly, the mouse 
DHFR gene has been reported in two conflicting reports, to 
have a bidirectional promoter. Both reports describe 
divergent transcription from the promoter region of this 
gene. However, Farnham et al. (1985) describe the 
opposite-strand RNAs as small (180-240 nucleotides), 
abundant in nuclear RNA, non-polyadenylated and with 
heterogenous 5 1 ends. This contrasts with the
opposite-strand RNA of Crouse et al. (1985) which is at 
least 14,000 nucleotides long and appears to code for a
40
protein. There is no good explanation for these conflicting 
data, but it should be noted that the discrete 3 1 end of 
the small nuclear RNA, described by Farnham and colleagues, 
corresponds to a good concensus donor splice site, 
suggesting a processing event.
The only conspicuous concensus sequences in the 5' 
flanking region of most of these "housekeeping" genes, are 
multiple copies of the previously discussed GC box (see 
section Il.a.iii). These motifs may be arranged
symmetrically, as in the human ADA promoter (Valerio et 
al., 1985) and the mouse APRT promoter (Dush et al., 1985), 
which have five and four copies of the repeat respectively. 
They may also be asymmetrically arranged, as are the five 
repeats of the hamster HMG Co A reductase promoter 
(Reynolds et al., 1984). As previously discussed, 
functional binding of the GC box binding factor, Spl, is 
independent of the orientation of these repeats and herein 
may lie a clue to the possible bidirectional transcription 
from "housekeeping" promoters, such as the mouse DHFR gene. 
Bidirectional transcription from a promoter region is not 
without precedent, as the 3 00 bp SV40 control region 
containing six GC boxes, is essential for both early and 
late viral transcription (section Il.a.iii). Furthermore, 
the SV4 0 late transcription unit uses no obvious TATA box 
and has multiple transcriptional initiation sites (Fromm 
and Berg, 1982; Brady et al., 1984).
The G + C rich 5 ’ flanking sequences of "housekeeping" 
genes have been suggested by Bird (1985) to be related to 
the previously reported Hpall tiny fragments, HTFs (Cooper 
et al., 1983). These HTFs represent about 1% of the 
genomes of a wide range of vertebrates and this fraction is 
derived from islands of non-methylated, G + C rich DNA, 
containing Hpall restriction endonuclease recognition 
sites, at approximately 15 times their frequency in bulk 
DNA. Cloning of three, non-ribosomal, mouse HTF islands, 
along with Cot analysis of the entire HTF subfraction of 
the mouse genome, has shown that HTF islands are mostly low
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copy number sequences (Bird et al., 1985). Indeed, the 
three clones hybridized to discrete transcripts on northern 
blots of mouse polyadenylated RNA. These results suggest 
that HTF islands are associated with genes and by using the 
criteria of Hpall site frequency and lack of methylation, 
putative HTF islands have been identified around some 
genes. The mouse HPRT gene has a highly G + C rich 5' 
flanking region (Melton, et al., 1984), which is 
hypomethylated and has clustered Hpall sites, but the rest 
of the gene is extensively methylated (Wolf, et al., 1984; 
Yen, et al., 1984). The hamster APRT, the mouse DHFR and 
the chicken «2(I) collagen genes are also hypomethylated 
(Stein, et al., 1983; McKean, et al., 1982). Furthermore, 
this pattern of hypomethylation appears to be invariant in 
all cells examined, including sperm, which agrees well with 
the constitutive patterns of expression of these genes. In 
vitro methylation of the hamster APRT gene also supports 
this pattern, as CpG methylation in the 5' region inhibited 
expression of this gene, whereas 3 1 methylation had no 
effect (Keshet, et al., 1985). Further circumstantial 
support for the hypothesis that hypomethylated HTF islands 
may be involved in the expression of "housekeeping" genes, 
comes from the observation that these sites are nuclease 
hypersensitive in the human glucose-6-phosphate 
dehydrogenase (G6PD) and HPRT genes (Wolf and Migeon,
1985).
The hypothesis that the c-Ha-rasl proto-oncogene
performs some sort of "housekeeping" function essential to 
all dividing cells, (see section I.d), suggests that some 
aspects of the regulation of this gene could resemble those 
of other "housekeeping" genes. From the above discussion 
of "housekeeping-type" promoters, it is noticeable that 
these promoters have an exceptionally high G + C content, 
which may be hypomethylated. They generally lack the usual 
concensus sequence motifs often associated with
"luxury—protein" genes, like the TATA and CAAT boxes and 
also the various tissue—specific motifs known. Furthermore,
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they often specify multiple transcriptional initiation 
sites and usually have multiple copies of the GC box.
The DNA sequence of the human c-Ha-rasl proto-oncogene 
has been determined for the 1669 bp upstream from the ATG 
translational initiation codon (Reddy, 1983; Capon, et al., 
1983a). This analysis revealed a number of interesting 
features (see section I.b and Figure 2) including: 1) the 
general G + C richness of the 5' flanking sequences, 2) a 
cluster of TATA-like and CAAT-like sequence motif, 3) a 
potential acceptor splice site 53 bp upstream from the ATG 
codon, 4) a potential donor splice site 1093 bp upstream 
from the ATG codon and 5) a pair of 15 bp direct repeats 
located adjacent to each of the upstream splice site. 
However, at the time the work presented in this thesis was 
begun, there were no RNA mapping data available to support 
any of these features. Furthermore, the information 
recently accumulated on the promoter structures of the 
various "housekeeping" genes was not yet available. The 
initial results presented here attempted to provide SI 
mapping data in support of the strongly proposed promoter 
region corresponding to the TATA- and CAAT-like sequence 
motif (Reddy, 1983; Capon, et al., 1983a). However, this 
analysis provided data in support of an upstream non-coding 
exon, 5 1 to the donor splice site 1093 bp upstream from the 
ATG codon. This upstream region has no TATA or CAAT boxes, 
is 80% G + C rich and has eleven randomly repeated (in 
either orientation) hexanucleotide core sequences 
corresponding to GC boxes. These GC boxes include three 
which have been characterized as strong binding sites for 
the Spl transcription factor (Kadonaga, et al., 1986). 
Furthermore, multiple transcriptional initiation sites have 
been identified in this region, which has been shown to 
function as a bidirectional promoter. Finally, in this 
thesis a mutational analysis of the promoter region 
identified was used to identify sequences important for the 
regulation of this gene. The effect of a known element (the 
SV40 enhancer) on c-Ha-rasl transcription was also examined
and shown to increase c-Ha-rasl transcription by 20 fold. 
The purpose of this thesis was to investigate the 
transcriptional regulational of the human c-Ha-rasl 
proto-oncogene. This investigation allowed some interesting 
speculations to be made concerning the question of whether 
transcriptional regulation of this gene, may in certain 
circumstances, be implicated in carcinogenesis.
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MATERIALS AND METHODS
I. GROWTH OF BACTERIA AND GENERAL MANIPULATIONS OF DNA
(a) Growth and maintainance of bacteria
The bacterial strain HB101 (Boyer and Roulland 
Eussoix, 1969) was grown in LB (Luria-Bertani) medium (1% 
bactotryptone, 5% bacto-yeast extract, 1% NaCl, pH 7.5) or 
occasionally in N medium (1% glucose, 1% bactotryptone, 
0.1% bacto-yeast extract, 0.8% NaCl, 0.03% CaCl2) and 
maintained on LB or N medium plates (LB or N medium 
containing 1.5% Difco minimal agar). Long term storage of 
HB101, as well as HB101 containing plasmids was by making 
aliquots of stationary phase culture 20% with respect to 
glycerol and storing at -20°C‘
(b) Preparation of calcium competent cells
A 10 ml overnight cluture of HB101 cells was grown 
from a single bacterial colony. This 10 ml overnight 
culture was used to inoculate 1L of LB medium and this 
culture was then shaken at 37 C until the cell density, as 
measured by absorbance at was 0.6 to 0.8. The cells
were chilled on ice for 30 minutes and pelleted at 5000 rpm 
for 5 minutes at 4°C. The supernatant was decanted, the 
bacterial pellet resuspended in 1L of ice cold lOmM MgSC>4 
and incubated on ice for 30 minutes. The cells were 
pelleted as before, resuspended in 500 ml of ice cold CaCl2 
and again incubated on ice for 3 0 minutes. The supernatant 
was decanted and the cells resuspended in 50 mis of ice 
cold 50mM CaCl2 and 20% glycerol. The cell suspension was 
distributed as 1 ml aliquots in Eppendorf tubes, 
snap-frozen in liquid nitrogen and stored in liquid 
nitrogen or in a -135°C freezer.
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(c) Transformation of calcium competent cells
A tube of competent HB101 cells was removed from 
storage in liquid nitrogen and thawed on ice. A 10 ul 
aliquot of the 20 ul ligation reaction (see earlier) was 
removed and placed on ice, to which was added, 40 ul of ice 
cold TNE buffer (50 mM Tris pH 7.5, 100 mM NaCl, ImM EDTA) , 
20 ul of ice cold 10X TCM buffer (100 mM Tris pH 7.0, lOOmM 
MgCl2 , 100 mM CaCl2) and 125 ul of competent HB101 cells. 
This suspension was incubated on ice for 2 0 minutes, heat 
shocked at 42°C for 1.5 minutes and allowed to sit at room 
temperature for 10 minutes. One ml of LB or N medium was 
added to each tube and the tubes were shaken at 37°C for 60 
minutes to allow the antibiotic resistance gene encoded by 
the plasmids to be expressed. The tubes were briefly (15 
seconds) spun in a microcentrifuge and the cells 
resuspended in 200 ul or 400 ul of LB or N medium and 200 
ul aliquots were plated onto LB or N medium plates 
containing 100 ug/ml ampicillin (Sigma). The plates were 
incubated at 37°C overnight.
(d) Rapid screening of bacterial colonies (Birnboim and 
Poly, 1979)
Bacterial colonies were picked from plates and used to 
inoculate 1.5 ml of LB medium in Eppendorf tubes, which 
were then left shaking at 37°C overnight. Cells were spun 
down (15 seconds in a microcentrifuge) and resuspended in 
100 ul of ice cold lysis solution (25 mM Tris pH 8.0, 50 mM 
glucose, 10 mM EDTA, 2mg/ml lysozyme). The resuspended 
cells were incubated on ice for 15 minutes, 2 00 ul 
alkaline- SDS (0.2 M NaOH, 1% sodium dodecylsuphate) was 
added and the suspension incubated on ice for a further 5 
minutes. Finally, 150 ul of ice cold High Salt solution (3M 
sodium acetate pH 4.8) was added, the contents of the tube 
were gently mixed by inversion and incubated on ice for a
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further 15 minutes. After being spun in a microcentrifuge 
for 3 minutes the supernatants were removed into fresh 
tubes and 0.6 volumes of ice cold propan-2-ol (Fisher) were 
added to precipitate the plasmid DNA. The precipitated 
plasmid DNA was washed with 80% ethanol, dried, redissolved 
in 50 ul of IX T.E. buffer plus 50 ug/ml RNase A (T.E. 
buffer is 10 mM Tris pH 8.0, 1 mM EDTA) and incubated at 
7 0°C for one hour. This incubation helps inactivate 
bacterial DNases which may contaminate the plasmid DNA 
isolated in this way and the RNase A digests contaminating 
RNA. Diagnostic restriction endonuclease digestions can now 
be performed on 10 ul aliquots of the crudely purified 
plasmid DNAs.
(e) Growth and isolation of plasmid DNA
A 5 ml aliquot of an overnight culture of bacteria, 
containing the plasmid of interest, was inoculated into 500 
ml of fresh LB medium containing 100 ug/ml ampicillin 
(Sigma). The culture was grown at 3 7°C for 6 - 8  hours when 
85 mg of chloramphenicol (Sigma) was added to give a final 
concentration of 170 ug/ml. The culture was then shaken at 
37°C overnight. For some plasmids the chloramphenicol 
amplification step was not necessary so cultures containing 
these plasmids were simply allowed to grow overnight in LB 
medium containing ampicillin.
The isolation of plasmid from overnight cultures was 
essentially a scaled up version of the method described for 
the rapid screening of bacterial colonies (Birnboim and 
Daly, 1979). Cells were harvested by centrifugation at 6000 
rpm at 4°C for 10 minutes in 500 ml bottles, washed by res- 
usending in 50 ml of ice cold 50mM Tris pH 8.0 and pelleted 
as before. The cells were then resuspended in 50 ml of 
freshly prepared lysis solution (25 mM Tris( pH 8.0), 50 mM 
glucose, 10 mM EDTA, 5 ug/ml lysozyme) and incubated on ice 
for 30 minutes. Then 80 mis of fresh alkaline-SDS (see 
earlier) was added, mixed gently and incubated on ice for 5
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minutes. Lastly, 40 ml of ice cold High Salt solution (3M 
potassium acetate, pH 4.8) was added, the mixture was 
gently mixed and incubated on ice for 15 minutes, before 
centrifugation at 8000 rpm for 5 minutes at room 
temperature. The supernatant was decanted into fresh 2 50 ml 
bottles and 0.6 volumes of propan-2-ol was added and mixed 
and spun immediately at 8000 rpm for 5 minutes at room 
temperature. The pellet was allowed to drain dry, 
resuspended in 5 ml of T.E. buffer (10 mM Tris pH 8.0, ImM 
EDTA) and loaded onto cesium chloride (BRL)-ethidium 
bromide equilibrium gradients. Cesium chloride-ethidium 
bromide equilibrium gradients were 0.95 g/ml cesium 
chloride, 0.5 mg/ml ethidium bromide and made up to 10 ml 
with the crudely purified plasmid DNA and T.E. buffer. 
These gradients were ultracentrifuged at 40,000 rpm for 36 
hours at 21°C in a Beckmann Type-65 rotor or Type -70 
rotor. The banded plasmid DNA was extracted, the ethidium 
bromide removed with propan-2-ol and the DNA dialysed 
against dH20 at 4°C overnight.
(f) Agarose gel electrophoresis
Agarose gels were generally made up to 1%, 1.5% or 2% 
agarose in IX TEA (40 mM Tris pH 8.0, 1 mM EDTA, 4 mM
sodium acetate) or in IX TBE (89 mM Tris-borate, 89 mM 
boric acid, 2mM EDTA, pH 8.0) by boiling. Ethidium bromide 
was added to a final concentration of 0.5 ug/ml and the gel 
was poured into an appropriately sized horizontal gel 
apparatus and allowed to solidify with an appropriate comb 
in place. Running buffer (IX TEA or IX TBE containing 0.5 
ug/ml ethidium bromide) was added and the samples were 
loaded into wells. Gels were generally run at 25 V 
overnight or at 100-150 V for 1 to 6 hours, and were 
photographed immediately under ultra violet (u.v.) light. 
Occasionally low melting point agarose gels were used for 
DNA fragment isolation (see below). These gels were 
prepared in a similar fashion using BRL low melting point
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agarose and were always poured and electrophoresed in the 
cold room (4°C).
(g) Polyacrylamide gel electrophoresis
Polyacrylamide gels (5 - 12%) were made up from a 50% 
stock solution (crosslinked 29:1, acrylamide:
bis-acrylamide). TBE was added to a final concentration of
IX and dH20 added to give the final volume of 50 mis.
Ammonium persulphate was added to 0.03% and N,N,N,N- 
tetramethylethlenediamine (temed) was added to 0.08% to 
catalyse the polymerization reaction. The solution was 
poured immediately between taped, siliconized glass plates 
to give a gel, upon polymerization, with dimensions 150 mm
X 180 mm X 1 mm. The running buffer was IX TBE and the gel
was run at 150 Volts for 3-6 hours or at 25-50 Volts
overnight. Following electrophoresis these gels were 
stained in 0.5 ug/ml ethidium bromide and photographed 
under u.v. light.
(h) Denaturing polyacrylamide gel electrophoresis
To visualize single stranded nucleic acid fragments, 
an acrylamide gel containing urea, which is a strong 
denaturant, was used. These gels were used to visualize SI 
nuclease protection products, primer extension products and 
Maxam Gilbert sequencing products (see analysis of DNA and 
RNA) . Depending on the size of the fragments to be 
visualized these gels were from 6 - 10% acrylamide
(crosslinked 19:1 acrylamide: bisacrylamide), 7M urea
(Pharmacia) and IX TBE. Ammonium persulphate was added to 
0.03% and N , N , N , N-tetramethylethylenediamine (temed) was 
added to 0.08%. Gel dimensions were 180mm X 380mm X 0.5mm. 
These gels were run at a constant 45 Watts for 1.5 - 2.0
hours in IX TBE with a precisely fitting aluminium plate 
clipped onto the larger glass plate to prevent uneven 
migration of bands. It is important to prerun these gels
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for at least one half hour prior to loading the sample,so 
that, the gel can heat up to its running temperature. 
Following electrophoresis the gels were autoradiographed at 
-70 C with an intensifying screen (Cronex) overnight or 
longer until the bands were visualized.
(i) Isolation of DNA fragments from low melting agarose 
gels (Smith, 1980)
After running the gel (see earlier section) the 
desired band was cut out under u.v. illumination and a 4 
5 fold excess of sterile was added. The agarose was
melted at 70°C for 10 minutes and placed at 37°C for 5 
minutes to lower its temperature. One volume of cold phenol 
was added, the mixture vortexed immediately for one minute 
and cooled on ice for 5 minutes. The phases were separated 
by centrifugation in an Eppendorf microcentrifuge for 2 
minutes. The aqueous phase was removed into a fresh tube 
and the phenol phase was re-extracted with a small volume 
of dH20. The pooled aqueous phases were phenol extracted 
once more to eliminate any remaining agarose. Fo 1lowing 
centrifugation, the aqueous phase was removed and either 
butan-2-ol extracted to reduce its volume and ethanol 
precipitated, or ethanol precipitated directly.
(j ) Isolation of DNA fragments from acrylamide gels
This procedure routinely gave yields of at least 90%, 
therefore it was the method generally employed for 
isolating both radioactively labelled and non-radioactively 
labelled DNA fragments. Following autoradiography, or 
ethidium bromide staining and u.v. visulization, the 
appropriate band was sliced from the gel and placed into a 
heat sealed 1ml pipette tip that contained a small amount 
of siliconized glass wool packed into the tip. The 
acrylamide was finely minced and Elution Buffer (0.2M 
sodium acetate pH 5.3, 0.1% SDS) was added to cover the
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acrylamide. The top of the pipette tip was sealed and this 
mixture was incubated at 37°C overnight. The liquid was 
drained into an Eppendorf tube and the acrylamide left 
behind was rinsed twice with a small amount of elution 
buffer. The collected solution was then ethanol 
precipitated on dry ice. Following precipitation, the 
pellet was washed carefully twice with 80% ethanol to
remove any SDS and the nucleic acid was resuspended in 
sterile dH20.
(k) Dephosphorylation of DNA
The 5 1 terminal phosphates were removed from linear 
DNA molecules prior to 5 1 end labelling with Kinase (see
later) and from linearized vectors to reduce background due 
to self ligation while cloning. Two different methods were 
employed. For 5' end-labelling, bacterial alkaline 
phosphatase (BAP, Worthington) was used to remove the
terminal 5' phosphates, and in order to prevent vectors 
from self-ligating during cloning, calf intestinal alkaline 
phosphatase (CIAP, Boehringer) was used. For the BAP
reaction, 1 to 20 picomol of 5' ends were brought to a 
volume of 50 ul with 50mM Tris pH 8.8, 0.5 units
Worthington BAP was added (this BAP was prepared and its
activity assayed as directed by the manufacturer) and the 
reaction incubated at 60°C for 3 0 minutes. The reaction was 
stopped with 0.5 ul of 0.1M EDTA and extracted twice with
phenol chloroform, once with ether, and then ethanol
precipitated. The CIAP reaction was simply carried out by 
adding 1 ul of CIAP (Boehringer) to the restriction digest 
after ensuring that digestion was complete, and further 
incubating at 37°C for 1 hour. The reaction was stopped 
with 10 ul of 0.1M EDTA and all the protein was removed as 
for the BAP reaction.
(1) Creating blunt ended fragments
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Overhanging 5' ends were filled in, using the DNA 
polymerizing activity of the Klenow fragment of E. Coli DNA 
polymerase I, exactly as described in the Molecular Cloning 
Manual (Maniatis et al., 1982). However, after the end 
filling reaction, the fragments were extracted with 
phenol/chloroform and then precipitated with ethanol, 
prior to ligation.
Overhanging 3 1 ends were made blunt-ended by using the 
3' exonuclease activity of bacteriophage T4 DNA polymerase. 
Again, this procedure is descibed in detail in the 
Molecular Cloning Manual (Maniatis et al., 1982).
(m) Ligations
Ligations were performed in 20 ul reaction volumes, as 
the concentration of ends and the concentration of ligase 
are the critical factors. Optimum efficiencies were 
obtained when 1 - 10 ng of vector DNA was ligated to a 3 -
5 fold molar excess of insert. Appropriate dilutions of
vector and insert DNA were made, to which 4 ul of 5X
Ligation Salts (150 mM Tris pH 7.5 at 4°C, 150 mM NaCl, 38
mM MgCl2) , 2 ul of 10X Ligation Mix (2.5 mM ATP (P-L
Biochemicals), 20 mM dithiothreitol (Sigma), lOmM
spermidine (Sigma) , 2mM EDTA, lmg/ml BSA) and 2 units of T4 
DNA ligase (Boehringer), were added and the volume made up 
to 2 0 ul with dH20. The reactions were incubated at room 
temperature for 1-2 hours (for ligation of overhaning ends) 
or at 4°C overnight followed by 1 hour at room temperature 
(blunt end ligations).
Linker ligations were done by resuspending the ethanol
precipitated blunt ended fragments (see earlier) in 9 ul of
dH20 and adding 4 ul of 5X Ligation Salts, 2 ul of 5X
Ligation Mix, 4 ul of phosphorylated linkers and 2 units of
T4 DNA ligase. In this study two different octameric
linkers were used; BamHl (d(pC-G-G-A-T-C-C-G)) NEB lot
6-59; one unit/50 ul) and Hindlll
2 D U
(d(pC-G-G-A-T-C-C-G)) NEB lot 8-100; one A26Q unit/50ul) .
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The linker ligation reactions were left incubating at 4°c 
overnight and for 1 hour at room temperature the next day. 
An aliquot of 49 ul dH20 ws then added, 10 ul of 
restriction buffer (10X BamHl buffer or 10X Hindlll 
buffer), 10 ul of lmg/ml BSA (BRL) and 10 ul of restriction 
endonuclease (25u/ul BamHl (NEB) or 20u/ul Hindll (NEB)). 
The vast excess of restriction endonuclease was required 
because of the molar excess of linkers. The digestion was 
left all day and overnight at 37°C to ensure complete 
digestion, extracted with phenol/chloroform, precipitated 
with ethanol and run on an 8% polyacrylamide gel 
(cross-linked 29:1, acrylamide:bis-acrylamide) to separate 
the digested linkers from the linkered fragment.
II. GROWTH AND TRANSFECTION OF HUMAN CELLS IN CULTURE
(a) Growth and maintainence of human cells
The cell lines used in this study are, EJ human 
bladder carcinoma cells, which are now known to be 
identical to the T24 human bladder carcinoma cell line 
(O'Toole et al., 1983), A431 human epidermal cells, derived 
from a human vulval carcinoma, HeLa human fibroblasts cells 
and Cos7 monkey Kidney cells. All of these cells were 
obtained from the Beatson Institute for Cancer Research, 
Glasgow. A431, HeLa and Cos7 cells were grown in Special 
Liquid Medium (SLM) containing penicillin, supplied by 
Gibco, supplemented with 10 - 15% fetal calf serum (Gibco) 
and 200 mM L-glutamine (Gibco) to give a final 
concentration of 2 mM. EJ cells were grown in SLM plus 
L—glutamine but only 5% fetal calf serum. HeLa cells were 
grown in Dulbecco's Modified Eagles (DME) medium 
supplemented with 10% fetal calf serum. All cells were 
grown at 37°C in chambers containing 5% C02 or pre-gassed 
with an air mixture containing 5% C02 and grown in tightly 
sealed flasks (Corning). As these cell lines are all
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adherent, confluent monolayers were passaged by aspirating 
away the medium, washing the cells with PBS (137 mM NaCl,
2.7 mM KC1, 8 mM Na2HPC>4 , 1.5 mM KH2P04 , pH 7.0) and adding
1 -2 mis of trypsin- EDTA (0.25% trypsin (Gibco), 0.1% EDTA
in PBS). The trypsin -EDTA was left in contact with the
cells until the cells rounded up and dissociated from the 
plate. 5 - 1 0  mis of fresh medium was added to each disk or 
flask, the cells were pipetted gently several times to 
break up clumps of cells and then added to fresh dishes or 
flasks in the ratio of 1ml cells suspension to 10 ml of 
fresh medium. To protect all cell strains against genetic 
divergence and microbiological contaminations, cell 
cultures growning in log phase were harvested and frozen 
slowly at 1°C per minute in the presence of 10% glycerol as 
a protective agent in 1 ml ampoules, each containing 2.5
g
10 X 10 cells. The ampoules were then permanently stored 
in liquid nitrogen until required, when a single ampoule 
was rapidly thawed by immersion in tepid water and the 
cells injected directly into culture medium for further 
propagation. In general any cells grown continuously in 
culture for long periods of time were replaced every 3 
months with a fresh seed taken from the liquid nitrogen 
freezer.
(b) Transfection of cultured cells by calcium phosphate 
precipitation (Wigler et al., 1979)
Twenty-four hours prior to transfection, cells were 
passaged to give on the day of transfection either, 50% 
confluent cultures for HeLa cells or 70% confluent cultures 
for Cos7 cells. Usually two 80 cm2 dishes or flasks were 
transfected for each plasmid of DNA of interest. Calcium 
phosphate precipitates were formed for each 80 cm dish or 
flask by bringing 40 ug of the plasmid DNA of interest up 
to a volume of 900 ul with sterile 0.1X TE buffer (ImM Tris 
at pH 8.0, O.lxnM EDTA), adding 100 ul of 2.5 M CaCl2 
(Mallinkrodt, filter sterilized) and adding all of the
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above to a separate tube, while vortexing, containing 1 ml 
of 2X Hepes Buffered Saline (HBS) (2X HBS is 50 mM Hepes, 
280 mM NaCl, 1.5 mM Na2HP04 accurately brought to pH 7.1 at 
room temperature). The DNA - CaP04 precipitate was allowed 
to form by letting the vigorously vortexed mixture sit at 
room temperature for exactly 3 0 minutes, after which all of 
the above was added to one 80 cm2 flask or dish and left 
for 8-16 hours at 37°C. Following this treatment, the 
medium containing the finely grained DNA -CaPC>4 precipitate 
was aspirated off and fresh medium added to allow cells to 
recover. The transfected cells were harvested 48 hours 
following addition of the frsh medium.
(c) Isolation of total RNA from cultured cells (Chirgwin 
et al., 1979)
Both transfected and non-transfected cells were washed 
with PBS and trypsinized as above, followed by 
centrifugation (1000 rpm at room temperature) and further 
washing of the cell pellet with PBS. The volume of the cell 
pellet was estimated and for an approximately 100 ul cell 
pellet, 800 ul of Lysis buffer (5M guanidineisothiocyanate 
(Fluka) , 50 mM Tris pH 7.5, 10 mM EDTA) and 50 ul of neat
2- mercaptoethanol (Sigma) were added to lyse the cells. 
The cell suspension was vortexed vigorously and passed 
through a fine hypodermic needle which sheared genomic DNA 
and hence reduced the viscosity. The lysed cell suspension 
was then left at room temperature for 2 0 minutes and then 5 
ml of filter sterilized 4M LiCl (Sigma) was added. After 
mixing, the lysed cell suspension was left at 4 C for at 
least 20 hours to specifically precipitate the RNA, 
followed by centrifugation at 6500 rpm for 1.5 hours at 
4°C. The supernatant was removed and discarded, the RNA 
pellet washed by resuspension in 3 ml of 3M LiCl, 
centrifuged at 6500 rpm for 30 minutes at 4 C and the RNA 
pellet dissolved in 200 ul of TE buffer. The dissolved RNA 
was extracted twice with phenol/chloroform, first with 0.5
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volumes of phenol/chloroform and second with 1 volume of 
phenol/chloroform, then precipitated with- ethanol and 
redissolved in 30 - 40 ul of sterile dH2<0. An aliquot of 2 
ul was removed and used to determine the yield of RNA by 
u.v. spectrophotometry.
This procedure was also used in a scaled up version to 
isolate total RNA from large cultures (up to twenty 175 
cm2 flasks) of EJ and A431 cells.
(d) Purification of polyadenylated RNA
Polyadenylated RNA was isolated from the total RNA 
prepared as above by oligo-dT selection (Favaloro et al., 
1980) . Total RNA was brought to 1 ug/ul. To this, one 
volume of 2X dT Binding buffer (20 mM Tris pH 7.5, 1M NaCl, 
0.1 % (w/v) Sarcosyl (Sigma)) was added to bring the mixed 
solution to IX dT Binding buffer (10 mM Tris pH 7.5, 500 mM 
NaCl, 0.1% (w/v) sarcosyl). This solution was then applied 
to an oligo-dT cellulose (BRL) column prepared in 5 ml 
hypodermic syringe by blocking off the opening to the 
syringe with a disc of Whatman 2.5 cm GF/C glass microfibre 
filter, adding oligo-dT celluolse up to the 0.5 ml mark on 
the syringe and washing the column carefully with IX dT 
Binding buffer. Up to 10 mg of total RNA can be processed 
per 1 ml of oligo-dT cellulose. After the prepared RNA 
sample was added to the column, the initial flow through 
was reapplied to the column to ensure complete binding of 
the polyadenylated RNA. The column was then washed 3 times 
with 2 ml of IX dT Binding buffer, per ml of column volume 
and washed 3 times more with 2 ml of dT Midwash buffer (10 
mM Tris pH 7.5, 100 mM NaCl, 0.1% sarcosyl), per ml of
column volume. Finally, the bound polyadenylated RNA was 
eluted off the column into four separate fractions by 
washing the column 4 times with 2 ml of dT Elution buffer 
(5 mM Tris pH 7.5, 1 mM EDTA, 0.1% (w/v) sodium
dodecylsulphate (Sigma)), per ml of column volume. Each 
fraction was assayed for RNA content by u.v.
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spectrophotometry.
III. Analysis of RNA
(a ) Preparation of end-labelled single-stranded DNA 
fragments
5 1 end-label DNA restriction fragments were first
dephosphorylated, by treatment with bacterial alkaline
phosphatase (see previous section), then precipitated with
ethanol and redissolved in 2.5 ul of 10 mM Tris pH 8.0,
17.7 ul of Kinase Buffer 1 (20 mM Tris 9.5, 1 mM spermidine
(Sigma), 0.1 mM EDTA). The mixture was incubated at 90°C
for 2 minutes, followed by quenching on ice. This
incubation facilitates the Kinase reaction by opening up
the ends of the molecule. Next, 2.5 ul of Kinase buffer 2
(500 mM Tris pH 9.5, 100 mM MgCl2 , 50 mM dithiothreitol
(DTT, Sigma), 50% (v/v) glycerol), and 20 units of
polynucleotide Kinase (P-L Biochemicals) were added. The
mixture was then transferred to another tube containing 125 
32uCi of y- P-ATP (> 5000 Ci/mmol, Amersham) which had been 
freeze dried to a volume of approximately 2.5 ul. The 
reaction was incubated at 37°C for 30 minutes, stopped with 
0.1 M EDTA and co-precipitated with 40 ug of yeast tRNA in 
preparation for strand separation (see later).
Fragments to be 3 1 end labelled were designed so that 
they had recessed 3' ends which could therefore be filled 
in using the enzyme T4 DNA polymerase I (BRL) . A
disadvantage of this technique is that DNA fragments with 
blunt-ends or 3 1 overhanging ends cannot easily be labelled 
in this way. The amount of DNA equivalent to 5 to 20 
picomol of 3' ends was calculated and after 
phenol/chloroform extraction, the dry ethanol precipitated 
pellet was resuspended in 3 ul of dH20. To this, 15 ul of
2X T4 buffer (130 mM Tris pH 8.0, 13 mM MgCl2 , 10 mM
dithiothreitol (Sigma)) , 1 ul of a 5 mM solution of each of
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dATP, dGTP and dTTP (obtained as 100 mM solutions from P-L 
Biochemicals) , 8 ul P—dCTP (> 7000 Ci/mmol, Amersham)
and 10 units of T4 DNA polymerase I was added. The reaction 
was incubated at 11°C for 3 hours, stopped with 10 ul of 
0.1 M EDTA and prepared for strand separation as for 5 1 end 
labelled probes. It is important to note that the choice of 
labelled deoxyribonucleotide triphosphate used depends on 
the presence in the 5' overhang of its complementary 
deoxyribonucleotide triphosphate.
Both 5 1 and 3' end-labelled DNA fragments were strand
separated as follows. Strand separation gels, of the
appropriate concentration were prepared from a 50% 
acrylamide stock solution (crosslinked 29:1, acrylamide: 
bisacrylamide), using 0.6X TBE running buffer. The gel 
dimensions were 180 mm X 380 mm X 1 mm and these gels were 
run at 100 - 300 Volts in IX TBE running buffer, for at
least 15 hours. The samples were prepared for strand 
separation by co-precipitating 40 ug of 30% DMSO mix (30% 
dimethylsulphoxide (Sigma), IX TBE, 0.1% bromophenol blue, 
0.1% xylene cyanol) or 80% formamide mix (8 0% formamide 
(Fluka), IX TBE, 0.1% bromophenol blue, 0.1% xylene
cyanol). When fully resuspended, the samples were placed
into a boiling water bath for 4 - 5 minutes, quenched
immediately on ice and loaded onto the gel. Usually the 
labelled fragments to be strand separated in this way were 
of such high specific activity that autoradiography for 2 
minutes at room temperature with an intensifying screen 
(Cronex) was sufficient to allow detection of the bands.
(b) SI nuclease analysis
End-labelled strand separated DNA probes were used for 
SI nuclease analysis performed by the method of Berk and 
Sharp (1977) as modified by Weaver and Weissman (1979). The 
appropriate RNA sample was freeze dried with the end 
labelled DNA probe, together with sufficient yeast tRNA 
(P-L Biochemicals) to give a specified total of nucleic
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acid, usually 20 ug. The freeze dried nucleic acid was 
resuspended in 10 ul of Formamide Hybridization Buffer (FHB 
is: 80% formamide (Fluka), 400 mM NaCl, 40 mM Pipes pH 6.4 
(Sigma) 1mm EDTA) pipetted into a siliconized glass 
capillary tube and the ends heat sealed. The capillary 
tubes were placed into glass test tubes containing 
immersed in a 90°C water bath for 10 minutes to denature 
the nucleic acids and immediately transferred to another 
water bath, set at the appropriate hybridization 
temperature, and incubated overnight. Whenever a new probe 
was used, control hybridizations were done to determine 
empirically, the optimum hybrizization temperature and also 
to ensure that the probe excess was reached.
Overnight hybridizations were stopped by quenching the 
capillaries in -20°C ethanol and flushing out the 
capillaries with ice cold SI nuclease assay buffer (250 mM 
NaCl, 30 mM sodium acetate pH 4.6, 1 mM ZnS04 (Sigma), 200 
ug/ml calf thymus DNA (Sigma)). 300 - 1000 units of SI
nuclease (Boehringer) were added and the reaction incubated 
at 37°C for 90 minutes unless SI nuclease digestion 
temperature controls were required when the temperature was 
varied between 21°C and 45°C. After SI nuclease digestion, 
the reactions were phenol/chloroform extracted once, 
ethanol precipitated in the presence of 10 ug of yeast 
tRNA, resuspended in formamide loading buffer (80% 
formamide, IX TBE, 0.1% bromophenol blue, 0.1% xylene 
cyanol), denatured for 2 minutes at 100°C, chilled on ice 
and the reaction products analysed on denaturing 
polyacrylamide gels, (see earlier) followed by 
autoradigraphy.
(c) Exonuclease VII analysis
Exonuclease VII analysis (Berk and Sharp, 1978) can 
be used to independently confirm data already obtained with 
SI nuclease. Exonuclease VII is a processive exonuclease 
that, unlike SI nuclease, releases small oligonucleotides
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from the 3' and 5 1 ends of single stranded DNA ( Chase and 
Richardson, 1964). Analyses using this enzyme were 
performed almost identically to SI nuclease analysis 
(Proudfoot, personal communication). However, the 
capillaries were flushed out with ice cold Exonuclease VII 
buffer (10 mM Tris pH 7.8, 13 mM KC1, 10 mM EDTA), 4 units 
of exonuclease VII (BRL) were added to the reaction 
mixture and the reaction incubated at 37°C for 2 hours. The 
rest of the procedure was as above for SI nuclease 
analysis.
(d) Primer extension analysis
Primer extension analysis was performed with short, 5' 
end-labelled, strand-separated DNA probes. These probes 
were prepared and hybridized to RNAs, as has previously 
been described for SI nuclease and exonuclease VII analysis 
(see above). The hybridizations were performed at 45-52°C 
and the hybridized nucleic acids were flushed from their 
capillaries with 200 ul of ice cold 0.2M sodi 'um acetate pH 
4.8, phenol extracted once, ethanol precipitated and
resuspended in 29 ul of sterile dH20, which had been 
treated with diethyl pyrocarbonate (Sigma). To the
resuspended nucleic acid, 10 ul of 5X Reverse Transcriptase 
buffer (250 mM Tris pH 8.2, 250 mM KC1, 10 mM MgCl2 , 5 mM
dithiothreitol), 10 ul of a solution containing all four 
deoxynucleotide triphosphates, each at 5 mM (Pharmacia), 
and 1 ul AMV reverse transcriptase at 2 5 units/ul 
(Boehringer), was added. The reaction was incubated at 42 C 
for 3 hours, with the addition of a further 10 units of AMV 
reverse transcriptase and 2 ul of the 5 mM
deoxyribonucleotide triphosphate mix, after 1 hour and 2 
hours of incubation. The reaction was stopped with 5 ul of 
0.1 M EDTA and the RNA was alkali hydrolyzed by the 
addition of 10 ul of 1 M NaOH and incubated at 42°C for 1 
hour. Phenol red indicator was added and the reaction 
titrated against 1M HCl until the solution was neutralized.
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The neutralized reaction was phenol/chloroform extracted 
twice, ethanol precipitated and the reaction products 
analysed on denaturing polyacrylamide gels, followed by 
autoradiography (see earlier).
(e) Northern blot analysis
RNA was electrophoresed on 1% denaturing agarose gels 
as follows. 2g of agarose (BRL) was autoclaved in 147 mis 
of dH20 for 20 minutes. After cooling to approximately 
50°C, 20 mis of 10X MOPS buffer (0.2M
morpholinopropanesulphonic acid (Sigma), 50 mM sodium
acetate (Sigma), 5 mM EDTA, pH 7.0) and 33 mis formaldehyde 
(Fluka) were added and the molten gel was poured onto 
appropriate gel moulds. The freeze dried RNA samples 
(usually 20 ug total or poly A RNA, or 5 to 10 ug poly A+ 
RNA) were resuspended in 25 ul of freshly prepared sample 
buffer (50% formamide (Fluka), 2.2M formaldehyde, IX MOPS 
buffer), denatured at 65°C for 5 minutes, chilled on ice 
and electrophoresed at 30 Volts overnight or 100 to 140 
Volts for 3 to 4 hours with buffer circulation. After 
photography, the gel was equilibrated to 2OX SSC (3M NaCl,
0.3 M sodium citrate) by soaking in 2OX SSC for 15 minutes. 
Excess gel was trimmed away and the dimensions of the gel 
measured. One piece of nitrocellulose (Sartorius), four 
pieces of filter paper (Whatman 3mm) and a 10-15 cm stack 
of paper towels were cut to the size of the. gel. The 
nitrocellulose filter was briefly wet in d ^ O  followed by 
soaking for 3 0 minutes in 2OX SSC. Meanwhile, a platform 
was fitted into a rectangular pyrex dish containing 500 ml 
of 20X SSC. Two appropriately sized pieces of wet filter 
paper were placed over the platform so that the ends formed 
wicks. The gel was placed on top and all air bubbles 
removed before the pre—wet nitrocellulose filter was placed 
on top of the gel, again making sure all air bubbles were 
removed. Next the four pieces of Whatman 3mm filter paper 
were placed on top of the nitrocellulose filter, the first
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two were pre-wet in 2OX SSC, and finally the stack of paper 
towels was placed on top along with a small weight. To 
ensure that blotting only occured through the gel, saran 
wrap was placed alongside the edges of the gel, this also 
prevented excessive evaporation. Blotting was allowed to 
continue at least overnight. After blotting, the 
nitrocellulose filter was removed, rinsed briefly in 5X 
SSC, placed between two sheets of Whatman 3mm filter paper 
and baked at 80°C for 2 hours.
The nitrocellulose filter was placed in a polystyrene
bag and heat sealed as close to the filter as possible,
carefully removing air spaces. Prehybridization solution
(50% formamide, 5X SSC, 5X Denhardts, 50 mM Na^HPO./NaH^PO,2 4' 2 4
pH 6.5, 0.1% SDS, 500 ug/ml salmon sperm DNA) was added to
2a final volume of at least 200 ul/cm per filter (note,
100X Denhardts is 2% ficoll (Sigma), 2% polyvinyl
pyrrolidone-40 (Sigma), 2% w/v Bovine Serum Albumin
(Sigma)). The bag was carefully sealed to remove all air
bubbles and the filter was incubated at 42°C for 6-16 hours
with gentle shaking. The prehybridization solution was
removed and hybridization solution (50% formamide, 5XSSC,
IX Denhardts, 2 0 mM Na2HP04/NaH2PC>4 pH 6.5, 0.1% SDS, 10%
dextran sulphate (Sigma), lOOug/ml salmon sperm DNA, which
contained labelled probe at a concentration of not more
2than 10 ug/ml was added to give a volume of 100 ul/cm per 
filter. The bag was sealed as before and the filter 
incubated at 42°C for 16-48 hours with gentle shaking.
Filters were washed in solutions of increasing 
stringency to remove any nonspecific hybridization. The 
first wash was with 500 ml of 2X SSC, 0.1% SDS at room 
temperature for 2 0 minutes. All other washes were performed 
at 65°C for 20 minutes and consisted of a 2X SSC; 0.1% SDS 
wash; two 0.5X SSC; 0.1% SDS washes, and one or two 0.1X 
SSC; 0.1% SDS washes. To remove traces of SDS the filter 
was washed in 0.1X SSC at room temperature for 10 minutes. 
Following the washes the filter was briefly blot dried and 
autoradiographed at -70°C with an intensifying screen
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(DuPont).
(f) Nick translation of DNA
Nick translations (Rigby et al., 1977) were performed 
exactly as directed by the Amersham Nick Translation Kit, 
using 50 - 100 ul of a -32p-dCTP (> 3000 Ci/mmol) .
Separation of incorporated label from unincorporated label 
was by chromatography through G-50 sephadex (Pharmacia) 
columns, equilibrated with 0.3M NaCl, 0.1% SDS, 20 mM Tris 
pH 7.5 and 1 mM EDTA. Fractions collected off the first 
radioactive peak were pooled and used directly.
(g) Oligo labelling (or Second Strand Synthesis) of DNA
A recent technique has been developed (Feinberg and 
Vogelstein, 1983) for radiolabelling DNA restriction 
endonuclease fragments to high specific activity. 50ng of 
DNA restiction fragment was brought to a volume of 32 ul 
with dH20 and denatured in boiling water for 10 minutes. 
Without quenching on ice, 10 ul of OLB buffer, 2 ul of 10 
mg/ml BSA (BRL), 5 ul a - 32P-dCTP (> 3000 Ci/mmol, Amersham) 
and 0.5 ul of Klenow fragment (Boehringer Mannheim) were 
added. The reaction was mixed well and incubated at room 
temperature for 2.5 hours (OLB buffer is 248 mM Tris pH 
7.4, 24mM MgCl2 , 56 mM 2-mercaptoethanol (BDH), 0.12mM in 
each of dATP, dGTP, dTTP (Pharmacia), 1M hepes pH 6.6 
(Sigma), 3 0 OD units/ml calf thymus
hexadeoxyribonucleotides (Pharmacia)). To further increase 
the specific activity of certain probes, a-32P-dGTP (> 3 000 
Ci/mol) was used as well as a - 32P-dCTP. In this case OLB 
buffer without the dGTP component was used. The reaction 
was stopped by the addition of 100 ul of 0.5 M EDTA and 
since the incorporation of labelled nucleotide triphosphate 
is usually greater than 50% it was usually not necessary to 
purify the precursor nucleotide triphosphate from the 
labelled product prior to hybridization. In this case the
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specific activity was determined by spotting a 1 ul sample 
onto a DEAE cellulose filter (Whatman DE81) and measuring 
Cherenkof radiation. The filter was then washed with a 
phosphate buffer such as 20X GeneScreen buffer (0.5M 
Na2HP04^NaH2P04 ' 6 *5)/ dried and Cherenkof radiation
remeasured. The latter reading gives the incorporated 
counts per minute and can be subtracted from the previous 
reading to determine the percentage incorporation.
A modification of this technique was also used, in 
which DNA restiction fragments were labelled without 
purification from low melting point agarose (Feinberg and 
Vogelstein, 1983a).
IV. ANALYSIS OF DNA
(a) Southern blotting and hybridization
Cellular DNA was analysed by the technique of Southern 
blot analysis (Southern, 1977). The DNA was digested to 
completion with restriction endonucleases and run on 1% 
agarose gels at 40 Volts overnight in a IX TEA buffer, for 
a 20 cm long gel. After staining in 0.5 ug/ml of ethidium 
bromide, the gel was photographed and the DNA transferred 
to GeneScreen hybridization transfer membranes (NEN) by the 
capillary blot procedure, exactly as recommended by the 
manufacturer. Hybridization to the DNA was performed using 
the dextran sulphate plus formamide method (i.e. GeneScreen 
hybridization method III) .
(b) DNA sequencing
Single stranded end-labelled DNA molecules were 
sequenced using a modification of the technique developed 
by Maxam and Gilbert (1980). Freeze dried end-labelled DNA 
was resuspended in 11 ul of and 2.5 ul aliquots were
dispensed into four siliconized Eppendorf tubes. The
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guanosine (G) specific cleavage reaction was performed as 
follows. To the aliquot of end-labelled DNA, 98 ul of DMS 
buffer (50 mM sodium cacodylate (Sigma) , 1 mM EDTA , pH 
8.0) was added and the mixture was placed on ice. Upon 
addition of 0.5 ul of dimethyl sulphate (DMS, Sigma) the 
mixture was incubated at 2 0°C for four minutes, after which 
24 ul of DMS "stop buffer" (1.5 M sodium acetate, 1.0 M 
mercaptoethanol, 100 ug/ml yeast tRNA (P-L Biochemicals)) 
and 4 0 ul of absolute ethanol were added. The mixture was 
then stored at -70°C for 15 minutes. The adenosine and 
guanosine (A + G) specific cleavage reaction was performed 
as follows. To the aliquot of end-labelled DNA, 11 ul of 
dH20 was added and the mixture was placed on ice. Upon 
addition of 2.5 ul of piperidine formate (4% v/v formic 
acid, adjusted to pH 2.0 with piperidine (Fisher)) the 
mixture was incubated at 30°C for 70 minutes. The mixture 
was then freeze-dried, resuspended in 10 ul of dH20 and 
freeze-dried once more. The cytosine (C) specific cleavage 
reaction was performed as follows. To the aliquot of 
end-labelled DNA, 5 ul of 5 M sodium chloride was added and 
the mixture placed on ice. Upon addition of 15 ul of 
hydrazine (Kodak), the mixture was incubated at 20°C for 8 
minutes. Meanwhile, the thymine and cytosine (T + C) 
specific cleavage reaction was set up as follows. To the 
aliquot of end-labelled DNA, 6 ul of dH20 was added and the 
mixture placed on ice. Upon addition of 15 ul of 
hydrazine, the mixture was incubated at 20°C for 6 minutes. 
Both the C and the T + C specific cleavage reaction 
mixtures were then placed on ice and 60 ul of hydrazine 
"stop buffer" (0.3 M sodium acetate, 0.1 mM EDTA, 50 ug/ml 
yeast tRNA) and 250 ul of absolute ethanol was added to 
each. These reaction mixtures were then stored at -70 C for 
15 minutes. The G, T + C and C specific reaction mixtures 
were then centrifuged at 10,000 rpm for 5 minutes. The 
resulting pellets were resuspended in 60 ul of 0.3 M sodium 
acetate, 200 ul of absolute ethanol was added and the 
mixtures were stored at -70°C for 15 minutes. Following
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centrifugation as before, the supernatant was removed and 
the pellets were washed twice with 200 ul of 70% ethanol. 
The dried pellets from all four reaction mixtures were then 
resuspended in 100 ul of 10% v/v piperidine (Sigma) ,
incubated at 90 C for 30 minutes and lyophilized overnight. 
The dried reaction mixtures were twice resuspended in 2 0 ul 
of dH20 and re-lyophilized prior to gel electrophoresis on 
6% denaturing polyacrylamide gels.
V. CAT ASSAYS
Chloramphenicol acetyl transferase (CAT) assays were 
used as an indirect means of determining the promoter 
activity, if any, of DNA fragments inserted immediately 
upstream of the bacterial CAT gene, contained in the
plasmid pLW2 (Gaffney et al., 1985). HeLa cells were
transiently transfected as described above and harvested as 
follows.
The tissue culture medium was carefully removed from 
the cells, the cells were washed with 5 mis of PBS buffer 
and then soaked in 1 ml of CAT-TEN buffer (40 mM Tris, pH 
7.4; 150 mM NaCl; ImM EDTA) for 5-15 minutes. The cells 
were scraped off the dishes, pipetted into Eppendorf tubes 
on ice, centrifuged at 10,000 rpm for 30 seconds at 4 C and 
the supernatant removed. The cell pellet was then
resuspended in 100 ul of 0.25 M Tris (pH 7.8), dispersed by 
pipetting and immediately transferred to an ethanol/ 
dry-ice bath. The cells were lysed by three successive
cycles of freezing and thawing (37°C) and centrifuged at
10,000 rpm for 8 minutes at 4°C. The supernatant was
removed and used as a crude cell extract for the CAT assay.
The levels of CAT activity contained within each cell 
extract were measured by incubating (37 C for 30 minutes) 
20 ul aliquots of each cell extract in a 50 ul mixture
containing, 250 mM Tris (pH 7.8), 3 mg/ml acetyl coenzyme A 
(Sigma) and 0.5 uCi of 14C-chloramphenicol (NEN, 100
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uCi/ml;60 mCi/mmol). Each reaction was stopped by the
addition of 300 ul of ethyl acetate (Fisher) and vortexed
vigorously for exactly 15 seconds. The timing is important
14because the amount of C chloramphenicol extracted into
the organic phase varies with time. After vortexing, the
reaction mixture was centrifuged at 10,000 rpm for 8
minutes at room temperature and the organic phase was
14removed and dried down m  a dessicator. The dried C 
chloramphenicol was redissolved in 20 ul of ethyl acetate 
and spotted onto SIL-G silica gel thin layer chromatography 
plates (Kodak). Ascending chromatography was performed in 
95% chloroform (Fisher): 5% methanol (Fisher), after which 
the chromatograms were autoradiographed overnight at room 
temperature without an intensifying screen.
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RESULTS
I. MAPPING THE PROMOTER SEQUENCES FOR THE HUMAN c-Ha-rasl 
GENE
Promoter sequences of genes are genetic regulatory 
elements which direct correct levels of transcription of 
linked genes from specific initiation sites. To understand 
transcriptional regulation of the human c-Ha-rasl gene, it 
is therefore necessary to identify the transcriptional 
initiation site(s) for this gene. Subsequent analysis of 
the linked promoter sequences controlling the levels of 
transcription from these sites can then be undertaken. 
Sequence data from Capon et al. (1983a) and Reddy (1983), 
as discussed in the Introduction, suggested that the 
promoter for the c-Ha-rasl gene might be located about 250 
bp upstream from the translational initiation site. This 
suggestion was based largely on weak homologies to the TATA 
and CAAT boxes, which are known to regulate transcription 
initiation in certain genes (Introduction, Il.b.i). Thus 
initial attempts at mapping the transcription initiation 
sites were focused on the region containing the putative 
TATA/CAAT promoter.
(a) SI mapping analysis of the putative TATA/CAAT promoter 
region
To identify transcription initiation sites in the 
region identified as the putative promoter region, the 
initial approach of SI mapping analysis was used, as 
described by Berk and Sharp (1977) and modified by Weaver 
and Weissman (1979). A series of DNA restriction fragments 
spanning the putative promoter region were used as SI 
hybridization probes. These fragments were isolated from 
pT24 (Figure 1-1), a plasmid containing the c-Ha-rasl
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Figure 1-1 The plasmid pT24.
Plasmid pT24 comprises the 6.4 Kb BamHI fragment (heavy line) containing 
the human c-Ha-rasl oncogene from the EJ/T24 bladder carcinoma cell line, 
inserted into the vector pBR322. Numbering of the BamHI insert is as in 
Reddy (1983), where 1670 gives the position of the ATG codon and 3751 
gives the position of the polyadenylation site. The positions of the four 
coding exons are indicated by shaded rectangles. The position of the 
selectable ampicillin resistance (Ap ) gene within the pBR322 sequence is 
shown by the arrow. B — BamHI.
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oncogene derived from the EJ/T24 human bladder carcinoma 
cell line (Introduction, I.b) , cloned as a 6.4 Kb BamHI 
fragment, into the unique BamHI site of pBR322. The pT24 
plasmid was obtained from Dr. Alan Balmain (Beatson 
Institute, Glasgow). Strand separated DNA fragments 
labelled with 7-32p-ATP at the 5' termini were hybridized 
to polyadenylated (poly A+ ) RNA from the EJ/T24 human
bladder carcinoma cell line. RNA from this cell line was
used, as transcription of the c-Ha-rasl gene was believed 
to be ten fold elevated with respect to other cell lines
available (Dr. Alan Balmain, personal communication). To
control for probe artifacts each probe was also hybridized 
to yeast transfer RNA (tRNA) , as this RNA contains no 
sequences homologous to ras genes.
Initially a 1146 bp Sau3A fragment, extending from the 
middle of exon 1 to approximately 1 Kb upstream of exon 1,
was isolated from pT24 (Figure 1-2). This fragment was 5'
3 2end-labelled with 7- P-ATP, strand-separated and the 
strand labelled at the Sau3A site within exon 1, was 
hybridized at 55°C for 16 hours in 8 0% formamide 
hybridization buffer (FHB, see Materials and Methods) to 10 
ug of poly A+ EJ/T24 RNA plus 10 ug of yeast tRNA, or to 20 
ug of yeast tRNA. Following hybridization, the hybrids were 
digested with 300 units of SI nuclease at 37°C for 90 
minutes and the products denatured and sized on a 6% 
denaturing polyacrylamide gel. Data representative of six 
independent SI mapping experiments, using this fragment, 
are given in Figure 1—2. A number of DNA fragments were 
protected from SI digestion. The major bands form a cluster 
approximately mapping to positions -40 to -50 relative to 
the ATG translational initiation codon, which is taken as 
position +1. Three minor bands were frequently observed, 
mapping just upstream of the main cluster, at positions -70 
+2, -75 +3 and -82 +3. However, no bands were detected in
the yeast control lane, indicating that these protected 
species are unlikely to be probe artifacts. Furthermore, no 
protected bands were observed mapping to the region
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Figure 1-2 SI mapping analysis of EJ poly A+ RNA using the 
1146 nucleotide Sau3A-Sau3A probe.
RNA was hybridized for 16 hours at 55°C to 7-^P-ATP 5' end-labelled 
anti-sense 1146 Sau3A-Sau3A probe DNA. The probe was labelled in the first 
coding exon as indicated by the asterisk in the line drawing and all 
hybridizations were carried out in probe excess. Hybrids were treated with 
SI nuclease, as described in the main text, and digestion products were 
denatured and separated on a 6% denaturing polyacrylamide gel. 
Autoradiography was for 10 days at -70 C with an intensifying screen. 
Lanes: (1) 7ug of EJ poly A and 13 ug of yeast tRNA; (2) 20 ug of yeast 
tRNA; (3) probe alone. Markers (M) are provided by Haelll fragments of 
0X174, whose sizes are indicated by closed arrow heads. The line drawing 
shows the positions of the first two coding exons (exl and ex2) and the 
position of the putative TATA/CAAT promoter (P) as an open box. Numbering 
is relative to the ATG translational initiation codon. S - Sau3A.
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containing the proposed TATA and CAAT boxes, as would be 
expected if these motifs were elements of the c-Ha-rasl 
promoter. To confirm this result, the independent 213 
nucleotide Pstl-Haelll probe, mapping from position -182 to 
+31, and the 415 nucleotide Xmal-Xmal probe, mapping from 
position -441 to -26, were labelled as shown in Figures 1-3 
and 1-4, and hybridized to EJ poly A+ RNA at 55°C and 45°C 
respectively. The lower hybridization temperature was used 
in the case of the 415 nucleotide Xmal-Xmal probe as the 
sizes of the hybrids formed were expected to be much 
smaller than those detected by the 213 nucleotide 
Pstl-Haelll probe. The protected hybrids were digested with 
300 units SI nuclease at 37°C and the products denatured
and sized on 8% or 10% denaturing polyacrylamide gels. As
shown in Figures 1-3 and 1-4, these independent probes 
confirm the presence of c-Ha-rasl specific messenger RNA 
(mRNA) with putative 5' termini clustered between positions 
-40 to -50 and approximately at positions -70, -75 and -80 
relative to the ATG codon. This confirms the putative 5' 
termini observed with the 1146 nucleotide Sau3A-Sau3A
probe. The weakness of the banding pattern observed with
the 213 nucleotide Pstl-Haelll probe (Figure 1-3) is
believed to be caused by a combination of the reduced 
efficiency of 5' end-labelling at a blunt end and because 
half the amount of EJ poly A+ RNA was used in the
experiment. The result obtained with the 415 nucleotide 
Xmal-Xmal probe was particularly useful for estimating the 
sizes of the protected fragments observed, as the position 
of the 5 1 end-label was only 20 nucleotides from the main 
cluster of bands observed. Additionally, this 415
nucleotide Xmal-Xmal probe did not detect RNA termini which 
would correspond to termini produced by the proposed 
TATA/CAAT promotor. In this experiment fainter bands were
also observed in the negative control (Figure 1-4, lane 2). 
These fainter bands were occasionally observed in 
experiments using the 415 nucleotide Xmal-Xmal probe and 
are now known to correspond to secondary structure within
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Figure 1-3 SI mapping analysis of EJ poly A+ RNA using the 213 nucleotide 
Pstl-Haelll probe.
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RNA was hybridized for 16 hours at 55 C to Y- P-ATP 5' end-labelled
anti-sense 213 nucleotide Pst-Haelll probe DNA. The probe was labelled in
the first coding exon as indicated by the asterisk in the line drawing and 
all hybridizations were carried out in probe excess. Hybrids were treated 
with SI nuclease, as described in the main text, and digestion products 
were denatured and separated on an 8% denaturing polyacrylamide gel. 
Autoradiography was for 10 days at -70 C with an intensifying screen. 
Lanes: (1) 4 ug of EJ poly A RNA and 16 ug of yeast tRNA; (2) 20 ug of 
yeast tRNA; (3) probe alone. Markers (M) are provided by Haelll fragments 
of 0X174, whose sizes are indicated by closed arrow heads. The line
drawing is as in Figure 1-2. P - PstI; H - Haelll.
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Figure 1-4 SI mapping analysis of EJ poly A+ using the 415 nucleotide 
Xmal-Xmal probe.
RNA was hybridized for 16 hours at 45°C to 7-^P-ATP 5' end-labelled 
anti-sense 415 nucleotide Xmal-Xmal probe DNA. The probe was labelled in 
the 5' untranslated sequence of exon 1, as indicated by the asterisk in 
the line drawing and all hybridizations were carried out in probe excess. 
Hybrids were treated with SI nuclease, as described in the main text, and 
digestion products were denatured and separated on a 10% denaturing 
polyacrylamide gel. Autoradiography was for 5+ days at -70 C with an 
intensifying screen. Lanes: (1) 7 ug of EJ polyA and 13 ug of yeast tRNA;
(2) 20 ug of yeast tRNA; (3) probe alone. Markers (M) are provided by 
Sau3A fragments of pBR322 whose sizes are indicated by closed arrow heads. 
The line drawing is as in Figure 1-2 except that the small inverted arrows 
represent a potential stem-loop structure centered at position -54. X - 
Xmal.
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the probe.
The technique of SI mapping analysis using 5' 
end-labelled probes allows the detection of either genuine 
RNA initiation sites, or, 5' RNA termini generated by 
digestion at a splice junction. Inspection of the DNA 
sequence immediately upstream from the region where the 
major cluster of SI protected fragments map, does indeed 
reveal an acceptor splice site (Capon et al., 1983a). 
Furthermore, closer examination of the DNA sequence in this 
region revealed a potential stem-loop structure. Figure 1-5 
shows this secondary structure, which consists of a stem of 
2 0 base-paired nucleotides and a 26 nucleotide loop. By 
assigning the rules of Tinoco et al. (1973), for estimating 
the most stable secondary structure for the RNA equivalent 
of this structure, a free energy of approximately -3 0 kCal 
at 25°C in neutral buffer of moderate or high ionic 
strength, was calculated. Therefore, it is possible that 
this stem-loop structure could be stable under the 
conditions of SI nuclease digestion. Taken together with 
the SI mapping analysis, there are three possible 
explanations for these data: 1) that the clusters of SI 
protected fragments map to genuine RNA transcription 
initiation sites, 2 ) that they are artifacts due to the 
strong stem-loop structure occuring in the probe molecule 
and that SI cleavage at this structure prevents detection 
of RNA species initiating from the putative TATA/CAAT 
promoter, 3 ) that they correspond to 5 1 termini generated 
by digestion at a splice junction present in a longer 
message initiating transcription further upstream than the 
corresponding intervening sequence.The possibility that the 
stem-loop structure may interfere with the detection of 
longer transcripts is supported by the SI mapping analysis 
using the 415 nucleotide Xmal-Xmal probe (Figure 1-4) since 
the bands observed with this probe accurately fit the model 
of the stem-loop structure shown in Figure 1-5. This does 
not, however, rule out the other two hypotheses.
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Figure 1-5 The stem-loop structure 24 bp upstream from the ATG
translational initiation codon.
This secondary structure consists of a stem of at least 20 bp and a 26
nucleotide loop. It is shown for the sense strand of the double stranded
DNA molecule. The free energy value (-30 kCal at 25°C) for the RNA
equivalent of this structure was calculated from the rules of Tinoco et 
al. (1973). Numbering is relative to the ATG codon and the position of the 
Xmal site used for 5' end-labelling in Figure 1-4 is shown. The arrows 
mark the approximate position of the SI protected fragments shown in 
Figure 1-4, where the size of the arrow is an indication of the intensity 
of the signal observed. The position of the concensus acceptor splice 
sequence within the loop region is shown by the enclosed curves and the 
splice site is at position -53. The horizontal dashes indicate hydrogen 
bonds.
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(b) Exonuclease VII mapping analysis
To further investigate which of the above hypotheses 
is correct, an alternative mapping analysis, using 
exonuclease VII rather than SI nuclease, was carried out. 
Exonuclease VII is also a single-stranded specific 
nuclease, but unlike SI nuclease, it cannot cut 
single-stranded regions within hybrid molecules. Its 
activity is limited to exonucleolytic attack at 
sdngle-stranded 5 1 and 3' ends, from which it sequentially 
releases small oligonucleotides (Chase and Richardson, 
1964). Thus, by using exonuclease VII mapping it should be 
possible to distinguish whether the RNA termini mapping 
between positions -40 to -82 are genuine transcription 
initiation sites or whether the stem-loop structure in the 
probe allows SI cleavage at this single stranded region 
thus preventing the detection of RNA(s) initiating further 
upstream, from the putative TATA/CAAT promoter. 
Furthermore, if the probe used for exonuclease VII mapping 
analysis completely spans the intervening sequence expected 
on the basis of the splice site hypothesis, then a very 
large protected fragment would be expected.
The 114 6 nucleotide Sau3A-Sau3A single stranded probe, 
5 ’ end-labelled with 7 -32P-ATP at position +71 within the 
first coding exon and extending to position -1079, was 
prepared as before. This probe was hybridized at 55 C for 
16 hours in 80% FHB to either 5 ug of EJ/T24 poly A and 15 
ug of yeast tRNA, or to 20 ug of yeast tRNA. Following 
hybridization, the hybrids were incubated at 37 C for 90 
minutes with varying amounts of SI nuclease or exonuclease
VII and the products were denatured and sized on a 6%
denaturing polyacrylamide gel (Figure 1-6). The SI mapping 
data was as before, with the major cluster of bands mapping 
to positions -4 0 to -50 and the three minor bands mapping
to positions -70 +2, -75 +3 and -82 +3 (lanes 2 and 3). To
determine the sensitivity of these bands to a higher
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Figure 1-6 SI and Exonuclease VII mapping analyses of EJ poly A+ RNA 
using the 1146 nucleotide Sau3A-Sau3A probe.
32RNA was hybridized to the y - P-ATP 5' end-labelled 1146 nucleotide 
Sau3A-Sau3A probe exactly, as indicated in Figure 1-2. Hybrids were 
treated with 300 units or 900 units of SI nuclease (Boehringer) for 1.5 
hours at 37 C or with 5 units or 15 units of exonuclease VII (BRL) for 2 
hours at 37 C. Digestion products were denatured and separated on a 6% 
denaturing polyacrylamide gel. Autoradiography was for 12 days at -70 C 
w.j.th an intensifying screen. Lanes: (1) probe alone; (2) 5 ug of EJ poly
A RNA and 15 ug of yeast tRNA, 300 units of SI; (3) 5 ug of EJ poly A
RNA and 15 ug of yeast tRNA, 900 un|.ts of SI; (4) 20 ug of yeast tRNA, 300
units of SI; (5) 5 ug of EJ poly A an<jl 15 ug of yeast tRNA, 5 units of
exonuclease VII; (6) 5 ug of EJ poly A and 15 units of yeast tRNA, 15
units of exonuclease VII; (7) 20 ug of yeast tRNA, 5 units of exonuclease 
VII. Markers are provided by Rsal (M) and Haelll (m) fragments of 0X174 
whose sizes are indicated by the closed arrow-heads. The line drawing is 
as in Figure 1-2. S *■ Sau3A.
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concentration of SI nuclease, the hybrids in lane 3 were 
digested with a 3 fold excess of SI nuclease. This results 
in the loss of signal expected for such a large excess of 
enzyme but interestingly, the two higher molecular weight 
bands in lane 2 , mapping to positions -75 +3 and -82 +3 ,
disappear completely in lane 3. This suggests that these 
bands may be probe artifacts due to the stem-loop structure 
in the probe molecule, as increasing the concentration of 
SI nuclease would be expected to increase the frequency of 
a second cut by SI nuclease at a position within the loop 
region nearer to the 5 1 end-label. Thus SI nuclease cuts, 
at sites within the secondary structure further away from 
the 5' end-label, would be observed less often. Following 
digestion with exonuclease VII, the only protected 
fragments not observed in the negative control (yeast tRNA; 
lane 7), map approximately to positions -55 and -60, 
relative to the ATG codon, which corresponds to a position 
within the loop region of the putative stem-loop structure 
in Figure 1-5. Since exonuclease VII digestion results in 
protected fragments approximately mapping to the same 
region as the major cluster of SI nuclease digestion 
products, this result strongly suggests that genuine 5' RNA 
termini (generated either by transcription initiation or by 
digestion at the splice junction) exist in this region. 
Thus this result effectively rules out the possibility that 
an RNA species is initated from the region of the proposed 
TATA/CAAT promoter, mapping approximately 190 bp upstream 
from the S 1/exonuclease VII protected fragments.
Furthermore, these bands map to a position close to the 
consensus acceptor splice site at position -53, of sequence 
5 * TCCTTGGCAG/GT 3', where the underlined G residue is the 
only point of divergence from the acceptor splice site 
consensus, 5' PyPyPyPyPyPyX(C/T )AG/G(G/t ) 3•, of Breathnach 
and Chambon (1981), in which Py is pyrimidine and X is any 
base. The observation of two protected fragments mapping 
close to this consensus acceptor splice site, even after 
digestion with a 3-fold excess of exonuclease VII (lane 6),
79
may be explained by the mechanism of action of this enzyme. 
Exonuclease VII rarely digests to a flush end because it 
releases oligonucleotides rather than mononucleotides. 
Therefore, the protected fragments observed are often 
slightly longer than those observed by SI mapping analysis 
(Dr. Nick Proudfoot, personnal communication). Thus there 
are two possible explanations for these SI nuclease and 
exonuclease VII mapping data: 1) the bands observed with 
both techniques reflect the putative splice junction but 
the complex banding pattern observed with SI, but not with 
exonuclease VII, is caused by the stem-loop structure 
occuring in the probe molecule, or 2 ) some of the bands 
observed are due to genuine transcriptional initiation 
sites mapping to a region approximately 4Q, to 50 bp 
upstream of the ATG codon (see Figure 1-5). Therefore, 
primer extension analysis was performed in order to 
distinguish between these two possibilities.
(c) Primer extension analysis
The preceding SI nuclease mapping analysis suggested 
the existence of 5 1 RNA termini mapping to a major cluster 
between positions -40 to -50, with minor termini 
approximately at positions -70, -75 and -82. With
exonuclease VII mapping 5 1 termini mapping between 
positions -55 to -60, were observed. These analyses do not 
distinguish whether the protected fragments observed with 
these two techniques reflect 5 1 RNA termini fgenerated by 
digestion at the splice junction or genuine transcriptional 
initiation sites. Both possible explanations of the data 
were further confused by the potential stem-loop structure 
occuring within each of the probes used. If the 5 1 termini 
detected by SI and exonuclease VII analysis represent 
genuine initiation sites, they will also be detected by 
primer extension. However, if a splice junction exists at 
this position (-54, relative to the ATG codon), then
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primers from within the first coding exon should extend 
through the acceptor splice site at position —5 4 , up to the 
actual 5' terminus or termini, located 5 1 to the 
corresponding donor splice site. Furthermore, the actual 5 ' 
termini are very likely to be located further upstream than 
the Sau3A site at position —1079, that is, the upstream 
Sau3A site of the 1146 nucleotide Sau3A-Sau3A probe used in 
Figure 1-6, since as previously mentioned, a much longer 
exonuclease VII protected fragment should have been 
observed if the corresponding donor splice site occurred 
within this probe. A candidate for the donor splice site 
has been reported at position -1094 (Capon et al., 1983a). 
Its sequence, 5' ACG/GTAGT 3 1 , is a good match for the 
donor splice site concensus sequence, 5' (A/C)AG/GT(A/G)AGT
3' (Breathnach and Chambon, 1981), as the second cytosine 
residue in the c-Ha-rasl sequence is the only point of 
divergence between the two. Alternatively, if the bands 
mapping to the region between positions -40 to -82,
represent genuine transcriptional initiation sites, as 
inferred from the SI nuclease and Exonuclease VII mapping 
analyses, then these sites should be confirmed by primer 
extension analyses.
Several short DNA restriction fragments were isolated 
and used for primer extension analysis with EJ or A431 cell 
line RNAs (A431 cells are a human vulval carcinoma-derived 
cell line, which were available at the Beatson Institute, 
Glasgow). However, only one of these fragments, the 51 bp 
AluI/PvuII fragment, mapping from position +13 to +65 
within exon 1 , could be successfully extended with reverse 
transcriptase. This fragment was 5' end-labelled with 
y -32p-ATP, strand-separated and the strand labelled at 
position +65 (see Figure 1-7) was hybridized at 50 C for 16
hours in 80% FHB to 10 ug of EJ poly A RNA, 10 ug of A431
poly A+ RNA or to 10 ug of yeast tRNA. The hybrids were
extended by treatment with reverse transcriptase (Materials 
and Methods) and the resulting extension products were 
denatured and sized on an 8% denaturing polyacrylamide gel.
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Figure 1-7 Primer extension analysis of EJ and A431 RNAs using the 51 
nucleotide AluI-PvuII primer.
O O
RNA was hybridized at 52 C to 7 - P-ATP 5'. end-labelled anti-sense 51 
nucleotide AluI-PvuII primer DNA. The primer was labelled within the first 
coding exon at position +-65 relative to ATG, as indicated in the line 
drawing by the asterisk. All hybridizations were carried out using 
approximately 200 cps of the primer. Hybrids were treated with 25 units of 
AMV reverse transcriptase (Boehringer) for 3 hours at 42 C and extended 
products were denatured and separated on an 8% denaturing polyacrylamide 
gel. Autoradiography was for 36 hours at -70 C with an intensifying 
screen. Lanes: (1) 10 ug of EJ poly A+ RNA; (2) 10 ug of A431 poly A RNA; 
(3) and (4) 10 ug of yeast tRNA. Markers are Rsal (M) and Haelll (m)
fragment of 0X174, whose sizes are indicated by the closed arrow heads.
The line drawing shows the position of the primer which extends from
positions, +13 to +65, relative to the ATG codon. The region upstream of D
to which the extended products above position 119 nucleotides map, is 
indicated by the large dots. The small dots represent the region of RNA 
removed by the splicing event. The arrow at position 119 nucleotides shows 
the position of the splice site. The large arrow-head marks the position 
of the primer and the open arrow-heads indicate the positions and sizes of 
major extension products above position 119 nucleotides. The donor (D) and 
acceptor (A) splice sites are numbered according to Reddy (1983).
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Data representative of primer extension analyses using this 
fragment are given in Figure 1-7. Multiple extension 
products of varying intensity were observed, which do not 
reflect the patterns observed with the preceding SI 
nuclease and exonuclease VII analyses. Furthermore, 
extension products are observed which would map to a region 
upstream of the SI nuclease and exonuclease VII protected 
fragments. Thus, this primer extension analysis suggests 
that the 51 nucleotide AluI-PvuII primer is extended 
through the acceptor splice site at position -5 4 , up to 5 1 
termini located 5 1 to the corresponding donor splice site. 
There are at least 16 extension products greater in size 
than 119 nucleotides (that is, the position of the
acceptor splice site). These are approximately sized in 
Figure 1-7 and correspond to putative transcriptional 
initiation sites mapping approximately to positions, 16, 
23, 28, 40, 45, 50, 59, 61, 76, 8 6 , 101, 106, 126, 135, 162 
and 191 bp upstream of the corresponding donor splice site. 
Those extension products smaller than 119 nucleotides, the 
position which marks the acceptor splice site (see Figure 
1-7) , are likely to be artifacts due to premature
termination of reverse transcriptase, perhaps caused by RNA 
secondary structures. Examination of overexposed 
autoradiographs revealed extension products at least as 
large as 310 nucleotides which would indicate transcripts 
initiating at least 191 bp upstream from the donor splice 
site. From the complexity of the banding pattern observed, 
it is possible that not all of the extended products
correspond to genuine 5 1 RNA termini. Another possibility 
is suggested by the fact that the primer was isolated from 
the first coding exon of the c-Ha-rasl gene. This exon is 
known to be highly homologous to other ras genes
(Introduction, section I.b), therefore it is possible that 
some of the extension products could be derived from 
hybridization of the primer to other "ras-like11 species 
(Introduction, section Ia,b) . While this work was in 
progress, Ishii et al. (1985) carried out primer extension
83
analysis of A431 cell RNA, using the same 51 nucleotide 
AluI-PvuII primer described here. They suggested that 
extension products observed above the band numbered 159 in 
Figure 1-7 are artifactual, but that the extension products 
corresponding to those numbered 13 5 , 14 2 , 147 and 159 in
Figure 1-7 are genuine transcriptional initiation sites. 
This claim is based on their reported sequencing of the 
extended primer, which showed that the sequences of the 
extended products above the 135, 142, 147 and 159 products 
were different from the sequence of the human c-Ha-rasl 
genomic clone. Unfortunately, their sequence data was not 
presented to support their hypothesis that the larger 
extended products were derived from cross hybridization to 
transcripts from other gene(s). In an attempt to resolve 
this question, the cell line EJ focus 8.3.5, was obtained 
from Dr. Alan Balmain (Beatson Institute, Glasgow) and RNA 
was isolated for primer extension analysis. EJ focus 8.3.5 
is a primary focus cell line, obtained by tranfection of 
high molecular weight EJ cell line DNA, into NIH 3T3 mouse 
fibroblasts. Using the techniques of Southern and northern 
blot analysis, EJ focus 8.3.5 has been shown to be 
positive for the EJ c-Ha-rasl oncogene (it is contained on 
a 23 Kb EcoRl restriction fragment present in 3 to 4 copies 
per cell) and that it expresses this gene at high levels 
(Dr. Alan Balmain, personal communication). Figure 1-8 
shows the result obtained when 50 ug of EJ focus 8.3.5 
total RNA and 50 ug of mouse Friend cell total RNA, were 
used for hybridization against the 5 1 end-labelled 51 
nucleotide AluI-PvuII primer (Friend cells are a murine 
erythroid leukaemia cell line and were used as a mouse RNA 
negative control). The RNAs were hybridized at 52 C for 16 
hours and the resulting hybrids were extended with reverse 
transcriptase as described before and in the legend for 
Figure 1-8. In this experiment 10 ug of EJ poly A RNA was 
used as a positive control and 40 ug of yeast tRNA as a 
negative control. As can be seen from comparison of lanes 1 
and 3 in Figure 1-8, essentially the same pattern of
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Figure 1-8 Primer extension analysis of EJ and EJ focus 8.3.5 RNAs using 
the 51 nucleotide AluI-PvuII primer.
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RNA was hybridized at 52 C to T- P-ATP 5' end-labelled anti-sense 51 
nucleotide AluI-PvuII primer DNA. The primer was labelled within the first 
codon exon as indicated by the asterisk in the line drawing. All 
hybridizations were carried out using approximately 100 cps of primer. The 
hybrids were incubated with reverse transcriptase as described in the 
legend to Figure 1-7, except that RNA was alkali hydrolysed following 
reverse transcription. Extended products were denatured and separated on 
an 8% polyacrylamide gel. Autoradiography was for, (a) 3 hours or (b) 16
hours, at -70 C with an intensifying screen. Lanes: (1) 50 ug of EJ focus 
8^3.5 total RNA; (2) 50 ug of Friend cell total RNA; (3) 10 ug of EJ poly 
A RNA; (4) 40 ug of yeast tRNA. Markers are Haelll fragments of pBR322 
(M) and Haelll fragments of 0X174 (m) whose sizes are indicated by the
closed arrow-heads. The position and sizes of the major extension products 
are indicated by open arrow-heads.
extended products can be seen with both the EJ focus 8.3.5 
and EJ RNAs. These extended products map approximately to 
positions 16, 23, 28, 40, 45, 50, 59, 61, 76, 8 6 , 101, 106, 
126, 135, 148, 162, 171 and 191 bp upstream of the
corresponding donor splice site (in this experiment two 
extra extension products of size 2 67 and 290 nucleotides 
were detected, mapping to 148 and 171 bp upstream of the 
donor splice site). However, the intensity of the signal 
observed for the EJ focus 8.3.5 total RNA is at least 100 
times greater than the EJ poly A+ RNA, assuming that 50 ug 
of total RNA is equivalent to about 1 ug of poly A+ RNA 
(Figure 1-8, lanes 1 and 3). No signal can be detected 
even at long exposures (up to 1 week), in lane 2 , in which 
50 ug of Friend cell total RNA was used. This result 
confirms that under the conditions used, all the extension 
products observed in Figure 1-8 are derived from extension 
on human c-Ha-rasl RNA.
In summary, the data in this section provide evidence 
for human c-Ha-rasl specific transcripts, mapping at least 
191 bp upstream from the putative donor splice site 
corresponding to the acceptor splice site at position -54 
relative to the ATG codon. These data imply that the 
c-Ha-rasl gene has an upstream exon, of at least 191 bp, 
which is analogous to the human N-ras and c-Ki-rasl genes 
(Introduction, Figure 1). Furthermore, sequence comparisons 
support the location of this upstream exon as being 
immediately upstream from the reported donor splice site at 
position -1094 (Capon et al., 1983a). Chichutek and 
Duesberg (1986) have compared the sequences of the human 
c-Ha-rasl gene with that of various sarcoma viruses 
containing the Harvey ras gene and also with that of the 
rat c—Ha—ras2 pseudogene. These analyses demonstrated that 
certain sarcoma viruses and the rat c-Ha-ras2 pseudogene 
are homologous with the human c-Ha-rasl genomic sequence up 
to the acceptor splice site at position -54, with homology 
resuming upstream of the donor splice site at position 
-1094. In addition, Ishii et al. (1985) report that the
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sequence of their extended 51 nucleotide AluI/PvuII primer 
reads through the —53 acceptor splice site, to be continued 
for 4 0 nucleotides upstream of the -1094 donor splice site. 
Thus the c-Ha-rasl upstream exon, which will now be termed 
exon —1 by analogy with the human N-ras upstream exon, is 
separated from the first coding exon by a 1040 bp intron. 
Since the pattern of primer extension products is complex 
(Figures 1-7 and 1-8), it is possible that not all of these 
products correspond to genuine 5 1 termini in the c-Ha-rasl 
mRNA. An attempt to eliminate any artifactual extension 
products was made by using actinomycin D and also by 
replacing dGTP with 7-deaza-dGTP
(7-deaza-2*-deoxyguanosine triphosphate), during the 
extension reaction. These reagents are believed to inhibit 
RNA secondary structure, or to relieve premature 
termination of the reverse transcriptase (Mizusawa et al., 
1986). However, no significant difference was observed in 
the extension products obtained with or without these 
reagents (data not shown).
(d) SI nuclease mapping analyses of the c-Ha-rasl upstream 
exon
The preceding primer extension analyses and the 
sequence comparisons of Chichutek and Duesberg (1986), have 
demonstrated that the 5* boundary of exon —1, as defined by 
the initiation site of the most upstream transcript 
detected, is likely to be located at least 191 bp upstream 
from the -1094 donor splice site. To independently confirm, 
this finding, and to determine more precisely which of the 
complex pattern of primer extension products represent 
genuine initiation sites, single-stranded 5* end-labelled 
probes were designed for SI nuclease mapping analyses of 
this region. However, SI nuclease mapping analyses in this 
region of the genome is hampered by its unusual G + C 
richness (the 576 bp upstream of the donor splice site at 
position -1094 is 80% G + C). SI hybridization probes
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which are G + C rich are more difficult to strand separate 
and require more stringent DNA:RNA hybridization 
conditions. In fact, Hess et al. (1985) have reported their 
inability to perform SI analysis on a region of 
approximately 90% G + c richness upstream of the human al 
globin gene, although the primer extension technique was 
successful. A similar observation has been made by Treisman 
et al. (1982).
A 3 89 bp Xcyl restriction fragment, mapping from 
positions 411 bp to 21 bp upstream from the donor splice 
site of exon -1, was isolated from plasmid pT24. This 
fragment was 5' end-labelled using V - 32P-ATP and strand 
separated using 4 0% DMSO or 80% formamide buffers (see 
Materials and Methods). Additionally, some of the 5 1 
end-labelled 389 bp Xcyl fragment was treated with the 
restriction endonuclease, Xhol, prior to strand separation. 
Xhol removes 32 bp from the 5' end of the 389 bp Xcyl 
fragment converting it into a 357 bp Xhol/Xcyl fragment. 
Figure 1-9 is an example of the species observed upon
strand separation of these 5' end-labelled restriction 
fragments. Unusually the 5' end-labelled 389 bp Xcyl
fragment is strand-separated into four major single-strand 
species following denaturation with DMSO (Figure l-9a, lane
2 ) and three major single-stranded species with formamide 
(Figure l-9a, lane 3, labelled I, II and III).
Interestingly, form X (Figure l-9a, lane 2) is specific 
only to denaturation by 80% DMSO as opposed to 80%
formamide. These alternate forms of the two strands are an 
indication of the secondary structure forming potential of 
this region of the c—Ha—rasl gene. No other fragments 
further upstream or downstream of this region, gave 
multiple single stranded forms upon strand separation. 
Figure l-9b is a strand separation gel of the Xhol digested 
5' end-labelled 389 bp Xcyl fragment, the resultant 357 bp 
Xhol/Xcyl fragment is labelled only at the Xcyl site 21 bp 
upstream from the donor site of exon -1. Therefore, only 
one strand can be visualized by autoradiography. In this
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Figure 1-9 Strand separation gels of the 389 bp Xcyl and the 357 bp 
Xhol/Xcyl DNA fragments.
Double stranded DNAs were ^ -32?-ATP 5' end-labelled, denatured with either 
dimethylsulphoxide (DMSO) or formamide as described in the Materials and 
Methods. The denatured DNAs were separated on strand separation gels 
(Materials and Methods) and autoradiography was for 2 minutes at room 
temperature with an intensifying screen, (a) a 5% strand separation gel 
electrophoresed at 300 V for 16 hours; (b) a 6% strand separation gel 
electrophoresed at 200 V for 16 hours. Lanes: (1) undenatured 389 bp Xcyl 
DNA; (2) 389 bp Xcyl DNA denatured with 80% DMSO; (3) 389 bp Xcyl DNA
denatured with 80% formamide; (4) 357 bp Xhol/Xcyl DNA denatured with 80% 
DMSO (This DNA was obtained by isolating the 389 bp Xcyl double stranded 
DNA from gel (a) and digesting it with Xhol); (5) 389 bp Xcyl double 
stranded DNA denatured with 80% DMSO (used as a marker). Single-stranded 
forms I, II and III used in Figure 1-10 are indicated by closed 
arrow-heads, whereas single stranded forms PI and P2 used in Figure 1-14 
are indicated by the arrows. Form X (lane 2) was not used in any SI 
nuclease mapping experiments, ds - double stranded form.
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case two alternative forms of this anti-sense strand were 
observed, presumably of different secondary structure 
(Figure l-9b, forms PI and P2) .
To identify potential transcription initiation sites 
upstream of the donor splice site of exon -1 , single 
stranded probe forms I, II and III (see Figure l-9a, lane
3) , derived from the 5 1 end-labelled 387 bp Xcyl fragment, 
were hybridized at 55°C in 80% FHB for 16 hours, to 4 ug of 
EJ poly A RNA and 16 ug yeast tRNA, or to 2 0 ug of yeast 
tRNA. Following hybridization, the hybrids were digested 
with 3 00 units of SI nuclease at 37°C for 90 minutes. The 
products were denatured and sized on a 6% denaturing 
polyacrylamide gel. As shown in Figure 1-10, only form II 
of the probe gave protected fragments which did not appear 
in the negative control lane (compare lanes 5 and 6 ). This 
signal consisted of multiple protected fragments ranging in 
size from approximately 180 to 98 nucleotides (mapping to 
positions 2 01 to 119 bp upstream of the donor splice site). 
The major clusters of protected fragments are bracketed and 
denoted by the letters A, B, C and D in Figure 1-10, where 
A corresponds to fragments between positions -210 to -191, 
B to fragments between positions -175 to -161, C to 
fragments between positions -151 to -141 and D to fragments 
between positions -128 to -119, all relative to the donor 
splice site of exon -1. This SI nuclease analysis 
independently confirms the primer extension analysis of the 
preceding section (Figures 1-7 and 1-8 ) as both techniques 
identify corresponding transcriptional initiation sites in 
the region mapping between approximately 191 bp to 119 bp 
upstream of the donor splice site. However, it was not 
possible in this experiment to confirm the sites identified 
by primer extension analyses below position -119 relative 
to the donor splice site. It is clear that under these 
conditions of hybridization and SI digestion, all three 
forms of the probe can form considerable secondary 
structures, as detected by the number of probe artifacts. 
Therefore, to confirm that probe form II is an anti-sense
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Figure 1-10 SI mapping analysis of EJ poly A+ using the 389 nucleotide 
Xcyl-Xcyl probe.
RNA was hybridized for 16 hours at 55°C to single-stranded forms I, II and
III (Figure 1-9). The probe was labelled at a position 21 nucleotides
upstream from the donor splice site (D) as indicated by the asterisk in 
the line drawing and all hybridizations were carried out in probe excess. 
Hybrids were treated with 300 units of SI nuclease (Boehringer) for 1.5 
hours at 37 C and digestion products were denatured and separated on a 6% 
denaturing polyacrylamide gel. Autoradiography was for 10 days at -70 C 
with an intensifying screen. Lanes: (1) an aliquot of unhybridized form I 
probe; (2) 5 ug of EJ poly A RNA and 15 ug of yeast tRNA; (3) 20 ^g of
yeast tRNA; (4) an aliquot of form II probe; (5) 5 ug of EJ poly A RNA
and 15 ug of yeast tRNA; (6) 20 ug of yeast tRNA; (7) 5 ug of EJ poly A 
RNA and 15 ug of yeast tRNA; (8) 20 ug of yeast tRNA. Lanes (1), (2) and
(3) are with form I; lanes (4), (5) and (6) are with form II and lanes (7) 
and (8) are with form III probes respectively. Markers (M) are Haelll 
fragments of pBR322 whose sizes are denoted by the closed arrow-heads. The 
line drawing is as in Figure 1-7. Protected fragments are indicated by 
open arrow-heads and these are arbitrarily grouped into clusters A to D as 
shown. X- Xcyl.
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form of the 389 nucleotide Xcyl—Xcyl probe, it was
subjected to the Maxam-Gilbert sequencing protocol and the
reaction products analysed on a 6% denaturing
polyacrylamide gel. Figure 1-11 confirms that probe form II 
32
the y — P—ATP 5' end labelled 389 nucleotide Xcyl—Xcyl 
probe is indeed anti-sense, as it is complementary to the 
sequence of the sense-strand published by Capon et al. 
(1983a) and Reddy (1983). An interesting feature of the 
sequence that facilitated its identification are the runs 
of 4 or 5 guanosine residues, followed by a single cytosine 
residue (see Figure 1-11).
To determine if different hybridization conditions 
would improve the weak signal observed in Figure 1-10, a 
range of different hybridization temperatures were used 
with probe forms PI and P2 of the 357 nucleotide Xhol-Xcyl 
probe (Figure l-9b) . The 5' end-labelled 389 bp Xcyl 
fragment was prepared, digested with Xhol to remove the 5 1 
end-label from the sense strand and strand separated as in 
Figure 1-9. In Figure 1-12 both forms PI and P2 of the 
resulting 357 nucleotide Xhol-Xcyl probe were hybrizized 
for 16 hours to 5 ug EJ poly A+ RNA and 15 ug yeast tRNA in 
80% FHB, at temperatures of; 59°C (lanes 1 and 5), 65°C
(lanes 2 and 6) and 72°C (lanes 3 and 7). The yeast tRNA 
(20 ug) negative control was hybridized at 65°C (lanes 4 
and 8 ). These hybridization controls revealed essentially 
the same pattern of protected fragments as in Figure 1-10 
and that the optimum signal is observed at 65 C. 
Furthermore, there are fewer probe artifacts at these 
higher temperatures, than was observed at 55 C for forms I, 
II and III of the 389 nucleotide Xcyl-Xcyl probe (Figure 
1-10) . It is not known why form P2 of the 3 57 nucleotide 
Xhol-Xcyl probe, does not form hybrids at the lowest 
temperature used (lane 5) , but does at the two higher
temperatures (lane 6 and 7) .
The 357 nucleotide Xhol-Xcyl probe (form PI) was also 
used for SI nuclease digestion controls. Increasing the 
amount of SI nuclease used to digest the hybrids formed,
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Figure 1-11 Maxam-Gilbert sequencing of the 5' end-labelled 389 
nucleotide Xcyl-Xcyl form II probe.
32
The “Y- P-ATP 5' end-labelled 389 nucleotide Xcyl-Xcyl form II probe 
(Figures l-9a and 1-10) was subjected to the Maxam-Gilbert sequencing 
protocol as described in the Materials and Methods. Reaction products were 
denatured and separated on a 6% denaturing polyacrylamide gel.
Autoradiography was for 10 days at -70 C without an intensifying screen.
Lanes: (1) G reaction; (2) G + A reaction; (3) T + C reaction and (4) C
reaction. The numbers indicate distances relative to the donor splice
site.
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Figure 1-12 SI mapping analysis of EJ poly A+ RNA using the 357 
nucleotide Xhol-Xcyl probe under different hybridization conditions.
RNA was hybridized f^j 16 hours at 59°C, 65°C or 72°C to either form PI or 
form P2 of the y  - P-ATP 5' end-labelled anti -sense 357 nucleotide 
Xhol-Xcyl probe DNA. The probe was labelled at a position 21 nucleotides 
upstream from the donor splice site (D) at position 576, as indicated by 
the asterisk in the line drawing and all hybridizations were carried out 
in probe excess. Hybrids were treated with 300 units of SI nuclease 
(Boehringer) for 1.5 hours at 37 C and digestion products were denatured 
and separated on a 6% denaturing polyacrylamide gel. Autoradiography was 
for 20 days at -70 C with an intensifying screen. Lanes: (PI) an+ aliquot 
of unhybridized probe form PI; (1), (2) and (3) 5ug of EJ poly A+ RNA and
15 ug of yeast tRNA hybridized to PI at 59°C, 65 C and 72 C respectively;
(4) 20 ug of yeast tRNA hybridized to PI at 65°C; (P2) an aliquot of 
unhybridized probe form P2; (5), (6) and (7) 5 ug of EJ poly A+ RNA and 15 
ug of yeast tRNA hybridized to P2 at 59°C, 65°C and 72°C respectively; (8) 
20 ug of yeast tRNA hybridized to P2 at 65 C. Markers are Haelll 
fragments of 0X174 (M) and Haelll fragments of pBR322 (m) as indicated by 
the closed arrow-heads. The line drawing is as in Figure 1-7. Protected 
fragments are indicated by the open arrow-heads and are arbitrarily 
grouped into clusters A to E as indicated. Xh- Xhol; X- Xcyl.
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should preferentially digest probe artifacts, whereas the 
signal due to the detection of genuine DNA:RNA hybrids 
should only decrease linearly upon increasing the SI
concentration. In Figure 1-13, the 357 nucleotide Xhol-Xcyl 
probe was hybridized at 65°C in 80% FHB, for 16 hours, to 
10 ug EJ poly A+ RNA and 10 ug yeast tRNA and the hybrids 
formed were digested with 300 units (lane 1), 600 units 
(lane 2) or 1000 units (lane 3) SI nuclease. The yeast tRNA 
negative control (20 ug) was digested with 300 units of SI
nuclease (lane 4) . All digestions were at 37°C for 90
-minutes, the products were denatured and sized on a 6%
denaturing polyacrylamide gel. As Figure 1-13 shows, none 
of the major protected species observed appear to be probe 
artifacts. Only the weak band of approximately 18 6 
nucleotides and the bands below 57 nucleotides appear to be 
artifactual. In this experiment another cluster of 
protected fragments could be identified (denoted as E, 
corresponding to 5' RNA termini mapping between positions 
-115 and -110, relative to the donor splice site) and 
weaker fragments of approximately 84, 73 and 64 nucleotides 
were also detected (mapping to positions -103, -94 and
-85). Thus, SI nuclease mapping independently confirms the 
primer extension analysis by localizing transcriptional 
initiation sites in the region mapping between positions 
-191 to -84 bp relative to the donor splice site (Figures 
1-7, 1-8, 1-10, 1-12 and 1-13).
To confirm this result with an independent SI probe,
the 195 bp MspI restriction fragment, mapping from 241 bp
to 4 6 bp upstream from the donor splice site of exon -1 ,
was isolated from plasmid pT24 (Figure 1-1) • The 195
32
nucleotide MspI-MspI anti-sense strand, 7 - P-ATP 5' 
end-labelled 46 nucleotides upstream from the donor splice 
site, was prepared and hybridized at 60 C or 65 C, in 80 -s 
FHB, to 4 ug EJ poly A+ RNA and 60 ug yeast tRNA. 
Hybridization to the yeast tRNA negative control (20 ug) 
was at 60°C. Figure 1-14 shows that SI digestion of the 
hybrids formed, confirms the clusters of bands previously
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Figure 1-13 SI mapping analysis of EJ poly A+ RNA using the 357 
nucleotide Xhol-Xcyl probe with increasing amounts of SI nuclease.
o 32RNA was hybridized for 16 hours at 65 C to form PI of the y- P-ATP 5'
end-labelled anti-sense 357 nucleotide Xhol-Xcyl probe DNA. The probe was
labelled as before (Figure 1-12) and all hybridizations were carried out
in probe excess. Hybrids were treated with 300, 600 or 1000 units of SI
nuclease (Boehringer) for 1.5 hours at 37 C and digestion products were
denatured and separated on a 6% denaturing polyacrylamide gel.
Autoradiography was for 10 days at -70 C with an intensifying screen.
Lanes: (P) an aliquot of unhybridized probe form PI; (1), (2) and (3) 10
ug of EJ poly A RNA and 10 ug of yeast tRNA digested with 300, 600 and
1000 units of SI nuclease respectively; (4) 20 ug of yeast tRNA digested
with 300 units of SI nuclease. Markers are Haelll fragments of 0X174 (M)
and Haelll fragments of pBR322 (m) as indicated by the closed arrow-heads.
The line drawing is as in Figure 1-7. Protected fragments are indicated by
open arrow-heads and are arbitrarily grouped into clusters A to E as
indicated. Xh- Xhol; X- Xcyl.
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Figure 1-14 SI mapping of EJ poly A RNA using the 195 nucleotide
MspI-MspI probe.
RNA was hybridized for 16 hours at 60°C or 65°C to 7 - 32P-ATP 5' 
end-labelled anti-sense 195 nucleotide MspI-MspI probe DNA. The probe was 
labelled as indicated in the line drawing at a position 48 nucleotides 
upstream from the donor splice site (D) at position 576, and all 
hybridizations were carried out in probe excess. Hybrids were treated with 
300 units of SI nuclease (Boehringer) for 1.5 hours at 37 C and digestion
products were denatured and separated on a 6% denaturing polyacrylamide
gel. Autoradiography was for 12 days at -70 C with an intensifying screen. 
L^nes: (P) an aliquot of unhybridized probe; (1) and (2) 4 ug of EJ poly 
A RNA and 16 ug of yeast tRNA hybridized to the probe at 60°C and 65°C 
respectively; (3) 20 ug of yeast tRNA hybridized to the probe at 60 C. 
Markers are Haelll fragments of pBR322 (m) as indicated by the closed 
arrow-heads. The line drawing is as in Figure 1-7. protected fragments are 
indicated by the open arrow-heads and are arbitrarily grouped into
clusters A to E as indicated.-M- Mspl.
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observed with the 3 89 nucleotide Xcyl—Xcyl probe (Figure 
1 10) and with the 357 nucleotide Xhol—Xcyl probe (Figures 
1—12 and 1—13). These five clusters are labelled A to E as 
before. However, protected fragments corresponding to the 
weak protected fragments of approximately 73 to 64 
nucleotides in Figure 1-13 (mapping to positions -94 and 
-84) , were not detected in Figure 1-14 with the 195 
nucleotide MspI-MspI probe. This is presumably because of 
the weak signal observed in this experiment (only 4 ug of 
EJ poly A+ RNA was used) and because transcripts initiating 
transcription at positions -94 and —84 would produce very
small protected fragments with the 195 nucleotide MspI-MspI 
probe. In Figure 1-14 the 5 f end-label is located 25
nucleotides further upstream from the exon -1 splice site 
compared with the 3 57 nucleotide Xhol-Xcyl probe. Thus, the 
gel banding pattern is lowered by 2 5 nucleotides.
In summary, the SI mapping analyses described in this 
section have provided evidence for multiple c-Ha-rasl mRNA 
5 1 termini, clustered into a broad domain located between 
approximately 200 to 84 bp upstream of the -1094 donor
splice site (see Figure 1-13). The multiple 5 1 termini have
been broadly grouped into five main clusters and three 
minor bands mapping to positions -103, -94 and -84 bp
relative to the -1094 donor splice site (Figure 1-13).
These SI protected fragments correspond to extension 
products of between approximately 320 to 2 03 nucleotides in 
the primer extension analyses presented earlier (Figures
1-7 and 1-8). Furthermore, the SI protected fragments in 
cluster A correspond closely to the extension products
mapping to position -191, relative to the donor splice 
site, those in cluster B correspond closely to extension 
products mapping between positions -179 to -162, those in 
cluster C correspond closely to extension products mapping 
between positions -148 to -135 and those in clusters D and 
E correspond to extension products mapping between
positions -126 and -106. The three SI protected fragments 
mapping between positions -103 and -84 correspond to
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extension products mapping between positions -101
and -86. Thus the multiple 5 1 termini mapping between 191 
to 84 bp upstream from the donor splice site of exon -1, 
appear to correspond to genuine transcriptional initiation 
sites since they have been confirmed by two independent 
techniques and using multiple probes. Furthermore, it has 
been shown by using total RNA isolated from murine NIH 3T3 
cells transfromed with EJ high molecular weight DNA and 
which express the human c-Ha-rasl gene at high levels, that 
none of the bands observed are derived from 
cross-hybridization to another "ras-like" gene (Figure 
1-8) . The RNA mapping data is summarized schematically in 
Figure 1-15. Unfortunately, the 85 bp region immediately 
upstream of the -1094 donor splice site could not be mapped 
by SI nuclease analysis with 5 1 end-labelled probes. 
Therefore, it was not possible to independently confirm the 
primer extension products mapping to positions -76, -61,
-59, -50, -45, -40, -28, -23 and -16 relative to the donor 
splice site of exon -1 (Figures 1-7 and 1-8).
(e) Northern blot analysis
To further confirm the presence of an upstream exon, 
the independent technique of northern blot analysis was 
used. EJ poly A+ RNA (5 ug) and EJ poly A~ RNA (25 ug) were 
electrophoresed on 1% formaldehyde gels and transferred 
onto nitrocellulose paper (Materials and Methods). The 591 
bp Sau3A restriction fragment, mapping from positions -1079 
to -1670, was nick-translated and used as the probe. As a 
positive control, an identical blot was probed with the 
nick—translated 571 bp XmaX restriction fragment, which 
contains sequences homologous to the whole coding region of 
the human c-Ha-rasl fourth coding exon (117 bp) and 2 32 bp 
of the 3 1 untranslated region. This fragment was chosen 
because the fourth coding exon is the region of greatest 
divergence between the different human ras genes 
(Introduction, section I.b). Figure 1-16 shows
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Figure 1-15 Summary of RNA mapping analysis.
A line drawing of the region upstream of the donor splice site (D), 
numbered as +1, which is 1094 bp 5' to the ATG codon (not shown). The 
position of the BstNI site which approximately defines the 5' limit of 
exon -1 is shown. Also shown are the map positions, relative to D, of the 
clusters of bands (A to E) detected by SI nuclease mapping (SI). The 
primer extension products (PE) are indicated by the arrows. For a complete 
list of the SI nuclease protected fragments, see Figure 1-13 and for the 
primer extension products, see Figure 1-8. The 5' termini of the primer 
extension products also identified by Ishii et al. (1985), are located 
between positions -40 and -16.
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Figure 1-16 Northern blot analysis of EJ RNA using probes homologous to 
exon -1 and exon 4.
RNAs were electrophoresed on 1% formaldehyde agarose gels, blotted onto 
nitrocellulose membranes and hybridized at 42 C overnight to 
nick-translated probes^ a) 591 bp Sau3A DNA (9.2 X 10 cpm/ug) and b) 571 
bp Xmal DNA (9.2 X 10 cpm/ug). Unhybridized probe was removed by serial 
washing to a final stringency of 0.IX SSC; 0.1% SDS, at 65°C (Materials 
and Methods). Autoradiography was for 2 days at -70 C with an intensifying 
screen. Lanes: (1) 25 ug of EJ poly A RNA; (2) 5 ug of EJ poly A RNA. 
Marker RNAs are human (28 S and 18 S) and bacterial (23 S and 16 S) 
ribosomal RNAs as indicated by the closed arrow-heads. The line drawing 
shows the positions of the probe fragments relative to the four coding 
exons. Numbering is as in Reddy (1983) and the consensus splice sites at 
positions 576 and 1616 are shown. D - donor splice, A - acceptor splice 
site; A - polyadenylation site.
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autoradiographs of both blots exposed for two days at -70° 
C with an intensifying screen. It is clear that both the 
591 bp Sau3A and 571 bp Xmal probes, hybridize to 
identically sized RNA molecules of approximately 1.4 Kb. 
This confirms the data obtained by primer extension since 
it shows that in c-Ha-rasl mRNA, sequences homologous to 
the upstream probe are contiguous with sequences homologous 
to the fourth coding exon probe. The most likely 
explanation for this result, is that the 591 bp Sau3A probe 
hybridizes to sequences in the c-Ha-rasl mRNA corresponding 
to an upstream, non-coding exon for this gene. The large 
difference in signal detected with these two probes can 
only be partly explained by the two times greater specific 
activity of the 571 bp Xmal probe. Another explanation 
could be that the 571 bp Xmal probe is likely to form a 
larger, more stable, hybrid with c-Ha-rasl mRNA, than does 
the 591 bp Sau3A probe. This is particularly true if, as is 
suggested by the primer extension analyses (Figure 1-7 and
1-8) , the majority of c-Ha-rasl transcripts are initiated 
close to the donor splice site of exon -1. In addition, it 
is possible that hybridization of the 591 bp Sau3A probe to 
c-Ha-rasl mRNA sequences corresponding to the upstream, 
non-coding exon may be inhibited by the demonstrated 
secondary structure forming potential of this region 
(Figures 1-9 and 1-10). Another interesting feature of the 
result shown in Figure 1-16 is that the 591 bp Sau3A probe 
appears to hybridize to another larger (approximately 6 
Kb) , less abundant RNA species, whereas the 571 bp Xmal, 
fourth exon probe, does not. An interpretation of this 
feature will be discussed later (Discussion, section I).
The presence of an upstream, probably non-coding exon 
for the human c-Ha-rasl gene is analogous to that of the 
human N-ras gene, which has recently been shown to have an 
upstream, non-coding exon of 235 bp (Hall and Brown, 1985). 
Primer extension and SI nuclease analyses have demonstrated 
that the human c-Ha-rasl upstream exon is at least 191 bp 
in size. To further investigate the size of the c-Ha-rasl
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exon -1, the 196 bp BstNl, the 195bp MspI and the 178bp
PvuII DNA restriction fragments were isolated from pT24 for
northern blotting analysis (Figure 1-17). The 196 bp BstNl
fragment maps from 392 bp to 196 bp upstream from the donor
splice site of exon -1 and the 195bp MspI fragment maps
from 244 bp to 48 bp upstream from this splice site. The
178 bp PvuII fragment was used as a positive control, as it
overlaps exon 1 by 119 bp. These three restriction
fragments were designed to be of approximately equal size
(the largest is only 18bp larger than the smallest) and due
to their small size and G + C richness, both a — 32P-dGTP 
32and a- P-dCTP were used to label each fragment, by the
technique of oligo-labelling (Materials and Methods). This
resulted in probes of nearly equal size, with approximately
equal specific activities. These probes were then
hybridized to three identical northern blots containing, 
0*01+ >!*>
9- 4- ug~ of the 19 05 bp BamHI/Xbal DNA restriction fragment 
(Figure 1-17, lanes 1), 10 ug A431 poly A+ RNA (lanes 2) 
and 10 ug EJ poly A+ RNA (lanes 3) . The 1905 bp BamHI/Xbal 
DNA restriction fragment was included for more accurate 
quantitation of the amount of hybridization of each of the 
probes to c-Ha-rasl mRNA. Figures l-17b and l-17c clearly 
show that the 195 bp MspI probe hybridizes to the 1.4 Kb 
RNA species, as does the 178 bp PvuII probe, whereas the 
196 bp BstNl probe does not (Figure l-17a). This result 
suggests that the extreme 5 1 end of the human c-Ha-rasl 
mRNA in both these cell lines, is likely to be located 
somewhere upstream of the MspI site at position 528 (-48,
relative to the donor splice site of exon -1) and somewhere 
downstream of the BstNl site at position 380 (-196,
relative to the donor splice site). Furthermore, as the 3* 
end of the 195 bp MspI probe is 48 bp upstream from the 
donor splice site (see Figure 1-17) it cannot hybridize to 
any of the initiation sites described by Ishii et al. 
(1985). Thus this result independently confirms that the 
region upstream of these initiation sites is transcribed. 
However, the signal detected with the 195bp MspI probe is
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Figure 1-17 Northern blot analysis of A431 and EJ RNA using probes from
the upstream exon -1 region and exon 1.
RNA and DNA controls were electrohoresed on 1% formaldehyde agarose gels, 
blotted onto nitrocellulose membranes- and hybridized to oligo-labelled 
probes, (a) 196 bp BstNl DNA (1.3 x 10 cpm/ug), (b) 195 bp MspI DNA (1.4 
X 10 cpm/ug) and (c) 178 bp PvuII DNA (1.7 x 10 cpm/ug). Hybridization 
was at 42 C overnight and unhybridized probe was removed by serial washing 
to a final stringency of 0.IX SSC; 0.1% SDS, at 65°C (Materials and 
Methods). Autoradiography was for 3 days at -70 C with an intensifying 
screen. Lanes: (1) 0.04 ng of 1.9 Kb BamHI/Xbal DNA fragment; (2) 10 ug of
A431 poly A RNA; (3) 10 ug of EJ poly A RNA. The line drawing is as in
Figure 1-16. B - BamHI, X - Xbal.
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approximately 10 fold weaker than that detected with the 
178 bp Pvu II probe, which can form a hybrid of 119 bp with 
the c-Ha-rasl mRNA. The low signal observed with the 195 bp 
MspI probe may suggest that this probe is not available for 
hybridization to the major initiation sites. Thus, the 5' 
termini of the majority of the c-Ha-rasl transcripts may be 
located either completely 3 1 to, or quite close to, the 3' 
end of the 195 bp MspI probe. Alternatively, sequences in 
this region may not be as available for hybridization due 
to the extra potential of this region for forming secondary 
.. structures (Figures 1-9 and 1-10) . This suggestion is 
supported by the decreased hybridization of the 195 bp MspI 
probe, relative to the 178 bp PvuII probe, to the 1905 bp 
BamHI/Xbal DNA control fragment, even though these probes 
have nearly identical specific activities (Figure 1-17) 
Finally, both the 195 bp MspI and the 178 bp PvuII probes 
also appear to detect the same less abundant RNA species of 
approximately 6.0 Kb (Figure 1-17), as did the 591 bp Sau3A 
probe in Figure 1-16.
In summary, the northern blotting analyses described
above confirm the existence of an upstream, possibly
non-coding exon (exon -1) , 1040 bp upstream from the ATG 
codon of the first coding exon. Furthermore, this analysis 
has defined the 5 1 boundary of this c-Ha-rasl upstream
exon, as being close to the BstNl site 196 bp upstream from
the donor splice site (see Figure 1-17) . This is in good 
agreement with the primer extension and SI nuclease 
analyses presented earlier. Additionally, evidence was 
obtained for a less abundant, approximately 6.0 Kb RNA 
species, with sequences homologous to at least exon -1 and 
exon 1, but not exon 4 (Figures 1-16 and 1-17).
II. CAT ANALYSIS; DISSECTION AND FUNCTIONAL ANALYSES OF 
THE HUMAN c-Ha-rasl PROMOTER REGION
Experiments described in the preceding section, using
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SI nuclease, primer extension, northern blot and sequence 
analyses, have located the promoter region of the human 
c-Ha-rasl gene to a region immediately upstream of the 
donor splice site of exon -1 , which is 1094 bp upstream of 
the ATG codon. It was decided to functionally confirm this 
promoter region by inserting the 591 bp Sau3A restriction 
fragment, mapping between positions 575 bp upstream and 15 
bp downstream of the donor splice site of exon -1 , in 
front of a "promoter-less" bacterial chloramphenicol 
acetyltransferase (CAT) gene. Promoter activity could then 
be measured by determining the levels of CAT activity in 
cells transfected with this construct. In addition, to 
search this promoter region for putative control regions, a 
series of constructs were made in which various deletion 
fragments covering this region were placed in front of the 
"promoter-less" CAT gene.
(a) Construction of CAT vectors
The human c-Ha-rasl promoter region (Figure 2-la), 
contained within the 591 bp Sau3A fragment was digested to 
yield the series of restriction fragments shown in Figure 
2-lb. The 591 bp Sau3A fragment, designated fragment 1, was 
cloned in both orientations into the unique BamHl site of 
the CAT vector, pCO (Figure 2-2) . This vector is a 
"promoter-less" form of the vector pLW2 (Gaffney et al. 
1985), obtained from Dr. Barklie Clements (Institute of 
Virology, Glasgow).The resulting constructs were designated 
pRasCATID and pRasCATIR, where D and R refer respectively 
to the direct and reverse orientations of the c-Ha-rasl 
fragment relative to the CAT gene. In Figure 2-2 a diagram 
of these constructs is given, along with the expected sizes 
of diagnostic digestion products, following digestion with 
BamHI or Pstl/Xhol. The 2% agarose gel (Figure 2-2b) 
confirms that the clones used for CAT analysis are indeed
pRasCATID and pRasCATIR.
The c-Ha-rasl promoter fragments 2 (390 bp Smal) and 3
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Figure 2-1 DNA fragments used in CAT constructs.
a) A line drawing of the region upstream of the exon -1 donor splice site
(D) , which summarizes the RNA mapping data (see Figure 1-15). b) The nine
fragments used in the CAT constructs numbered relative to D. 1- 591 bp
Sau3A; 2- 390 bp Smal; 3- 270 bp Mnll; 4- 195 bp MspI; 5- 184 bp
Sau3A/BstNI; 6- 196 bp BstNl; 7- 165 bp BstNl; 8- 118 bp SstII/Sau3A and 
- 173 bp Sstll.
107
a) J22 j.____ 1D397
780
pCO
(3-6 Kb)
Figure 2-2 The pRasCATID and pRasCATIR constructs.
a) A schematic drawing showing the sizes of fragments expected from 
diagnostic BamHI and Pstl/Xhol digestions of pCO, into which fragment 1 
(Figure 2-1) has been inserted. pCO is a derivative construct of pLW2 
(Gaffney et al., 1985) in which the 200 bp BamHI fragment containing the 
HSV-I IE gene-4/-5 promoter has been removed.^ The position of the 
bacterial CAT gene (open box) and ampicillin (Ap ) resistance gene are 
shown, as is the 100 bp Pstl/Xbal terminator sequence (T, closed box), 
from the HSV-I IE gene-4/-5. B- BamHI, P- Pstl. The short vertical lines,
marked X on the insert fragments, are Xhol sites and the numbers on either
side are distances from Xhol to BamHI in bp. There are no Xhol sites in
pCO. b)a 2% agarose gel in which pRasCATID was digested with BamHI (lane
1) and Pstl/Xhol (lane 2), pRasCATIR was digested with BamHI (lane 3) and 
Pstl/Xhol (lane 4). Marker DNAs were 0X174/HaeIII (M) and lambda/HindiII 
(m) fragments. Arrows indicate the expected sizes for the diagnostic 
digestion products.
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(270 bp Mnll) were prepared for cloning into the BamHI site 
of pCO, by addition of BamHI linkers (see Materials and 
Methods). The 5' overhanging ends of fragments 4 (195 bp 
MspI), 5 (184 bp Sau3A/BstNI), 6 (196 bp BstNl) and 7 (165
bp BstNl) were filled in using the Klenow fragment of 
E.coli DNA polymerase, subsequently ligated to BamHI 
linkers and inserted into the BamHI site of pCO. Fragment 8 
(118 bp SstII/Sau3A) had a 3 1 overhang at the Sstll site 
and a 5' overhang at the Sau3A site. The 3 1 overhang was 
removed using the 3'-5' exonuclease activity of T4 DNA 
polymerase and the 5 1 overhang simultaneously filled-in 
using the 5'-3! polymerase activity of T4 DNA polymerase. 
The resulting blunt-ended fragment was ligated to BamHI 
linkers and inserted into the BamHI site of pCO. The 2% 
agarose gels in Figure 2-3b show pRasCAT2D and 2R, 
pRasCAT6D and 6R and pRasCATSD and 8R, diagnostically 
digested with BamHI and also Pst/Bgll double digested to 
determine orientations. As can be seen, all digests gave 
the correctly sized diagnostic restriction fragments.
Similarly, the 2% agarose gels in Figure 2-4b show 
pRasCAT3R, pRasCAT4D, pRasCAT5D and 5R, and pRasCAT7D 
and 7R, diagnostically digested with BamHI and also
Pstl/Sstll double digested to determine orientations. 
Digestion of pRasCAT5D and 5R and pRasCAT7D and 7R gave 
the correctly sized diagnostic restriction fragments.
However, construct pRasCAT3D was obtained in a later round 
of cloning experiments and diagnostically digested for the 
direct orientation using a Pstl/Sstll double digestion, 
which released the correctly sized 40 bp fragment (Figure 
2-4a) . The diagnostic gel is not shown in this case.
Unfortunately, subsequent diagnostic digestions of the 
construct shown in lanes 7 and 8 of Figure 2-4b reveal that 
this construct was not, in fact, construct pRasCAT4R. It 
was not possible in the time remaining to complete this
thesis to obtain pRasCAT4R.
Finally, another series of constructs was prepared by 
cloning fragment 9 (the 173 bp Sstll fragment, shown in
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Figure 2-3 The pRasCAT2D and 2R, pRasCAT6D and 6R, and pRasCAT8D and 8R 
constructs.
a) A schematic drawing showing the sizes of fragments expected from 
diagnostic BamHI and Pstl/Bgll double digestions of pCO, into which 
fragments 2,6 and 8 (Figure 2-1) have been inserted. B- BamHI, Bg- Bgll,
P- Pstl. The short vertical lines on the insert fragments indicate Bgll
sites and the numbers on either side are distances from Bgll to BamHI in 
bp. The distances in bp between the diagnostic restriction sites are 
indicated on the vector, b) 2% agarose gels showing diagnostic digestions. 
All the odd numbered lanes are BamHI digestions and all even numbered 
lanes are Pstl/Bgll double digestions. Lanes 1 and 2 - pRasCAT2D; lanes 3 
and 4 - pRasCAT2R; lanes 5 and 6 - pRasCAT6D; lanes 7 and 8 - pRasCAT6R; 
lanes 9 and 10 - pRasCAT8D; lanes 11 and 12 - pRasCAT8R. Marker DNAs are
as in Figure 2-2. Arrows indicate the expected sizes for the
diagnostic digestion products.
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Figure 2-4 The pRasCAT3R, pRasCAT4D, pRasCAT5D and 5R, and pRasCAT7D and 
7R constructs.
a) A schematic drawing showing the sizes of fragments expected from 
diagnostic BamHI and Pstl/Sstll digestions of pCO, into which fragments
3,4 5 and 7 (Figure 2-1) have been inserted. B= BamHI, P=- Pstl. The short 
vertical lines on the insert fragments indicate Sstll sites and the 
numbers on either side are distances from Sstll to BamHI in bp. There are 
no Sstll sites in pCO. b) 2% agarose gels showing diagnostic digestions. 
All the odd numbered lanes are BamHI digestions and all the even numbered 
lanes are Pstl/Sstll double digestions. Lanes 1 to 4 - pRasCAT3R (in this 
cloning experiment, both clones isolated were pRasCAT3R); lanes 5 and 6 - 
pRasCAT4D; lanes 9 and 10 - pRasCAT5R ; lanes 11 and 12 - pRasCAT5D ;
lanes 13 and 14 - pRasCAT7D; lanes 15 and 16 - pRasCAT7R. The construct
shown in lanes 7 and 8 was not used. Marker DNAs are as in Figure 2-2. 
Arrows indicate the expected sizes for the diagnostic digestion products.
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Figure 2-lb) into the unique Hindlli site, located in the 
polylinker region of the plasmid pCO, immediately 5' to 
fragment 8 in pRasCAT8D. Fragment 9 was treated with T4 DNA 
polymerase to create blunt ends at the Sstll site, prior to 
the addition of Hindlli linkers (Materials and 
Methods).Following addition of Hindlli linkers, the 173 bp 
Sstll fragment was then ligated into the Hindlli site of 
pRasCAT8D. Figure 2-5a shows the resulting constructs, 
where the 2% agarose gels in Figure 2—5b show diagnostic 
restriction digestions of each of the clones isolated. In 
lanes 1 and 5 of Figure 2-5b, BamHI digestion of these 
constructs confirms that fragment 8 is indeed present, and 
in lanes 2 and 6 the orientation of fragment 8 has been 
determined by Pstl/Bgll double digestion, as before (Figure 
2-3) . This confirms that fragment 8 is in the direct 
orientation in both constructs. In lanes 3 and 7, Hindlli 
digestion of these constructs confirms that fragment 9 is 
present and in lanes 4 and 8 the orientation of fragment 9 
was determined by Hinfl digestion. The Hinfl digestion 
shown in lane 4 reveals that fragment 9 is present as a 
dimer, arranged in a head-to-tail fashion, as a fragment of 
exactly the same size as the 173 bp (Sstll) Hindlli insert 
was obtained (marked with an asterisk in Figure 2-5b, lane 
4). Thus^this construct was designated pRasCAT8D.9D.9D. The 
Hinfl digestion shown in lane 8 confirms that fragment 9 is 
present as a monomer in the reverse orientation, therefore 
this construct was designated pRasCAT8D.9R. During a later 
round of cloning experiments, fragment 9 was successfully 
cloned as a monomer in the direct orientation, to give the 
construct pRasCAT8D.9D (data not shown). Similarily 
fragment 9 was also cloned into the unique Hindlli site in 
the polyliker of pCO during subsequent cloning experiments. 
This generated the constructs pRasCAT9D and pRasCAT9R, 
which were diagnostically digested with Hindlli and 
orientated by Hinfl digestion (data not shown).
(b) Analysis of CAT vectors
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Figure 2-5 The pRasCAT8D.9D.9D and pRasCAT8D.9R constructs.
a) A schematic drawing showing the sizes of fragments expected from 
diagnostic digestions of pRasCAT8D (Figure 2-3), into which fragment 9 
(Figure 2-1) has been inserted. H= Hinfl; Hd= Hindlli; P= Pstl. The 
position of the BamHI linkered fragment 8 in the direct orientation is 
shown by the closed box and arrow-head. The short vertical lines on the 
insert fragments indicate Hinfl sites and the numbers on either side are 
distances from Hinfl to Hindlli in bp. The differences in bp between the 
diagnostic restriction sites are indicated on the vector, b) 2% agarose 
gels showing diagnostic digestions. Lanes 1 and 5 are BamHI digests 
specific for fragment 8. Lanes 3 and 7 are Hindlli digests specific for 
fragment 9. Lanes 2 and 6 are Pstl/Bgll double digests to confirm the 
orientation of fragment 8 (Figure 2-3). Lanes 4 and 8 are Hinfl digests to 
determine the orientation of fragment 9. Marker DNAs are as in Figure 2-2. 
Arrows to the left of each gel indicate the positions of the diagnostic 
fragments expected for fragment 8 in the direct orientation, after 
Pstl/Bgll double digestion. Arrows to the right of each gel give the 
positions of the diagnostic fragments expected for both orientations of 
fragment 9, after Hinfl digestion. The asterisk indicates the fragment 
arising due to tandem duplication of fragment 9. Horizontal lines indicate 
non-diagnostic fragments following Hinfl digestion.
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To functionally confirm the presence of promoter
sequences in the region upstream of the donor splice site
of exon -1, the constructs pRasCATID and pRasCATIR (see
Figure 2-2), along with pCO, the "promoter-less" version of
these constructs, were introduced into exponentially
growing human HeLa cells by the calcium phosphate
precipitation technique (Materials and Methods). Crude
cellular extracts were prepared from the transfected cells
48 hours after transfection by scraping the cells off the
surface of the petri dishes and lyzing the cells by
repeated freeze-thawing. After centrifugation, the
supernatant obtained was used as a crude cellular extract
and the CAT activity in each was assayed (Materials and
Methods). An aliquot of each crude extract was incubated
for 30 minutes at 37°C with acetyl coenzyme A and 14C
labelled chloramphenicol. The acetylated products were
14separated from unacetylated C-chloramphenicol by
ascending chromatography on SIL-G, silica gel thin layer 
chromatography (TLC) plates in 95% chloroform: 5% methanol. 
The TLC plates were air-dried and autoradiographed at room 
temperature overnight. An example of such an analysis is 
shown in Figure 2-6. Cells transfected with pCO (HeLa/pCO) 
contained undetectable CAT activity, whereas HeLa/pRasCATID 
cells contained strong CAT activity. This CAT activity was 
equivalent to the activity observed in HeLa cells following 
transfection with a construct containing the strong 
promoter from the Herpes Simplex Virus type I (HSV-I) 
immediate early gene-4/-5 (IE gene-4/-5), cloned into the 
BamHI site in the polylinker of pCO (Dr. Maggi Allan, 
personal communication). Unexpectedly, HeLa cells 
transfected with pRasCATIR also produced similar levels of 
CAT activity. Thus, the human c-Ha-rasl promoter region, 
contained in the 591 bp Sau3A restriction fragment, mapping 
from positions -575 to +15 relative to the exon -1 donor 
splice site, can function as a strong promoter directing 
CAT gene expression in HeLa cells regardless of its
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Figure 2-6 A representative autoradiograph of CAT assays performed after 
transient expression of pCO, pRasCATID and pRasCATlR in HeLa cells.
HeLa {jells at mid-log stage were transfected with 40ug of plasmid DNA per 
80 cm tissue culture dish. 48 hours after transfection, cell lysates were 
prepared and assayed for CAT activity (Materials and M|£hods). The letters 
A, B and C indicate the positions of the unacetylated C-chloramphenicol, 
the 1-acetylchloramphenicol and the 3-chloramphenicol, respectively. 0 -
PCO; ID - pRasCATID and 1R - pRasCATlR.
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orientation. These data suggest that th© human c—Ha—rasl 
promoter may function as a bi-directional promoter in vivo. 
Bi-directional promoter regions have been described in 
other systems, such as the SV4 0 3 00bp control region (see 
Introduction, section II) and similarities between these 
and the c-Ha-rasl promoter region will be discussed in a 
later section. Furthermore, this finding also provides 
strong functional confirmation of the RNA mapping analyses 
presented in the preceding section which suggested that 
human c-Ha-rasl promoter sequences are located at least 200 
bp upstream of the exon -1 donor splice site. To further 
localize the sequences within the 591 bp Sau3A fragment 
possessing promoter activity, and to investigate the 
regulatory sequences required for full promoter activity, 
the series of CAT deletion constructs shown in Figures 2-3 
and 2-4 was used in transient expression assays in HeLa 
cells.
(1) Mutational analysis of the "direct-orientation" 
c-Ha-rasl promoter
The 591 bp Sau3A c-Ha-rasl promoter fragment was 
digested to provide nine fragments, numbered 1 to 9 as 
shown in Figure 2-1, and these fragments were inserted, in 
both orientations, into the unique BamHI site in the 
polylinker of the "promoter-less" CAT construct (pCO) as 
described earlier (Figures 2-3 and 2-4). This series of 
constructs was transiently introduced into exponentially 
growing HeLa cells by the calcium phosphate precipitation 
technique and CAT assays performed as previously described. 
Figure 2-7 shows representative autoradiographs of some 
assays after approximately 16 hours exposure at room 
temperature. Figure 2-8 summarizes data derived from all 
the CAT constructs and includes a line drawing which shows 
the positions of the initiation sites detected by SI 
mapping and primer extension analyses (sections, I.c and
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Figure 2-7 A representative autoradiograph of CAT assays performed after 
transient expression of pRasCAT constructs in HeLa cells.
HeLa £ells at mid-log stage were transfected with 40 ug of plasmid DNA per 
80 cm tissue culture dish. 48 hours after transfection cell lysates were 
prepared and assayed for CAT activity (Materials and M^hods). The letters 
A, B and C indicate the positions of the unacetylated C-chloramphenicol, 
the 1-acetylchloramphenicol and the 3-acetylchloramphenicol, respectively. 
0 - pCO and the numbers 1, 2, 3, 5, 6 and 7 refer to fragments used in the 
construction of the pRasCAT series of constructs, where D or R refers to 
the direct or reverse orientations respectively.
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Figure 2-8 Summary of CAT data.
a) A line drawing of the region upstream of ^ ^ T h e  nine
(D) which summarizes the RNA mapping data (see Figure l ; ;
fragments used in the CAT s t r u c t .  ^  ^ c h  g-es
numbers representing conversion normalized against the
acetylated products. These conversions have been ™ ™ a l i z e d  agai 1>00.
conversion observed for pRasCATID, which has been g:
These results were obtained from several experiments m  each case.
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I.d) . In all cases, several repetitions of each assay,
using two independent plasmid DNA preparations of each
construct, were used. The numbers represent average
14
conversions of C chloramphenicol into its acetylated 
products and have been normalized against the conversion 
observed for pRasCATID, which is given a value of 1.00. 
As can be seen in Figure 2-8, pRasCAT2D, which contains all 
the transcriptional initiation sites identified in the 
preceding section, except the two nearest the donor splice 
site at positions -16 and -23 relative to the donor splice 
site of exon -1 (Figure 2-8b), produced approximately 75% 
of the CAT activity observed with pRasCATID. Although this 
slight reduction in CAT activity is likely to be within the 
bounds of experimental error, an alternative interpretation 
might be the loss of the first two initiation sites which 
correspond to strong bands in the primer extension analyses 
presented earlier (Figures 1-7 and 1-8). Another 
explanation might be the absence of positive regulatory
elements upstream of position -415. The construct pRasCAT3D 
produces approximately 3 0% of the CAT activity observed 
with pRasCATID (Figure 2-8b) , but does not contain the 
first three transcriptional initiation sites at -16, -23
and -28, which correspond to strong bands in the primer 
extension analyses. However, it is still not clear whether 
this lower CAT activity is caused by the absence of 5 1 
flanking sequences upstream of position -3 04 or whether
this reduction is caused by the loss of three strong
transcriptional initiation sites. The construct pRasCAT4D, 
which does not contain the first five initiation sites
detected by primer extension analyses at positions -16 to
-45 (Figures 1-7 and 1-8), produces approximately 20% of 
the CAT activity of pRasCATID (Figure 2-8b). Once again 
this result could be explained either by loss of
initiation sites or by the loss of regulatory sequences. 
However, it is clear that the initiation sites upstream of 
position -48 (that is, upstream of those previously
suggested by Ishii et al., (1985) to be the only initiation
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sites), must be functionally active and account for at 
least 20% of the c-Ha-rasl transcripts. Conversely, as 
pRasCAT4D does not contain the first four initiation sites 
detected as strong primer extension products in Figures 1-7 
and 1-8 , these data could suggest that these four 
initiation sites may indeed account for the majority of the 
c-Ha-rasl transcripts. However, as will be shown, 
preliminary data obtained with construct, pRasCAT9D, 
suggest that it is more likely that the low signal obtained 
with pRasCAT4D results from the loss of regulatory, rather 
than transcriptional initiation sites.
Constructs pRasCAT5D and pRasCAT6D, contain sequences 
entirely upstream of the initiation sites identified in the 
preceding section, and both of these constructs produced 
similar CAT activities to the "promoter-less" pCO (Figure 
2-6 and 2-9). This result strongly suggests that there are 
no transcriptional initiation sites upstream of position 
-196, in agreement with the RNA mapping data. 
Interestingly, pRasCAT7D which contains all the 
transcriptional initiation sites upstream of position -31, 
including the strong site at position -40 (that is, it 
lacks only the three initiation sites nearest the donor 
splice site and is therefore, equivalent in this respect to 
pRasCAT3D) produced no more CAT activity than construct 
p C O . Thus, important promoter regulatory sequences located 
between position -196 and -304, appear to have been deleted 
in this construct. Furthermore, pRasCAT4D does not contain 
any of the strong initiation sites between positions -16 
and -40, but nevertheless produced approximately 2 0% of the 
CAT activity observed with pRasCATID, which is similar to 
that observed with pRasCAT3D. This observation strongly 
suggests that the positively acting regulatory sequences 
located upstream of position -196 mainly reside within the 
47 bp of sequence between positions —196 and —243 (Figure
2-8b). Examination of the sequence of this 47 bp region 
(Capon et al., 1983a, Reddy 1983) revealed that it contains 
a CAAT box and a Spl binding site (see Discussion, section
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II and Figure 5-1). It is possible that these sequence 
motifs, known to have regulatory function (see 
Introduction, section II), may be the positively acting 
regulatory elements responsible for the CAT activity of 
pRasCAT3D and pRasCAT4D. However, additional sequence 
elements, other than the transcriptional initiation sites 
these constructs lack, may be required to provide CAT 
activity comparable to pRasCATID. A similar result to that 
obtained with pRasCAT7D was observed with pRasCAT8D; that 
is, pRasCAT8D produced similar CAT activity to pCO. This 
construct contains all of the initiation sites up to 
position -103, therefore it appears that important promoter 
regulatory sequences have also been deleted in this 
construct.
Finally, the construct pRasCAT9D contains only the 
transcriptional initiation sites detected upstream of 
position -103, that is, all of the clusters of initiation 
sites detected by SI mapping analyses and the weak primer 
extension products greater than 22 0 nucleotides observed in 
Figures 1-7 and 1-8 (see also Figure 2-8a). This construct 
produced approximately 80% of the CAT activity observed for 
pRasCATID. However, the data obtained with prasCAT9D is 
preliminary, in that it was obtained with only one DNA 
preparation, and must be interpreted cautiously until it 
has been confirmed. Nevertheless, since pRasCAT7D has the 
same transcriptional initiation sites as pRasCAT3D, but 
produces no more CAT activity than the "promoter-less" 
construct pCO, this result suggests that positively acting 
regulatory element(s) are localized between positions -196 
and -276 (Figure 2-8b). Furthermore, as pRasCAT9D produced 
greater CAT activity than pRasCAT4D, it is likely that the 
47 bp sequence, between positions -196 and -243 within 
pRasCAT4D, and which has been identified as a positive 
regulatory element, requires additional sequence 
information between positions -243 to -276 for increased 
CAT activity. In addition, as pRasCAT9D produces 
significantly greater CAT activity than pRasCAT3D (although
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pRasCAT3D contains 28 bp more 5' and 79 bp more 3* 
c-Ha-rasl promoter sequence information). This suggests 
that pRasCAT3D (and pRasCAT4D) may also contain negatively 
acting regulatory elements. This/these negatively acting 
regulatory element(s) is/are likely to be located between 
positions -34 and -103, as constructs pRasCAT3D and 
pRasCAT7D differ in sequence information only at their 5' 
ends, a region shown to have positively acting regulatory 
activity. However, confirmation of this putative negative 
regulatory element and also the putative positive 
regulatory element located between positions -276 to -243, 
awaits confirmation of the result obtained with pRasCAT9D.
(2) Reconstruction of the "direct-orientation" c-Ha-rasl 
promoter
As pRasCAT8D was known from the previous analysis to 
produce negligible CAT activity (Figure 2-8b), it was 
decided to attempt to restore promoter activity to this 
construct by addition of fragment 9. This fragment was 
inserted in both orientations into the Hindlll site 
immediately upstream of fragment 8 in pRasCAT8D and the 
resulting constructs (Figure 2-5, data for pRasCAT8D.9D not 
shown) were then transfected into HeLa cells and CAT assays 
performed as before. Figure 2-9 summarises the data 
obtained in these experiments using two independent plasmid 
DNA preparations of each construct, except in the case of 
pRasCAT8D.9D in which only one plasmid DNA preparation was 
used. The construct pRasCAT8D.9D produced approximately 40% 
of the CAT activity observed with pRasCATID and 
approximately 40 fold more activity than pRasCAT8D alone. 
Thus5 fragment 9 has to a large extent restored promoter 
function to pRasCAT8D, confirming that there are positively 
acting regulatory elements within fragment 9. However, as 
fragment 9 on its own in construct pRasCAT9D produced 
approximately 80% of the CAT activity observed with 
pRasCATID, this result also supports the earlier suggestion
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Figure 2-9 Summary of CAT data.
a) A line drawing of the region upstream of the exon-1 donor splice site 
(D), which summarizes the RNA mapping data (see Figure 1-15). b) Fragments 
8 and 9 used in the CAT constructs either on their own (pRasCAT8D, 
pRasCAT8R, pRasCAT9D and pRasCAT9R), or covalently linked 
(pRasCAT8D.9D.9D, pRasCAT8D.9D and pRasCAT8D.9R), are ^hown alongside a 
table which gives numbers representing conversions of C-chloramphenicol 
into its acetylated products, normalized against the conversion observed 
for pRasCATID, which has been given a value of 1.00.
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that sequences between -34 and -103 act in this assay as a 
negative regulatory element. Interestingly, this 69 bp 
sequence has a 90% G + C content and contains 5 repeats of 
the sequence 5'G(C)n , where n= 4 or 5, four of which are 
tandemly repeated (Figure 1-11 shows the sequence of the 
anti-sense strand).
Fortuitously, a construct was obtained in which 
fragment 9 was present as a tandem duplication in the 
direct orientaion, pRasCAT8D.9D.9D (Figure 2-5). This 
construct produced approximately 10 fold more CAT activity 
than pRasCATID, approximately 25 fold more CAT activity 
than pRasCAT8D.9D and approximately 1000 fold more CAT 
activity than pRasCAT8D. In fact, pRasCAT8D.9D.9D produced 
10 fold greater CAT activity than the strong promoter from 
the HSV-I IE gene-4/-5, cloned into pCO (Dr. Maggi Allan, 
personal communication). As pRasCATSD.9D.9D has duplicated 
the positively regulatory elements between positions -196 
and -243, and also all the transcriptional initiation sites 
located upstream of position -103, it is likely that 
duplication of these important sequences is responsible for 
the elevated CAT activity of this construct. This result 
also suggests that fortuitous duplications in this region 
of the human c-Ha-rasl promoter, in vivo, would have the 
potential to increase c-Ha-rasl promoter function to ten 
times its normal level. Interestingly, the construct 
pRasCAT8D.9R produced approximately 25% of the CAT activity 
observed with pRasCATID, which is just over half the CAT 
activity observed for pRasCAT8D.9D. This result suggests 
that the regulatory elements present within fragment 9 can 
operate in either orientation. The bi-directional nature of 
the c-Ha-rasl promoter region will be more fully discussed 
in the next section.
(3) Mutational analyses of the "reverse-orientation" 
c-Ha-rasl promoter
Promoter fragments 2 to 9 (Figure 2-1) were also
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obtained in the reverse orientation relative to the CAT 
gene. Thus the sequences within pRasCATlR responsible for 
the reverse orientation CAT gene expression (Figure 2-6) 
could be more accurately localized. Using pRasCAT2R, 
approximately 70% of the CAT activity obtained with 
pRasCATlR was observed (Figure 2-6 and 2-8), suggesting 
that most of the sequences required for the 
"reverse-promoter" activity are located within fragment 2 . 
The construct pRasCAT3R produced approximately 40% of the 
CAT activity obtained with pRasCATlR (Figure 2-6 and 2-9). 
While a less than 2 fold difference in CAT activity may be 
within the bounds of experimental error, this result could 
suggest that sequences located between positions -415 and 
-304 may either positively regulate the
"reverse-orientation" promoter activity, or may provide 
"reverse-orientation" transcriptional initiation sites. 
Unfortunately construct pRasCAT4R was not obtained, since 
this construct would have allowed a more accurate location 
of the "reverse-promoter" activity. The almost undetectable 
CAT activity obtained with with pRasCAT5R, pRasCAT7R and 
pRasCAT8R (Figures 2-6 and 2-8), suggest that the 
"reverse-promoter" activity must be located between 
positions -392 and -196. Indeed, pRasCAT6R, containing 
sequences between positions -392 and -196 directs levels of 
CAT activity comparable with pRasCATlR. Furthermore 
pRasCAT9R produces approximately 45% of the CAT activity 
observed for pRasCATlR (which is similar to the level of 
CAT activity produced by pRasCAT3R). This result suggests 
that sequences located between positions -196 and -276 also 
provide positively acting sequence information for the 
"reverse-orientation" promoter, as well as for the 
"direct-orientation" promoter. However, as pRasCAT3R and 
pRasCAT9R provide less than half the CAT activity observed 
for pRasCATlR and pRasCAT6R, it is likely that additional 
sequences upstream of position -3 04 are required for full 
"reverse-orientation" promoter activity. The analyses 
presented above using a range of mutants have located the
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region required for full "reverse- orientation" promoter 
activity to the region between -196 to -392’ (Figure 2-8b). 
At least some of this activity has been further located at 
the region between positions -196 and -276. Furthermore, as 
pRasCAT6D produces only negligible CAT activity, this 
result suggests that the "reverse-promoter" activity can be 
physically uncoupled from the "direct-promoter" activity. 
This is presumably because fragment 6 does not provide any 
transcriptional initiation sites for the
"direct-orienation" promoter, which further supports the 
RNA mapping analyses of section I. Since no RNA analyses 
which detect opposite strand transcripts have been 
obtained, it is not possible at this point to dissect the 
relative importance of transcriptional initiation sites, as 
opposed to regulatory elements, in these constructs. The 
relevance of the data presented in this thesis, which 
identifies regulatory sequences important for regulation of 
the activity of the human c-Ha-rasl gene, will be discussed 
in terms of known regulatory elements. These data are 
summarized in Figure 5-1.
111. THE EFFECT OF SV40 REGULATORY SEQUENCES ON 
TRANSCRIPTION OF THE c-Ha-rasl GENE
It has been demonstrated that for many genes encoding 
"luxury-function" proteins, the presence of a covalently 
linked active enhancer increases transcription of the 
linked gene (de Villiers et al., 1982; Wasylyk et al., 
1983; Allan et al., 1984). However, it is not known if 
enhancers can increase transcription of genes like the 
human c-Ha-rasl gene which does not contain a functional 
TATA box and, as has been shown in this thesis, contains a 
large number of transcriptional initiation sites, rather 
than a single, discrete site. Furthermore, if transcription 
of the human c-Ha-rasl gene is increased by a linked
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enhancer, it is not known if the enhancer affects 
transcription from all of the transcriptional initiation 
sites equally, or if the enhancer effect is specific to a 
subset of the transcriptional initiation sites. Such a 
differential enhancer effect on transcriptional initiation 
sites, within the same gene, has been observed with the 
human e-globin gene when it is linked to the SV4 0 enhancer 
(Allan et al., 1984). Transcription from the major 
initiation site of the *-globin gene was increased, but
transcription from the initiation site at position -200 
relative to the <-globin ATG codon, was unaffected. 
Interestingly, it is possible that increased transcription 
of the c-Ha-rasl proto-oncogene, by activation of a nearby 
enhancer or by fortuitous insertion of an enhancer, is a 
potential event involved in oncogenic activation of this
gene in vivo (see Introduction, section I.c and
Discussion).
To investigate the effect of the SV40 enhancer 
sequence on the expression of the human c-Ha-rasl gene, the 
6.4 Kb BamHI restriction fragment of construct pT24 (Figure 
1-1) , was cloned into the unique BamHI sites of the SV40 
vectors, pSVOD (Mellon et al., 1981) and pSVED (Proudfoot 
et al., 1984). The vector pSVOD contains pBR322 sequences, 
from which the sequences inhibitory to replication in
mammalian cells have been removed (Luskey and Botchan, 
1981), and the 311 bp EcoRII G fragment, of the SV40 genome 
(Figure 3-1). This 311 bp EcoRII fragment contains 55 bp of 
one of the SV40 72 bp repeats, all three £1 bp repeats, the 
TATA-like sequence, the early RNA initiation sites and 
approximately 120 bp of sequence homologous to early RNAs 
(Introduction, II.a and Figure 3-1). Therefore, pSVOD 
contains the SV40 origin of replication, but not a 
functional SV40 enhancer (McKnight and Tjian, 1986). The 
vector pSVED contains the 342 bp PvuII/Hindlll fragment, 
spanning the complete SV40 300 bp control region and 
essentially differs from pSVOD only in the possession of 
two full copies of the 72 bp enhancer repeats (Figure 3—1).
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Figure 3-1 Fragments from the SV40 control region used in the pSVOD and 
pSVED plasmids.
The various cis acting control sequences of the SV40 300 bp control region 
are shown schematically. The origin (ori), "TATA-like" sequence (A/T) and 
the 72 bp repeats (72) are indicated by open rectangles. The GC boxes of 
the 21 bp repeats are numbered I to VI, where the horizontal arrows 
indicate the three 21 bp repeats. The directions and the 5' ends of both 
the early (E.RNA) and late (L.RNA) transcripts are also indicated, as are 
the 311 bp EcoRII and 342 bp Hindlll/PvuII fragments used in the plasmids 
pSVOD and pSVED, respectively. RII — EcoRII; Hd — Hindlll; Pv — PvuII 
(Adapted from McKnight and Tjian, 1986).
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These constructs, pSVODraslD and pSVEDraslD, containing the 
c-Ha-rasl 6 .4 Kb BamHI fragment at their unique BamHI 
sites, are shown in Figure 3-2. Since these constructs 
contain the SV40 origin of replication, but not T antigen, 
replication can occur only in Cos7 cells, in which T 
antigen is endogeneously supplied (Gluzman, 1981).
Therefore these constructs were introduced into
exponentially growing Cos7 cells, by the calcium phosphate
precipitation technique. Total RNA was prepared 48 hours
after transfection and c-Ha-rasl specific mRNA molecules 
were primer extended, using the 51 AluI-PvuII primer as 
before (Results, I.c) This single-stranded > - 32P-ATP 5 1
end-labelled primer, mapping from position +68 to +119, 
relative to the ATG codon, was hybridized at 52°C for 16 
hours, in 80% FHB, to 50 ug of total RNAs isolated from 
pSV0DraslD/Cos7 and pSVEDraslD/Cos7 transfected cells and 
untransfected Cos7 cells. The resulting hybrids were 
treated with reverse transcriptase as before (Materials and 
Methods) and the extended products denatured and sized on 
an 8% denaturing polyacrylamide gel. As can be seen from 
Figure 3-3, the pattern of extension products is 
essentially identical to the pattern previously observed 
with EJ, EJ focus 8.3.5 and A431 cell RNAs (Figures 1-7 and 
1-8) . A comparison of lanes 1 and 2 shows that the presence 
of the SV4 0 enhancer element, present in construct 
pSVEDraslD (lane 2), enhances c-Ha-rasl transcription 
approximately 2 0 fold more than when the functional 
enhancer is absent, as in construct pSVODraslD (lane 1). 
Furthermore, the enhancer effect appears to increase 
transcription from each initiation site proportionately and 
cannot therefore be specific to a subset of the initiation 
sites used. It is also noteworthy that the SV4 0 enhancer 
has only an approximately 20 fold increase in transcription 
with the c-Ha-rasl gene, whereas with globin genes the 
corresponding increases are 50 - 200 fold (Allan et al., 
1984) . Unfortunately, the reverse orientation of the 
c-Ha-rasl gene relative to the SV40 regulatory sequences
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Figure 3-2 The pSVODraslD and pSVEDraslD constructs.
a) A schematic drawing showing the sizes of fragments expected from 
diagnostic EcoRI/Xbal double digestions of pSVOD and pSVED, into which the
6.4 KB BamHI fragment, containing the human c-Ha-rasl gene (Figure 1-1), 
has been inserted in the direct orientation. The open boxes indicate the 
relative positions of the c-Ha-rasl coding sequences. pSVOD and pSVED are 
essentially pBR322, from which the sequences inhibitory to repliction in 
mammalian cells have been removed (Mellon et al,, 1981), into which the 
311 bp EcoRII (ori) or 342 bp Hindlll/PvuII fragments (ori + 72) have been 
inserted (Mellon et al., 1981; Proudfoot et al., 1984). E - EcoRI; B - 
BamHI and X = Xbal, b) a 0.8% agarose gel showing diagnostic EcoRI/Xbal 
digestions of either pSVODraslD (lane 1) or pSVEDraslD (lane 2). The gel 
shows the diagnostic fragments of 7.4 Kb and 2.4 Kb expected for the 
direct (5' to 3') orientation of the c-Ha-rasl 6.4Kb BamHI insert.
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Figure 3-3 Primer extension analysis of total RNA isolated from Cos7 
cells transiently transfected with pSVODraslD and pSVEDraslD.
2
Cos7 cells at late-log phase were transfected with 20ug/75 cm of either
pSVODraslD or pSVEDraslD., Total RNA was prepared 48 hours later and
hybridized at 52°C to y - P-ATP 5' end-labelled anti-sense 51 nucleotide
AluI-PvuII primer DNA. The primer was labelled within the first coding
exon as indicated by the asterisk in the line drawing. All hybridizations 
were carried out using approximately 200 cps of primer. The hybrids were 
incubated with 25 units of AMV reverse transcriptase (Boehringer) as
described in the legend of Figure 1-7, except that RNA was alkali 
hydrolysed following reverse transcription. Extended products were 
denatured and separated on an 8% denaturing polyacrylamide gel. 
Autoradiography was for (a) 16 hours or, (b) 3 hours, at -70 C with an
intensifying screen. Lanes: (1) 50ug of Cos7/pSV0DraslD total RNA; (2)
50ug of Cos7/pSVEDraslD total RNA and (3) 50ug of Cos7 total RNA. Markers 
are Haelll fragments of 0X174 (M), whose sizes are indicated by the closed 
arrow-heads. The line drawing is as in Figure 1-7, except that the 
distance from the acceptor splice site at position 1616 to the 5'
end-label is indicated by >119<. The arrow at position 119 nucleotides
shows the position of the splice junction and the large closed arrow-heads 
(P) mark the position of the primer.
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used here was not obtained. Therefore it was not possible 
to assay any enhancer activity in the oppposite 
orientation.
IV. THE UPSTREAM INTRON OF THE HUMAN c-Ha-rasl GENE 
CONTAINS REPETITIVE SEQUENCES
(a) Northern blot analysis indicates the presence of 
abundant RNAs homologous to sequences within the upstream 
intron
During the analysis of the transcription pattern of 
the c-Ha-rasl gene, using the northern blotting technique, 
it was noticed that, when probes homologous to the intron 
between exon -1 and exon 1 were used , that RNAs from 
various human sources gave an unusual banding pattern when 
hybridized to these probes (data not shown). This banding 
pattern consisted of up to six bands which were 
superimposed onto a relatively uniform smear. Thus it was 
decided to pursue this further using a more detailed 
analysis. The RNAs used were: total and poly A RNA from EJ 
cells, total RNA from EJ focus 8.3.5 cells (a cell line 
derived from a focus induced in NIH 3T3 murine fibroblasts 
by transfection with high molecular weight EJ DNA, see 
Results I.c), total and poly A RNA from K562 cells (a 
human erythroleukemia cell line) and total RNA from human 
white blood cells. These RNAs were denatured, 
electrophoresed on 1% formaldehyde agarose gels and
transferred to nitrocellulose paper (Materials and
Methods). Identical blots were probed with, a) the
nick-translated 1905 bp BamHI/Xbal restriction fragment, 
mapping from 1669 bp upstream to 235 bp downstream from the 
ATG translational initiation codon of the human c-Ha-rasl 
gene and b) nick-translated BS-9 plasmid DNA (Ellis et al., 
1980). This plasmid contains viral Ha-ras sequences from 
the Harvey murine sarcoma virus (HaMSV) genome in a 4 60 bp
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EcoRI fragment cloned into pBR322. Therefore, it contains a 
spliced form of the murine c-Ha-rasl gene and should only 
hybridize to RNA sequences homologous to the exons of the 
human c-Ha-rasl gene. Hybridizations were performed exactly 
as described in the Materials and Methods. In both cases 
excess, unhybridized probe was removed using high 
stringency washing conditions, (the final two washes were 
for 20 minutes each at 65°C in 0.1X SSC; 0.1% SDS). As 
shown in Figure 4-la, when hybridized against the 1905 bp 
BamHI/Xbal c-Ha-rasl probe, total and poly A~ RNAs from 
human cells, produced a strong signal composed of up to six 
bands, superimposed on to a relatively uniform smear, as 
had been observed previously in earlier experiments. The 
most intense signal corresponded to a band slightly larger 
than the 28 S ribosomal RNA (rRNA) marker and other 
prominent bands were observed at approximately 26 S, 2 0 S,
17 S and 14 S. Interestingly, EJ focus 8.3.5 total RNA
(Figure 4-la, lane 3), which is essentially N1H 3T3 murine 
fibroblast RNA, containing transcripts from the transfected 
human EJ c-Ha-rasl gene, did not produce the intense signal 
observed with the human RNAs. In this case only the
approximately 1.4 Kb c-Ha-rasl mRNA was observed. Southern 
blot analysis has shown that EJ focus 8.3.5 cells are
positive for the EJ c-Ha-rasl oncogene, which is contained 
on a 23 Kb EcoRI restriction fragment present in 3 to 4 
copies per cell (Dr. Alan Balmain, personal communication). 
An identical blot to that shown in Figure 4-la was probed 
with the nick-translated BS-9 plasmid (Figure 4-lb). 
However, this probe did not produce the abundantly 
transcribed human specific RNA. With this probe the 1.4 Kb 
c-Ha-rasl transcript was clearly observed with EJ and with 
EJ focus 8.3.5 total RNAs (lanes 2 and 3), as both of these 
cell lines are known to have elevated expression of the 
human c-Ha-rasl gene. However, in the exposure shown, the 
c-Ha-rasl transcript was only weakly detected with K562 
total RNA (lane 5) and not at all with human white cell 
total RNA (lane 6). The high molecular weight signal
Figure 4-1 Northern blot analysis of human RNAs and EJ focus 8.3.5 total 
RNA.
RNAs were electrophoresed on 1% denaturing agarose §e -^s > blotted onto 
nitrocellulose membranes and hybridized at 42 C overnight to 
nick-translated probes: (a) 1905 bp oBamHI/Xbal DNA (1.5 x 10 cpm/ug) or 
(b) BS-9 plasmid DNA (1.6 x 10 cpm/ug). The 1905 bp BamHI/Xbal 
restriction fragment is shown in the line drawing and the BS-9 plasmid 
contains sequences homologous to the Harvey murine sarcoma virus contained 
in pBR.322 (Ellis et al., 1980). Unhybridized probe was removed by serial 
washing to a final stringency of 0.IX SSC; 0.1% SDS, at 65°C (Materials 
and^Methods). Autoradiography was for (a) 50 hours or (b) 80 hours, at
-70 C with an intensifying screen. Lanes: (1) 20 ug of EJ poly A- RNA; (2) 
20 ug of EJ total RNA; (3) 20 ug of EJ focus 8.3.5 total RNA; (4) 20 ug of 
K562 poly a " RNA; (5) 20 ug of K562 total RNA and (6) 20 ug of human white 
cell total RNA. Marker RNAs are human (28S and 18S) and bacterial (23S and 
16S) ribosomal RNAs, as indicated by the closed arrow-heads. The line 
drawing is as in Figure 1-16, where B - BamHI and X - Xbal.
detected in Figure 4-lb, lane 1 is believed to be 
contaminating plasmid DNA.
The data presented above suggest that sequences
contained within the 1905 bp BamHI/Xbal probe, but not
within the BS-9 plasmid (which does not contain sequences 
homologous to the murine Harvey ras introns), are 
homologous to the abundantly transcribed human specific 
RNAs. As earlier northern data (Figure 1-16) show that the 
591 bp Sau3A probe, which is homologous to the first 591 bp
at the 5 1 end of the 1905 bp BamHI/Xbal probe, did not
hybridize to the abundant RNAs described here, whereas the 
1905 bp BamHI/Xbal probe did. These data suggest that the 
region of the 19 05 bp BamHI/Xbal probe which hybridizes to 
the abundant RNAs, must correspond to sequences within the 
upstream intron, or the 125 bp of the first intron 5' to 
the Xbal site (Figure 4-1).
To further test the possibility that sequences within 
the human c-Ha-rasl upstream intron are homologous to the 
abundant RNAs, EJ poly A+ and poly A RNAs, were denatured, 
electrophoresed on 1% denaturing gels, transferred to 
nitrocellulose paper and probed with the 377 bp Sau3A/DdeI 
fragment, mapping from positions -1079 to -702 and the 453 
bp BstNI fragment, mapping from position -62 3 to -170, 
relative to the ATG codon. These fragments were labelled by
the technique of second strand synthesis (or oligo
3 2 .labelling) using cr- P-dCTP, hybridized to identical blots
containing EJ poly A+ and poly A RNAs. Excess,
unhybridized probe was removed using high stringency
washing conditions as before. Figure 4-2 shows that only
the 377 bp Sau3A/DdeI probe detected the abundant RNAs
observed with the 1905 bp BamHI/Xbal probe (Figure 4-1).
From these data, it is clear that the region containing
sequences homologous to the abundant RNAs, present in
various human cells, lies approximately between the Sau3A
site at position -1079 and the BstNI site at position -596,
relative to the ATG codon.
In summary, the data presented in this section suggest
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Figure 4-2 Northern blot analysis of EJ RNA using probes homologous to 
the upstream intron.
RNAS were elecrophoresed on 1% denaturing gels blotted onto nitrocellulose
membranes and hybridized at 42 CQovernight, to oligo-labelled probes: (a)
37^ bp Sau3A/DdeI DNA (1.0 x 10 cpm/ug) or (b) 453 bp BstNI DNA (1.4 x
10 cpm/ug). Unhybridized probe was removed by serial washing to a final 
stringency of 0.IX SSC; 0.1% SDS, at 65°C (Materials and Methods). An 
autoradiograph of the same blot (probed with the 377 bp Sau3A/DdeI probe) 
after either 3 hours or 16 hours exposure is shown in (a) and an
autoradiograph of an identical blot (hybridized to the 453 bp BstNI probe) 
after a 16 hour exposure is shown in (b). Autoradiography was performed as 
described in Figure 4-1. Lanes were either, A — 3 ug of EJ poly A RNA or 
A — 20 ug of EJ poly A RNA. Marker RNAs are human (28S and 18S) and 
bacterial (23S and 16S) ribosomal RNAs,as indicated by the closed
arrow-heads. The line drawing is as in Figure 1-16, where the relative 
positions of probes (a) and (b) are indicated.
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that a region of approximately 456 bp, mapping to the 5' 
half of the upstream intron of the human c-Ha-rasl gene, 
contains sequences homologous to some highly transcribed, 
heterogeneously sized, non-polyadenylated RNAs. These RNAs 
range in size from approximately 30 S (_5Kb) to, at least 
as small as, 14 S (^lKb). However, these data do not 
provide information as to whether the repetitive region of 
the c-Ha-rasl upstream intron is itself, transcribed.
(b) Southern blot analysis of the region containing 
sequences homologous to the abundant RNAs
The abundant, heterogeneously sized RNA molecules, 
homologous to the 5' half of the human c-Ha-ras 1 intron 
between exon -1 and exon 1, may correspond to abundant 
transcripts derived from a few DNA sequences, or 
alternatively from repetitive DNA sequences within the 
human genome. To reserve this question, the abundance of DNA 
sequences homologous to the c-Ha-rasl upstream intron was 
determined. EJ cell line DNA, normal human colon DNA and 
mouse liver DNA were digested with either BamHI, or EcoRI 
and electrophoresed on a 0.8% agarose gel. The size 
fractionated genomic DNA was denatured, Southern blotted 
onto a GeneScreen filter and hybridized to oligo-labelled 
probes exactly as described in the GeneScreen manual. The 
probes used were, a) the 591 bp Sau3A fragment, which 
contains exon -1 mapping from positions -1669 to -1079 
relative to the ATG codon, and b) the 1146 bp Sau3A 
fragment, mapping from position -1079 to +64, which 
includes the upstream intron and 12 0 bp of exon 1. As shown 
in Figure 4-3, the 591 bp Sau3A probe hybridized to the 
appropriately sized genomic fragments expected for BamHI or 
EcoRI digested human DNA. The human c-Ha-rasl gene is found 
within an approximately 6.6 Kb BamHI fragment, or within an 
approximately 23 Kb EcoRI fragment (Pulciani et al., 1982; 
Shih and Weinburg, 1982; Goldfarb et al., 1982). This probe 
also detects a BamHI genomic fragment of approximately 3.5
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Figure 4-3 Southern blot analysis of human and mouse DNAs.
DNAs were digested with either BamHI or EcoRI, electrophoresed on 1% 
agarose gels, blotted onto GeneScreen membranes and hybridized at 42 C 
overnight to oligo-labelled probes, (al 591 bp Sau3A DNA (6.6 x 10 cpm/ug 
or (b) 1146 bp Sau3A DNA (4.0 x 10 cpm/ug). Unhybridized probe was
removed by serial washing to a final stringency of 0.lx SSPE; 0.1% SDS, at 
65 C (Materials and Methods). Autoradiography was for 36 hours in both 
cases, at -70 C with an intensifying screen. Lanes: (1) and (2) 10 ug of 
EJ DNA; (3) and (4) 10 ug of human colon DNA; (5) and (6) 10 ug of mouse 
liver DNA. The DNA in the odd numbered lanes was BamHI digested and the 
DNA in even numbered lanes was EcoRI digested. Marker DNAs (M) are Hindlll 
fragments of lamba phage DNA, whose sizes are indicated by the closed 
arrow-heads. The line drawing is as in Figure 1-16, where the relative 
positions of the probes (a) and (b) are indicated.
138
Kb in mouse liver DNA, but barely detects the approximately 
23Kb EcoRI genomic fragment, expected for mouse genomic 
DNA. When the 1146 bp Sau3A probe is hybridized to an 
identical blot, an intensely hybridizing smear is observed 
in all six lanes, even after the high stringency washes 
used to remove excess probe (the final two washes were for 
one hour each at 60°C, in 0.1X SSPE; 0.1% SDS). However, in 
shorter exposures (not shown) slightly less hybridization 
is seen with the mouse DNA. Moreover, each lane has more 
intense bands of discrete sizes, superimposed onto the 
background smear, although no two lanes have an identical 
pattern. Interestingly, these superimposed bands are 
slightly polymorphic not only between human DNA and mouse 
DNA, but also between the two different human DNAs.
This Southern blot analysis suggests that sequences 
within the upstream intron of the human c-Ha-rasl gene are 
moderately repetitive throughout the human genome and that 
these sequences have some homology with similar sequences 
within the mouse genome. The northern blot analysis of the 
preceding section suggested that sequences homologous to 
the 5' half of the upstream intron, were homologous to 
abundantly transcribed, heterogeneous RNAs in human cells, 
but not to any RNAs present in mouse (NIH 3T3) cells. 
Therefore, the moderately repetitive sequences within the 
human c-Ha-rasl upstream intron, are homologous to both 
human and mouse genomic DNAs and also to some transcribed 
human sequences, but not to any detectable transcribed 
mouse sequences.
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DISCUSSION
I. IDENTIFICATION OF THE TRANSCRIPTIONAL INITIATION SITES 
FOR THE HUMAN c-Ha-rasl GENE
Until recently, little information was known about the 
sequence motifs involved in the transcription of the 
"housekeeping" genes. For this reason early attempts 
described in this thesis to determine the 5'
transcriptional boundary of the human c-Ha-rasl gene, 
focused on the region immediately upstream from the first 
coding exon which contained a putative TATA/CAAT promoter 
region (Capon et al., 1983a; Reddy, 1983 and see Figure 2). 
SI mapping analysis of this region identified a series of 
protected fragments consisting of a major cluster of bands 
between positions -4 0 and -50, relative to the ATG
i
translational initiation codon and three minor bands mapping 
to positions -70 +2, -77 +3 and -82 +3 (Figures 1-2, 1-3,
1-4 and 1-6). However, a strong, potentially stable, stem 
loop structure was identified in the DNA sequence from this 
region. This structure could be recognised by SI nuclease, 
if it occurred in the probe molecule during SI nuclease 
digestion, and would explain the pattern of bands observed 
in the SI mapping analyses (Figure 1-5). This secondary 
structure and also the occurrence of a consensus acceptor 
splice site at position -53 (Capon et al., 1983a; Reddy, 
1983), suggested that the SI protected fragments did not 
map to genuine transcriptional initiation sites. There were 
three possible explanations for this data, 1) that the 
protected fragments observed represented genuine 
transcriptional initiation sites, 2) that they were 
artifacts due to the stem-loop structure and that the true 
5 1 termini of the c—Ha—rasl RNA are located further 
upstream of the stem-loop structure, (perhaps initiated by 
the putative TATA/CAAT promoter region), or 3) that, since 
there is an acceptor splice site at position -53 the 
protected fragments reflect a processing event in c-Ha-rasl
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RNA and that the fortuitous occurrence of the stem-loop 
structure at this site accounts for the multiple protected 
bands observed. Exonuclease VII mapping analysis (Figure
1-6) did not eliminate the first possibility, as two major 
protected fragments mapping within approximately 10 bp of 
the major cluster of SI protected fragments were also 
obtained with exonuclease VII. The possibility that 
transcripts which originated upstream of the stem-loop 
structure are not detected because of internal cleavage by 
SI nuclease at the stem-loop structure, could be eliminated 
as no protected fragments mapping upstream of the stem-loop 
structure to a region expected for the putative TATA/CAAT 
promoter were detected. In addition, SI mapping analyses 
with probes 5' end-labelled at positions upstream of the 
stem-loop structure, did not produce protected fragments 
when hybridized to EJ RNA (data not shown).
Taken together with the occurrence of an acceptor 
splice site at position -53, these analyses provide support 
for the hypothesis that the protected fragments observed 
reflect the processing of RNA at the accceptor splice site 
at position -53. The ability of the probe molecules to form 
the stem-loop structure is likely to explain the confusing 
occurrence of the multiple protected fragments. However, it 
is unlikely that this stem-loop structure has any 
functional significance, as inspection of the recently 
determined sequence of the mouse c-Ha-rasl gene, did not 
reveal any analogous structure at this region (Dr. Alan 
Balmain, personal communication). To test the hypothesis 
that a processing event does occur at the putative acceptor 
splice site, the independent technique of primer extension 
analysis was used (Figures 1-7 and 1-8). A primer from 
within the first coding exon of the c-Ha-rasl gene was 
extended through the position of the acceptor splice site 
to produce multiple extension products. These extension 
products formed a series of at least eighteen resolvable 
bands of varying intensities, which presumably map between 
191 bp to 16 bp upstream of the corresponding donor splice
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site, reported at position -1095 (Capon et al., 1983a). To 
confirm this, SI nuclease mapping probes, 5 1 end-labelled 
at positions upstream of the donor splice site, were used 
in an attempt to detect c-Ha-rasl mRNA 5 1 termini.
When probes labelled at positions 21 and 46
nucleotides upstream from the donor splice site were used 
for SI nuclease mapping analysis, protected fragments were 
detected mapping as far upstream from this site as 
approximately 210 bp (e.g. Figure 1-13). The multiple 
protected fragments observed in these experiments were 
arbitrarily grouped into five clusters (A through E) and 
three weaker fragments (Results, section I.d). It is
possible that all the bands detected in these SI nuclease 
mapping experiments correspond to genuine transcriptional 
initiation sites. This suggestion is strengthened by the 
observation that the bands in cluster A correspond to 
extension products mapping close to the extension product 
at positon -191 (relative to the donor splice site of exon 
-1) , the bands in cluster B correspond to the extension 
products between positions -179 and -162, those in cluster 
C correspond to the extension products between positions 
-148 and -13 5 and those in clusters D and E correspond to 
the extension products between positions -12 6 and -106. 
Furthermore, the three SI protected fragments mapping 
between positons -103 and -84 correspond to extension 
products between positions -101 and -86 (Results, sections
I.c and I.d, also see Figure 5-1). Hence, the upper limit 
to the size of the upstream exon (called exon -1) , as
estimated by these two independent techniques, must be at
least 191 bp. It is difficult to be certain of the precise 
location of each initiation site, in this rather complex 
situation, since at least some of the SI protected 
fragments may correspond to secondary structures in the 
probe molecule. In this respect, it has been demonstrated 
that this region has considerable secondary structure 
forming potential (Figures 1-9 and 1-10). Furthermore, some 
of the primer extension products detected, may correspond
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Figure 5-1 Summary of the RNA mapping analysis and the mutational 
analysis of the c-Ha-rasl promoter region.
a) A line drawing of the region upstream of the donor splice site (D) , 
numbered as +1. The position of the BstNI site, which approximately 
defines the 5' limit of exon -1 is shown. Also shown are the map 
positions, relative to D, of the clusters of bands (A to E) detected by SI 
nuclease mapping (SI). The primer extension products (PE) are indited by 
the arrows. The 5' termini of the extension products also identified by 
Ishii et al., (1985), are located between positions -40 and -16. b) A line 
drawing of the same region as that shown in (a) . The positions of the two 
BstNI sites which define the ends of fragment 6, used in constructs 
pRasCAT6D and pRasCAT6R, are shown. Also shown are the positions of GC 
boxes (closed boxes), where the arrow-heads give their orientations. Solid
arrow-heads indicate putative high affinity binding sites and open
arrow-heads indicate low or medium affinity binding sites, for the Spl 
transcription factor (Kadonaga et al., 1986). The roman numerals I to VI 
are demonstrated Spl binding sites, as determined by in vitro DNAse I 
footprinting studies (Ishii et al. 1986). Spl binding site number I is
shown as an open box since it does not contain a core GGGCGG
hexanucleotide repeat. Also shown below this line drawing are the positons 
of the positive (+) and negative (-) regulatory elements defined in this 
thesis, where the question marks indicate the putative elements. The wavy 
arrow indictes the direction of transcription and the possible position of 
the putative opposite-strand transcript for the "reverse-orientation" 
promoter, defined in this thesis.
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to premature termination of the reverse transcriptase. 
Nevertheless, these two independent techniques have 
independently confirmed that multiple human c-Ha-rasl mRNA 
5' termini exist approximately between 191 and 84 bp 
upstream of the donor splice site (that is, the primer 
extension products above position 2 03 nucleotides in 
Figures 1-7, 1-8 and 3-3). Thus the situation with the
human c-Ha-rasl gene is strikingly reminiscent of at least 
one other "housekeeping" gene. The HMG CoA reductase gene 
also has multiple transcription initiation sites, which in 
this case are grouped into five major clusters and several 
minor bands, spread over a region of approximately 90 bp 
(Reynolds et al., 1984).
The short distance between the c-Ha-rasl exon -1 donor 
splice site and the primer extended product mapping 
approximately 84 bp upstream of it (i.e., the position 
nearest the donor splice site to which an SI protected 
fragment mapped), prevented the independent confirmation of 
these putative initiation sites by SI mapping analysis, 
with 5' end-labelled probes. As this region contains the 
four strong extension products described by Ishii et al. 
(1985), and also some of the extension products described 
in this study, it would be desirable to confirm these 
extension products with an independent technique.
Uniformly labelled single stranded probes, offer a 
possibility for independently mapping some of the putative 
initiation sites identified by primer extension analyses 
between positions -84 and -16. To this end, the 591 bp 
Sau3A fragment mapping from position -575 to +15 relative 
to the exon -1 donor splice site, has been cloned in both 
orientations into the vector pSP64. This vector will allow 
the production of uniformly labelled single stranded RNA 
probes complimentary to this insert, by transcription with 
the bacterial SP6 RNA polymerase. These probes could then 
be used for RNase protection experiments, to detect 
transcripts originating from either strand in the region 
covered by the 591 bp Sau3A fragment. However, it is still
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unlikely that such probes could detect hybrids 
corresponding to those expected for the putative initiation 
sites of Ishii et al. (1985), as the longest hybrid 
(corresponding to site 4, see Figures 1-7 and 1-8) would 
only be 40 bp long. Therefore, in order to independently 
confirm the presence of these sites it would be necessary 
to construct a cDNA clone, which could then be used to 
design 5' end-labelled probes for SI mapping analyses. 
Ultimate proof of the occurrence of a true transcriptional 
initiation site however, depends on the identification of a 
aap structure at the 5 1 termini of the transcripts 
themselves.
The report from Ishii et al. (1985), describes the use 
of the same 51 nucleotide AluI-PvuII primer from the first 
coding exon of the human c-Ha-rasl gene, as used in this 
study. These authors suggests that the extension products 
observed above the bands numbered 13 5, 142, 147 and 159 in 
Figures 1-7 and 1-8, are derived from cross hybridization 
to transcripts from some other gene or genes. Of critical 
importance to this suggestion is their claim that when they 
sequenced their extended primer, the sequences of the 
extended products above the extension products numbered 
135, 142, 147 and 159, were different from the sequence of 
the human c-Ha-rasl genomic clone. Unfortunately, they did 
not present their sequence data. To test their suggestion, 
primer extension analyses were repeated using RNAs derived 
from c-Ha-rasl transfected cells. When EJ focus 8.3.5 RNA 
was used (Figure 1-8) , the same pattern of bands was 
observed as before for EJ and A431 cell RNAs. EJ focus 
8.3.5 cells are mouse NIH 3T3 fibroblasts, containing the 
human c-Ha—rasl gene from EJ/T24 bladder carcinoma cells, 
and they produce greatly elevated levels of human c—Ha—ras1 
RNA. The pattern of banding observed with this RNA can only 
be derived from the human c-Ha-rasl gene and not from any 
mouse genes, since no cross hybridization to mouse RNA was 
observed. Similarly, the primer extension analysis using 
RNA derived from monkey Cos7 cells transfected with the
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SV40 based vectors, pSVED.raslD and pSVOD.raslD (Figure 
3-3), must detect only RNA derived from the 6.6 Kb BamHI 
insert containing the human c-Ha-rasl gene, since only 
negligible cross hybridization to monkey Cos7 control RNA 
occurs. Since this analysis also produced the same pattern 
of bands as was observed with human EJ and A431 cell RNA, 
although with nearly a 100-fold stronger signal, it is
clear that the 5 1 transcriptional boundary of the human 
c-Ha-rasl gene is further upstream, than that proposed by 
Ishii et al. (1985).
Further support for the suggestion that the 5 1
transcriptional boundary of the human c-Ha-rasl gene is
further upstream than position -40 comes from sequence 
comparisons. Chichutek and Duesberg (1986) have compared 
the sequences of the human c-Ha-rasl gene with that of 
: various Harvey ras-containing sarcoma viruses and the rat 
c-Ha-ras2 processed pseudogene. The Harvey sarcoma virus 
(HaSV) and the rat c-Ha-ras2 processed pseudogene, were 
found to be homologous with the human c-Ha-rasl DNA 
sequence for 127 bp and 145 bp respectively, from the donor 
splice site of exon -1. Therefore, this sequence analysis 
strongly suggests that the 5 1 transcriptional boundary of 
the human c-Ha-rasl gene is at least 145 bp upstream from 
the exon -1 donor splice site, which provides further 
support for the data presented in this thesis. However, 
this sequence analysis disagrees with the estimated size of 
40 bp for exon -1, obtained by Ishii et al. (1985).
To further define the 5 1 boundary of the human 
c-Ha-rasl transcriptional unit, northern blot analyses were 
also performed (Figures 1-16 and 1-17). These analyses 
revealed that probes containing sequences up to, but not 5 1 
to, the BstNI site 196 bp upstream from the donor splice 
site, hybridized to the same sized RNA species as did 
probes homologous to the coding exons of the human 
c-Ha—rasl gene. This suggests that the 5 1 boundary of exon 
-1, must be close to the BstNI site 196 bp upstream from 
the donor splice site. This is in close agreement with the
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SI mapping and primer extension data presented in this 
thesis. Furthermore, the 195 bp MspI probe, does not 
contain any of the transcriptional initiation sites defined 
by Ishii et al. (1985), but still hybridizes to the 1.4 Kb 
c-Ha-rasl message. Thus, these data strongly suggest that 
sequences upstream of the MspI site, mapping to a position 
48 bp upstream from the donor splice site, are indeed 
transcribed and contiguous with the 1.4 Kb c-Ha-rasl 
message. In addition, this analysis was designed to allow a 
quantitative comparison of the signals detected by the 
upstream exon -1 and exon 1 probes (Figure 1-17). The 195
bp MspI probe, mapping from 243 bp to 48 bp upstream from
the exon -1 splice site, hybridized approximately 10-fold 
less efficiently to c-Ha-rasl RNA, than did the 178 bp 
PvuII probe, which had 129 bp of exon 1 sequences available 
for hybridization. This less efficient hybridization could 
suggest that the majority of c-Ha-rasl transcripts may 
initiate near the donor splice site and therefore produce a 
less stable, smaller hybrid, than the 129 bp hybrid formed 
between the 178 bp PvuII probe and the c-Ha-rasl RNA. 
Alternatively, the reduced signal with the 195 bp MspI
probe, may be explained by the demonstrated strong
secondary structure forming potential of this region 
(Figures 1-9 and 1-10), which may interfere with the 
hybridization between the probe and the c-Ha-rasl RNA.
Interestingly, northern blot analysis using probes 
specific for, exon -1 and exon 1, revealed a less abundant 
RNA species of approximately 6.0 Kb, whereas only the 
expected 1.4 Kb c-Ha-rasl transcript was observed with an 
exon 4 probe. This observation suggests that the human 
c-Ha-rasl gene, like the c-Ki-ras2 and N-ras genes, has two 
differently sized mature transcripts (Shimizu et al., 
1983a; McGrath et al., 1983; Capon et al., 1983b and Hall 
and Brown, 1985). In the case of the human N-ras gene, it 
is known that the 4.3 and 2.0 Kb transcripts, observed by 
northern blot analysis, are generated by the use of two 
polyadenylated processing signals. Furthermore, it is known
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that the 2.0 Kb transcript is less abundant since it uses 
the less efficient polyadenylation processing signal 
(Introduction, I.b). The situation is even more analogous 
to the human c-Ki-ras2 gene, where the two mature 
transcripts are 5.5 and 3.8 Kb respectively, both of which 
contain predominantly exon 4B information but also a rarer 
species containing exon 4A information (Introduction, I.b). 
Thus it is possible that the human c-Ha-rasl gene may also 
contain an alternative fourth coding exon located further 
downstream. Alternatively, the exon -1 and exon 1 probes 
may cross hybridise to a transcript from another ras-like 
gene. A similar higher molecular weight transcript has been 
noticed occasionally in mouse RNA probed with mouse 
c-Ha-rasl probes (Dr. Alan Balmain, personal communication) 
and also in human RNAs probed with human Ha-ras specific 
probes (Parada et al., 1982; Ellis et al., 1982).
The 5 1 transcriptional boundary of the human N-ras 
gene has been accurately determined (Hall and Brown, 1985). 
This gene also has an upstream non-coding exon, called exon 
-1, and SI mapping has been used to define two 
transcriptional initiation sites separated by 10 bp at 
positions 225 +2 bp and 235 +2 bp upstream from the exon -1 
donor splice site (Introduction, I.b). These data contrast 
with that for the human c-Ha-rasl gene, where the region 
containing the 5 1 transcriptional boundary has multiple 
transcription initiation sites spread over a region of 
approximately 190 bp. However, for the human N-ras gene, 
the 100 bp region containing the two transcriptional 
initiation sites is approximately 65% A + T rich, in 
contrast with the overall approximately 75% G + C richness 
of the 5' end of the c-Ha-rasl gene. Interestingly, this 
notable difference between the structures of the promoter 
regions for these two human ras genes, may indicate 
significant differences in their mechanisms of 
transcriptional regulation.
A recent report from Honkawa et al., (1987) has 
described SI nuclease mapping analyses using total and poly
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A RNAs isolated from the EJ human bladder carcinoma cell 
line. These investigators used two uniformly labelled 
single-stranded probes mapping between positions -3 64 to 
-125 or -575 to -125, relative to the donor splice site of 
exon -1. These probes detected one small cluster of 
putative transcriptional initiation sites mapping to 
positions -275, -272 and -271, and two further sites at
positions -205 and -204, relative to the donor splice site. 
However, no data from an independent technique was provided 
to support their SI mapping analyses. Data from this thesis 
provides strong evidence against the possibility that RNAs, 
initiating at the cluster centered at position -272, are 
contiguous with the c-Ha-rasl gene. Northern blot analysis 
using the 196 bp BstNI probe mapping between positions -392 
and -196 (Figure 1-17) did not detect the 1.4 Kb human 
c-Ha-rasl mRNA in poly A+ RNAs isolated from either the EJ 
or the A431 cell lines. However, the 195 bp MspI probe 
which is homologous to the upstream non-coding exon -1, 
identified here, and the 178 bp PvuII first coding exon 
probe (Figure 1-17), did hybridize to 1.4 Kb message. This 
strongly suggests that transcripts originating upstream of 
position -196 and contiguous with the c-Ha-rasl gene are 
not present in poly A+ , nor poly A RNAs, from the EJ and 
A431 cell lines, since they should be able to form at least 
an 82 bp hybrid with the 196 BstNI probe. Furthermore, 
neither the SI mapping analyses (Figures 1-10, 1-12, 1-13
and 1-14) nor the primer extension analyses (Figures 1-7,
1-8 and 3-3), presented here, provide any evidence for such 
transcripts. Additionally, analyses of the CAT activities 
produced by construct pRasCAT6D, which contains c-Ha-rasl 
sequence information between positions -392 to -196, 
revealed that although it contained all the regulatory 
sequences necessary for expression, it lacked initiation 
sites (Results, section II.b). The cluster at position 
-204, identified by Honkawa et al., (1987), is 
approximately 3 bp upstream from the most 5' transcription 
initiation site identified in this thesis. No bands mapping
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below position —204 could be observed in the autoradiograph 
shown by Honkawa et al., (1987) as the autoradiograph was 
cut off immediately below the cluster at position -204 
(that is, only 79 nucleotides upstream from the 5' end of 
their probe). A possible explanation for the mapping data 
obtained by Honkawa et al., (1987), given that the human 
c-Ha-rasl promoter region has been identified as a 
bidirectional promoter region (Results, section II.b.3), is 
that their probes may be detecting transcription initiation 
sites for the putative opposite-strand RNA molecules 
XFigure 1-15). This is supported by the fact that the 
transcription initiation sites which they identified, 
correspond to the region shown by CAT analysis to have 
"reverse-orientation11 promoter activity (Figure 2-8) . 
Furthermore, fragment 6 which contains these apparent 
transcription initiation sites, but not the transcription 
initiation sites identified in this thesis, directs the 
synthesis of CAT activity only when it is in the 
reverse-orientation relative to the CAT gene (Figure 2-8).
II. FUNCTIONAL ANALYSIS OF THE HUMAN c-Ha-rasl PROMOTER 
REGION
(a) CAT analysis defines functionally important sequences 
for the c-Ha-rasl promoter
The 591 bp Sau3A fragment, mapping from 575 bp 
upstream to 15 bp downstream of the exon -1 donor splice 
site, was assayed for promoter activity. This fragment, 
when inserted in front of the bacterial chloramphenicol 
acetyl transferase (CAT) gene, was found to direct the 
synthesis of the CAT gene product at high levels in HeLa 
cells (Figure 2—6). Thus, this analysis confirms 
functionally that the region containing the transcriptional 
initiation sites identified by RNA mapping analysis 
possesses has promoter activity. To further delineate the
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region containing transcriptional initiation sites, and to 
determine the sequences within the 591 bp Sau3A fragment 
required for promoter activity, the restriction fragments 
shown in Figure 2-lb were subcloned into the 
"promoter-less" pCO vector. Subsequent transient expression 
assays performed with these constructs revealed that in 
order to produce CAT activity, the fragments used must 
contain at least some of the transcriptional initiation 
sites identified in the region between positions -196 to 
-16 and must also contain sufficient sequence information 
upstream of these sites. Fragments 5 and 6 contain none of 
the initiation sites identified by SI nuclease mapping and 
primer extension analyses. Thus they produce no more CAT 
activity, in the direct orientation, than the 
"promoter-less" control construct, pCO. However, fragments 
7 and 8 both contain most of the transcriptional initiation 
sites (Figure 2-1) but do not produce significant CAT 
activity in the direct orientation, suggesting that neither 
of these fragments contain appropriate regulatory 
sequences. Fragment 2 contains virtually all the initiation 
sites identified, lacking only the two nearest the donor 
splice site of exon -1, and correspondingly produced only 
slightly less CAT activity than fragment 1 when in the 
direct orientation. Fragment 4, in the direct orientation, 
produced approximately 2 0% of the CAT activity observed for 
fragment 1 (Figure 2-8). In this fragment the first four 
initiation sites identified as major extension products in 
Figures 1-7 and 1-8 are missing and furthermore, it 
contains 47 bp more upstream sequence than fragment 7. Thus 
these data provide further evidence for the functional 
significance of the initiation sites, detected in this 
study, which are upstream of those described by Ishii et 
al. (1985) and suggests that these upstream initiation 
sites account for at least 20% of the human c-Ha-rasl 
transcripts. It would have been interesting to SI nuclease 
map the initiation sites used by these constructs, using 5' 
single-stranded probes, end-labelled within the CAT gene.
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Such an analysis would determine quantitatively the 
distribution of the initiation sites Used by these 
constructs and could also confirm the initiation sites 
detected by primer extension analysis with EJ and A4 31 cell 
RNA. pRasCATID is the construct of choice for such an 
analysis, as it contains the most 5 1 information and such 
information may affect the specification of the initiation 
sites used. This consideration is particularly important as 
the effect of upstream sequences on a monkey "SV40-like" 
promoter, has been reported to influence the position and 
relative efficiency of the apparent RNA initiation sites 
used by this promoter (Saffer and Singer, 1984) . Thus, 
analysis of the initiation sites used by pRasCATID may not 
eliminate the possibility that sequences upstream of 
fragment 1, or those within the CAT gene itself, may have 
an effect on transcription. It would be interesting for 
future studies to assay the effect on transcription, if 
any, of sequences upstream of fragment 1, using this 
system. To this end, the lambda Charon 9A phage designated 
T24-15A (Pulciani et al., 1982), which contains the 
c-Ha-rasl gene from the T24 human baldder carcinoma cell 
line, was obtained from Dr. Mariano Barbacid. This lambda 
phage has approximately 5 Kb of extra 5' flanking sequence, 
relative to fragment 1.
Comparisons of the CAT activity produced by fragments 
4 and 7 in the direct orientation, revealed that although 
fragment 4 contains fewer initiation sites, it produced 4 
times greater CAT activity than fragment 7 (Figure 2-8). 
Thus, it is likely that the 47 bp of extra 5' flanking 
sequence of fragment 4, contains important positive 
regulatory elements (Figure 5-1). This sequence,
232 212
CGGGGTGGGGCGGGGCCCGATGGCGCGCAGCCAATGGTAGGCCGCGC
contains a GC hexanucleotide repeat and a CAAT box
(underlined) beginning at positions -232 and -212
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respectively, relative to the exon -1 donor splice site. 
The regulatory significance of these sequence motifs within 
other promoters has been extensively discussed in the 
introduction. Interestingly, both of these sequence motifs, 
within the human c-Ha-rasl promoter region, have been shown 
in in vitro binding assays to be bound by their respective 
transcription factors, Spl (Ishii et al., 1986) and CTF 
(Jones et al., 1987). However, the data reported in the 
present study, provides the only data suggesting 
functional significance for these two sequence motifs in 
transcription of the c-Ha-rasl gene, as they occur in the 
47 bp region which had been identified as a positive 
regulatory element in CAT assays. Confirmation that this 47 
bp region has a regulatory function also comes from the 
analysis of constructs containing both fragments 8 and 9 
covalently linked to the CAT gene (Figure 2-9). Fragment 8 
produced only negligible CAT activity on its own, although 
it contains all the transcription initiation sites up to 
position -103 (Figure 2-7). However, when fragment 9 in the 
direct orientation was inserted 5' to fragment 8 in the 
construct pRasCAT8D, promoter activity was increased by 16 
fold, relative to fragment 8 in the direct orientation on 
its own. Fragment 9 contains the 47 bp regulatory region, 
plus an additional 33 bp of upstream sequence (Figure 2-9) 
and therefore provides further support for the functional 
significance of this region (Figure 5-1). When fragment 9 
was placed in the reverse orientation 5 1 to fragment 8, 
resulting in the construct pRasCAT8D9R (Figure 2-5), the 
positive regulatory effect of fragment 9 was reduced by 
less than half, relative to when it was in the direct 
orientation (Figure 2-9). This slight reduction in the 
positive regulation by fragment 9, when it is in the 
reverse orientation, is likely to be within the bounds of 
experimental error. However, as fragment 9 must have 
transcription initiation site(s) for the
"reverse-orientation" promoter (Results, section II.b), it 
is also possible that these initiation sites may be used
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less efficiently than those used by the 
"direct—orientation" promoter. Interestingly, the construct 
pRasCAT8D9D9D, containing fragment 9 as a tandem
duplication in the direct orientation (Figure 2-5), was 
also obtained. When pRasCAT8D9D9D was analysed for CAT 
activity in HeLa cells, it was found to produce over 10 
fold greater activity than pRasCATID (Figure 2-9). Thus, 
duplication of fragment 9 accounts for the highly
elevated CAT activity observed with construct
pRasCAT8D9D9D, and it is possible that the 47 bp regulatory 
region within fragment 9 is essential for this elevated 
activity. However, it is not known whether it is the Spl 
binding site, the CAAT box, both of these sequences, or 
additional sequences within the 47 bp regulatory region, 
which are responsible for the regulatory function observed. 
It is also possible that sequences within the 33 bp of 
sequence upstream of the 47 bp regulatory region may have 
an effect. To determine exactly which sequences are 
responsible, it would be necessary to mutate this region at 
a finer scale than in the analyses presented here. Addition 
of the initiation sites located downstream of fragment 4 to 
pRasCAT4D, would also be useful in determining the minimum 
sequence information required for the restoration of 
comparable promoter activity to that observed for fragment 
1. It is possible that fragment 4, plus the missing 
initiation sites, may contain sufficient regulatory 
sequences for "full" promoter activity. This seems 
unlikely since pRasCAT8D9D produced only 40% of the CAT 
activity associated with pRasCATID. Furthermore, fragment 9 
contains fewer transcription initiation sites than fragment 
4, but has 3 3 bp of additional 5 1 flanking sequence and 
produces approximately 4 times the CAT activity of fragment 
4, when both are assayed in the direct orientation. This 
result suggests that the extra 33 bp of 5 1 flanking 
sequence within fragment 9, relative to fragment 4, may 
indeed contain additional sequence information for promoter 
activity. However, the possibility that this result
reflects the presence in fragment 4 of a negative 
regulatory element cannot, at present, be excluded. 
Furthermore, support for this interpretation comes from the 
observation that fragment 9 in the direct orientation, 
produces 3 fold more CAT activity than fragment 3 in the 
direct orientation. This is despite the fact that fragment 
3 contains 28 bp more 5 f flanking sequences and 69 bp more 
3' flanking sequences. However, to confirm the presence of 
this putative 69 bp negative regulatory element, pRasCAT9D 
must be used in multiple experiments. Additionally, it 
would be of some interest, in this context, to add smaller 
subclones of fragment 4 to the 3' side of fragment 9 in 
pRasCAT9D, in an attempt to further delineate the position 
of this putative negative regulatory element. As noted 
earlier (Results, section II.b.2), the 69 bp sequence 
corresponding to the putative negative regulatory element 
has a G + C content of nearly 90% and contains 5 repeats of 
the sequence 5' G(C)n on the sense strand (where n = 4 or 
5) , four of which are tandemly repeated. It is not known 
how this unusual sequence could be exerting a negative
effect on promoter activity. It is possible to imagine
models whereby this G + C sequence may inhibit the passage
of the transcription complex, either by inhibiting to some 
extent the denaturation of the DNA strands, or by allowing 
the formation of an unusual secondary structure.
Although the CAAT box located 212 bp upstream of the 
human c-Ha-rasl exon -1 donor splice site can bind strongly 
to the CAAT-binding transcription factor, CTF (Jones et 
al., 1987), this fact itself does not necessarily implicate 
this motif in transcriptional regulation. This is 
particularly true for CTF, as it is known to be identical 
to the previously identified adenovirus DNA replication 
stimulating factor, NF-1 (Jones et al., 1987 and see
Introduction section II). Thus CTF/NF-1 may be involved in 
both transcriptional and replicational processes. It is 
likely that the positioning of the CAAT box relative to 
other regulatory elements, e.g., the TATA box, may be the
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important factor in determining whether the CAAT box has a 
transcriptional or replicational role. In this respect, it 
is interesting that the high affinity CTF binding site, 
located 200 bp upstream of the human at-globin ATG codon, 
does not contribute to a-globin gene expression, whereas 
the low affinity binding site at position -80 is fully 
functional (Jones et al., 1987).
Notable features of the entire c-Ha-rasl promoter
region are its high G + C content (the 576 bp upstream of
the exon -1 donor splice site are 80% G + C rich) and the 
eleven randomly spaced GC hexanucleotide repeats (Figure
5-lb). In this study it has been shown that a 47 bp region
which includes the GC hexanucleotide repeat centered at 
position -232 (Figure 5-lb) is important for promoter 
activity. Ishii et al. (1986) have established that the Spl 
transcription factor binds to five of these core 
hexanucleotide repeats, plus a sixth related sequence 
(Figure 5-lb). It is not known from this study if the two 
most upstream hexanucleotide repeats shown in Figure 5-lb, 
are bound by Spl. Ishii et al. (1986) have also suggested 
that only binding sites IV, V and VI are required for 
promoter activity. This suggestion was made on the basis of 
a restriction fragment, mapping from position -149 to + 90
relative to the exon -1 donor splice site (that is, it 
contains 75 bp more 3 1 sequence than any of the constructs 
used here), which produced a low level of CAT activity when 
placed in front of the bacterial CAT gene and transiently 
expressed in monkey CV1 cells. These data suggest that 
sequences between positions +15 to +90 may contain further 
positive regulatory information, as fragments 7 (position 
-196 to -31) and 8 (position -103 to +15) produced only 
negligible CAT activity when transfected into HeLa cells. 
In support of this assumption, Reddy (1983) has reported 
that deletion of sequences between the Xmalll sites at 
positions +19 and +324, drastically reduced the 
transforming activity of the c—Ha—rasl gene from T24 cells. 
However, preliminary data, obtained by comparing the levels
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of c-Ha-rasl mRNA produced by a construct containing this 
3 05 bp Xmalll deletion, with an unmutated construct, did 
not reveal any differences in the levels of mRNA produced 
when these constructs were transiently expressed in monkey 
Cos7 cells (data not shown). An alternative explanation for 
the reported CAT activity of the fragment between positions 
-149 to +90 (Ishii et al., 1986), could be because this 
fragment contains sequences known to be homologous to 
abundant non-polyadenylated RNAs (Results, section IV). It 
is possible that sequences between positions +15 and +90, 
may in fact contain information-jor transcribing a member of 
/these abundant, non-polyadenylated RNAs and that this 
information is responsible for the CAT activity observed 
for the construct described by Ishii et al. (1986).
The high G + C content and the high frequency of 
restriction endonuclease sites which contain the CpG 
dinucleotide in the promoter region of the c-Ha-rasl gene, 
suggests that this region is a good candidate for a HTF 
island (Cooper et al., 1983; Bird et al., 1985; Dr. Adrian 
Bird, personal communication). HTF islands are 
hypomethylated regions of genomic DNA known to be 
associated with unique, transcribed sequences
(Introduction, section II). Circumstantial evidence for a 
regulatory role for HTF islands comes not only from their 
usual location in the 5 1 flanking sequences of 
"housekeeping-type11 genes, but also from the observation 
that these regions are hypersensitive in the human 
glucose-6-phosphate dehydrogenase (G6DP) and the 
hypoxanthine phosphoribosyl transferase (HPRT) genes (Wolf 
and Migeon, 1980). Furthermore, in vitro methylation of the 
hamster adenine phosphoribosyl transferase (APRT) 5 1 
region inhibited expression, whereas 3 1 methylation had no 
effect (Keshet et al., 1985). However, support for the 
hypothesis that the promoter region of the human c-Ha-rasl 
gene constitutes a HTF island, awaits thorough examination 
of the methylation status of this region of the genome.
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(b) The human c-Ha-rasl promoter region functions 
bidirectionally
An unexpected result was obtained when pRasCATIR, 
containing fragment 1 in the reverse orientation (Figure
2-2), was transiently expressed in HeLa cells. This 
construct was found to produce similar CAT activity to 
pRasCATID, in which fragment 1 is in the direct orientation 
(Figures 2-6 and 2-8). Thus the human c-Ha-rasl promoter 
region contained in fragment 1 , mapping from position -575 
to +15, can function as a strong promoter directing CAT 
gene expression in HeLa cells regardless of its 
orientation. Dissection of this "reverse-orientation" 
promoter activity by subcloning the fragments shown in 
Figure 2-1 in the reverse orientation, allowed the 
sequences directing this activity to be further localized. 
Fragment 6 , mapping between positions -392 and -196, 
produced a "reverse-orientation" promoter activity slightly 
greater than that observed for fragment 1 in the reverse 
orientation. Furthermore, fragments 5, 7 and 8 produced
negligible CAT activities, confirming that the 
"reverse-orientation" promoter activity maps between 
position -392 and -196 relative to the donor splice site of 
exon -1 (Figure 2-8 and Figure 5-1). It is possible that 
the positively acting regulatory sequences previously 
identified between positions -243 and -196 for the 
"direct-orientation" promoter, may also have a regulatory 
function for the "reverse-orientation" promoter. This 
interesting possibility could be tested by a further 
mutational analysis of this region. However, it is more 
difficult to interpret CAT data determined for "reverse 
promoter" regulation, since transcription initiation sites 
have not been mapped for the "reverse-orientation" 
promoter. Therefore, it is not known whether lack of CAT 
activity, for a given fragment in the reverse-orientation, 
is the result of lack of initiation sites, regulatory 
elements, or both. Interestingly, fragment 6 has
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"reverse-orientation" promoter activity only, presumably 
because this fragment lacks transcription initiation sites 
in the direct orientation. This result suggests that the 
"reverse-orientation" promoter activity can be functionally 
uncoupled from the "direct-orientation" promoter activity. 
Fragment 3 in the reverse-orientation produced only a 
"reverse-orientation" promoter activity of approximately 
3 0% of the activity observed with fragment 6 and 
approximately 40% of the activity observed with fragment 1 
(Figure 2-8 and Figure 5-1). An almost identical result was 
obtained with fragment 9 in the reverse-orientation (Figure
2-8) . Thus j sequences important for the
"reverse-orientation" promoter activity have been deleted 
in constructs pRasCAT3R and pRasCAT9R. Hence, the minimum 
sequence information required for the "reverse-orientation" 
promoter activity must lie between positions -276 to -196. 
Finer-scale mutational techniques and RNA mapping analyses 
would be necessary to determine more accurately which 
sequences contain information for transcriptional 
initiation and which contain regulatory information, for 
the "reverse-orientation" promoter activity.
The bidirectional nature of the human c-Ha-rasl 
promoter region has raised the question of whether or not 
transcripts are initiated on the anti-sense strand in vivo. 
Furthermore, as previously discussed, it is possible that 
Honkawa et al. (1987) have actually identified an 
opposite-strand RNA in this region (Discussion, section
I). However, 5' end-labelled sense strand probes, derived 
from the restriction fragments designated 1, 2 and 4 in 
Figure 2-1, did not detect transcripts with EJ poly A+ RNA 
(data not shown). These data suggest that if opposite 
strand, divergently transcribed RNA species exist, they 
were not detected in the present study because they are 
either too short, non-polyadenylated, of low abundance or 
very unstable in vivo. This situation may be analogous to 
the mouse DHFR gene promoter region (described in the 
Introduction, section II.b), from which divergent, opposite
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strand transcription has been reported (Farnham et al., 
1985; Crouse et al., 1985). However, in this case some 
confusion exists as the opposite strand RNAs have been 
variously described as small (180-240 nucleotides), 
abundant in nuclear non-polyadenylated RNA, or as a long 
(at least 14,000 nucleotides) protein-encoding divergent 
transcription unit. Bidirectionally active promoter 
regions, other than the mouse DHFR promoter, are not 
without precedent, as the previously discussed SV40 300 bp 
and the HSV-1 700 bp control regions (Introduction, section
II) are also bidirectional promoter regions, promoting 
transcription of opposite-strand RNAs from the same 
regulatory region. Also, Saffer and Singer (1984) have 
characterized a genomic fragment from monkey DNA which was 
isolated on the basis of homology to the SV4 0 control 
region. Both strands of this "SV40-like11 fragment 
hybridized to transcripts from CV-1 monkey Kidney cells and ' 
multiple initiation sites were determined for both 
orientations of this fragment. All of these bidirectional 
promoter regions, like the human c-Ha-rasl promoter, are G 
+ C rich, contain multiple Spl binding sites and initiate 
transcription from multiple initiation sites. Furthermore, 
an indication that bidirectional promoter activity can also 
be associated with primitive genes, comes from the 
observation that both human mitochondrial promoters 
function bidirectionally (Chang et al., 1986).
Finally, it is worth speculating on putative functions 
for a divergently transcribed, opposite-strand RNA. The 
first possibility is that such an RNA may represent a 
divergently transcribed, opposite strand gene, such as is 
the case with the SV40 300 bp and the HSV-1 700 bp control 
regions. This possibilty is less likely in the case of the 
human c-Ha-rasl gene, as no opposite-strand transcripts 
could be detected in poly A+ RNA isolated from EJ and A431 
cells. However, it is possible that such a gene may not be 
transcribed in these cell lines. Another possibility is 
that divergent transcripts may help to "protect" the gene
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they are associated with, from insertional activation by 
agents such as viruses and transposons (Wood et al., 1984; 
Allan and Paul, 1984; Rohrbaugh et al., 1985). In this 
context, it is interesting that oncogenic activation of the 
c-Ha-rasl proto-oncogene by retroviral insertion into 
adjacent sequences has yet to be reported. Alternatively, 
divergent transcripts may function as trans regulatory 
elements either by interfering with gene transcripts coming 
from further upstream or by facilitating a general domain 
opening of the region containing the gene.
Ill. THE EFFECT OF THE SV40 ENHANCER ON TRANSCRIPTION OF 
THE HUMAN C-Ha-rasl GENE
When the SV40 enhancer was covalently linked 5' to the 
human c-Ha-rasl gene (Figure 3-2) it was found to enhance 
transcription approximately 10 to 20 fold in transient 
expression assays performed in Cos7 cells. Furthermore, the 
enhancer effect was not specific to a subset of 
transcription initiation sites, rather, transcription was 
increased proportionately from each initation site (Figure
3-3) . It is not known from this study whether a similar 
effect would be observed if the SV40 enhancer was located 
3* to the c-Ha-rasl gene, or if it was located at a greater 
distance. This analysis is the first direct demonstration 
that the SV40 enhancer element can affect transcription of 
genes with "housekeeping-type" promoters. Furthermore, this 
result is not surprising as similarities between the 
promoter regions of the SV40 early transcription unit and 
the c—Ha—rasl gene have already been noted (Introduction, 
section II.a). However, the enhancement effect on each 
initiation site of the c—Ha—rasl gene is rather small, 
compared to the enhancement observed when this enhancer is 
linked to genes of the "luxury-protein" class (e.g. the 
(J-globin genes) . Such CAAT and TATA box containing 
promoters are typically enhanced at least 50 to 200 fold,
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usually at a single transcription initition site (de 
Villiers et al., 1982; Wasylyk et al., 1983 and Allan et 
•I 1984) . However, as the c-Ha-rasl gene has multiple 
transcription initiation sites, the additive effect of a 10 
to 2 0 fold enhancement at each site is potentially very 
large.
An interesting implication of these results is that 
mechanisms by which transcription of this gene could be 
quantitatively increased in vivo, would include not only 
activation of a putative nearby enhancer (perhaps coupled 
with inhibition of opposite-strand transcription), but also 
insertion of an enhancer into the vicinity of the c-Ha-rasl 
gene (e.g. by translocation of retroviral insertion). This 
speculation is important because levels of elevated 
c-Ha-rasl transcription,as low as only 10 to 20 fold, have 
been implicated in carcinogenesis (Introduction, section 
I.c). Chang et al., (1982) have also shown that elevated 
expression of the c-Ha-rasl gene when it was placed under 
the control of an enhancer from a retroviral long terminal 
repeat, resulted in tumourigenic transformation of murine 
NIH 3T3 cells.
IV. THE UPSTREAM INTRON CONTAINS REPETITIVE SEQUENCES
Northern blot analysis of c-Ha-rasl RNA indicates that 
sequences within the upstream intron are homologous to 
abundantly transcribed species of RNA. These sequences map 
between the Sau3A site and the BstNI site, at positions 
-1079 and -623 respectively, relative to the ATG codon (the 
donor splice site of exon —1 is at position -1094). The 
abundant RNAs observed, produced a strong band slightly 
larger than the 28 S ribosomal RNA (rRNA) marker and other 
prominent bands at approximately 26 S, 20 S, 17 S and 14 S, 
which were superimposed on a relatively uniform smear. 
These bands do not correspond to the sizes expected for 
ribosomal RNAs and were observed with human total and poly
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A RNAs (Figures 4-1 and 4-2), but only to a limited
extent with human poly A RNA (Figure 4-2). This suggests
that the transcribed sequences homologous to the 5 ' half of 
the c-Ha-rasl upstream intron are mainly present in the 
poly A RNA fraction. This observation may be explained if 
the human c—Ha—rasl intronic sequences are fortuitously 
homologous to ribosomal RNAs. However, the banding pattern 
was not observed with EJ focus 8.3.5 total RNA, which is
essentially mouse NIH 3T3 total RNA containing elevated
levels of the human c-Ha-rasl transcript. Therefore the 
human c-Ha-rasl upstream sequences, between positions
-1079 to -623, cannot be homologous to mouse ribosomal 
RNAs. Since ribosomal RNAs are known to be highly 
homologous between all organisms (Pace et al., 1986), it 
would be surprising that if the banding pattern is caused 
by ribosomal RNA species, that a similar pattern is not 
observed with EJ focus 8.3.5 total RNA. An explanation
could be that there are sequence differences between mouse 
and human ribosomal RNAs and that the homology to the human 
c-Ha-rasl intron fortuitously occurs at such a divergent 
region. Torczynski et al. (1985) have cloned and sequenced 
a human 18 S ribosomal RNA gene. Comparisons between the 
human and mouse ribosomal RNAs reveal that the only
significant region of divergence between the two occured 
between the 5' terminal forty nucleotides which corresponds 
to the external transcribed spacer sequence. A less
significant divergent region was also identified between 
bases 190 to 300, which was due to G or C single base 
insertions or deletions. Overall, the human and mouse 18 S 
ribosomal RNAs are 98.8% homologous to each other. 
Unfortunately no sequence information is available on the 
human 28 S ribsomal RNA sequence. Therefore, it is possible 
that if the bands below the major band in Figures 4-1 and
4-2 correspond to degradation products, that differences 
between mouse and human 28 S ribosomal RNA sequences could 
explain the differences observed when mouse and human RNAs 
are probed with the c-Ha-rasl upstream intron sequences.
However, the bands below the major band (slightly greater 
than 28 S in Figures 4-1 and 4-2) have been observed with 
independent RNA preparations, in three separate 
experiments. This suggests that they indeed correspond to 
genuine discrete RNA species. Thus not all of these bands 
could be caused by hybridization to ribosomal RNA species, 
but rather to other predominantly G + C rich, mainly 
non-polyadenylated, human specific species of RNA.
The Southern blot analysis presented in Figure 4-3 
suggested that sequences within the human c-Ha-rasl 
upstream intron are also moderately repetitive. The 
repetitiveness of this region could be caused by fortuitous 
homologies to other G + C rich regions throughout the human 
genome. Furthermore, this Southern blot analysis also 
established that the sequences within the upstream intron 
of the human c-Ha-rasl gene are homologous to sequences 
within the mouse genome, although the previous northern 
blot analyses established that homologous transcripts are 
not produced. These data suggest an alternative explanation 
for the origin of the homology to both genomic DNA and 
human RNAs. The homology could be due to a family of 
moderately repetitive G + C rich sequences in the human 
genome, which are transcribed. This homology could 
be fortuitous, or the sequences in the 5 1 portion of the 
c-Ha-rasl upstream intron could represent a member of this 
putative family. However, mouse genomic DNA hybridized 
nearly as strongly to these sequences, as did human genomic 
DNA and computer searches of gene banks and the 22 Kb of 5' 
sequence flanking the human epsilon globin gene did not 
reveal any strong homologies. Finally, the recent cloning 
and sequencing of the mouse c-Ha-rasl gene (Dr. Alan 
Balmain, personal communication), revealed that while 
approximately the 3 1 half of the mouse and human upstream 
introns are highly homologous, the 5 1 half of these introns 
diverge considerably. The lack of sequence homology in the 
5 1 portions of these introns suggests that these sequences 
may not be functionally significant. However, these
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sequence comparisons contrast somewhat with data reported, 
but not shown, by Reddy (1983). Reddy describes a 3 05 bp 
deletion between two Xmalll sites (mapping between 
positions +19 to +324 relative to the donor splice site of 
exon - 1 , whereas the repetitive region has been mapped here 
between positions +15 to +47$ which is believed to 
drastically reduce the transforming activity of the 
c-Ha-rasl oncogene isolated from the human bladder cell 
line ,T24. It is interesting that the repetitive 456 bp 
region identified in this thesis, closely corresponds to 
the 305 bp deletion decribed by Reddy (1983). Additionally, 
comparisons between the CAT activities produced by 
constructs described in this thesis and the CAT construct 
described by Ishii et al. (1986), which assayed a c-Ha-rasl 
promoter fragment containing sequences between positions 
-149 to +90, suggested that sequences between positions +15 
to +90 may contain a positive regulatory element(s).
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CONCLUSIONS
1) A non-coding exon (termed exon -1) has been identified 
for the human c-Ha-rasl gene. Exon -1 is located 1049 bp 
upstream of the ATG codon and consists of an approximately 
2 00 bp region containing multiple transcription initiation 
sites. The existence of exon -1 and the locations of the 
transcription initiation sites have been confirmed by a 
variety of RNA mapping techniques (SI nuclease mapping, 
primer extension and northern blot analysis) and 
functionally by CAT analysis. The implied intron between 
exon -1 and the ATG codon, is bounded by consensus donor 
and acceptor splice sites, at positions -1094 and -54 
respectively, relative to the ATG codon.
: 2) Mutational analysis of exon -1 and the region of 
approximately 400 bp upstream of the most 5 1 transcription 
initiation site, using the CAT system, has identified a 
regulatory element mapping between positions -243 to -196, 
relative to the donor splice site. This element 
up-regulates transcription by approximately 4 fold and
contains CAAT and GGGCGG sequence motifs, both of which are
\ > i  . . .
known t o ^  bound by their respective DNA binding proteins
(Ishii et al., 1986; Jones et al., 1987). A second positive
regulatory element may also exist between positions -276
and -243, which appears to up-regulate transcription at
least 2 fold. However, the evidence for this second
regulatory element is more tentative. A putative negative
regulatory element has also been identified. This element
is located between positions -103 and -34, relative to the
donor splice site and appears to down regulate promoter
activity by up to 4 fold.
3) A further promoter region has been located by CAT 
analysis which maps between positions —392 to —196, 
relative to the donor splice site. This promoter has been 
shown to direct transcription in the opposite-orientation,
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relative to the c-Ha-rasl gene. The arrangement of the 
bidirectional promoter, situated on either side of a 
positive regulatory region (Figure 1-5), is strikingly 
similar to the 3 00 bp SV40 control region.
4) Insertion of the SV40 enhancer 5 1 to the c—Ha—rasl gene 
was shown to increase transcription of each c-Ha-rasl
transcript by approximately 10 to 2 0 fold. This is the 
first direct demonstration that the SV40 enhancer can 
influence a "housekeeping-type" gene. Although each
initiation site is increased in activity by only 10 to 20 
fold, the total activity of the gene in terms of the 
protein produced is potentially very large. Insertion, or 
activation of a nearby enhancer could therefore be an 
important event in the oncogenic activation of this gene.
5) A region corresponding to the 5 1 half of the intron 
between exon -1 and exon 1 (between positions +15 to +471, 
relative to the donor splice site) was found to be 
moderately repetitive in the human and mouse genomes and 
homologous to abundant human, non-polyadenylated RNAs. 
These RNAs are sized between 29 S to 10 S. It is not known
if this region of the intron between exon -1 and exon 1 is
itself transcribed, or what its function, if any might be. 
Sequence comparisons with the "equivalent" region of the 
mouse c-Ha-rasl gene, did not reveal any homology.
6) In summary, the work reported in this thesis has 
identified the major region of transcription initiation, 
for this important oncogene, and has suggested several 
mechanisms by which quantative regulation of this gene can 
be achieved. These may have important implications for the 
regulation of this gene and its oncogenic activation in 
v i v o .
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